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Synthesis of carbon-analogues of 2,4-diaminopyrimidine and
2-oxo-4-aminopyrimidine homo-DNA nucleosides 
Abstract
This doctoral work is divided into two sections: the first part deals with the synthesis of
carbon-analogues of 2,4-diamonpyrimidin homo-DNA nucleosides and 2-oxo-4- aminopyrimidin
homo-DNA nucleosides. In the second part homo-DNA-oligonucleotides containing carbon-analogues
of the 2,4-diaminopyrimidine homo-DNA nucleoside were investigated. Starting from known stabilities
of exocyclic amino nucleosides (EAN's) a model compound was designed to increase the stability of
these compounds. By replacing the exocyclic nitrogen by a carbon the unstable aminohemiacetal was
replaced by a stable cyclic ether. Due to the fact that EAN's undergo a furanose-pyranose isomerization
and the pyranose is thermodynamically favored species, a pyranoside analogue of DNA, the homo-DNA
was evaluated. In the first part of the thesis a series of homo-DNA-carbon-nucleosides were prepared
from tris-O-acetyl-D-glucal. The key step of the synthesis was the diastereoselective preparation of the
β-C-glycoside, as shown below. The β-C-glycoside was accessible by a rearrangement from the
α-C-glycoside under Lewis acidic conditions. ii In the second part of the thesis the carbon-analogue of
the 2,4-diaminopyrimidinehomo- DNA-nucleoside was incorporated by solid phase synthesis in
homo-DNAoligonucleotides. It was shown that an adenine(A)-2,4-diaminopyrimidine(D) exchange near
the 4' end in the self complementary octamer ddGlc[UX(UA)3] did not result in a enthalpic
destabilization of the Watson-Crick A-U base pairing (ΔH -165 kJ/mol (D); -163 kJ/mol (A)). The
entropic destabilization was explained by the increase of rotational degrees of freedom of the
D-nucleoside compared to the A-nucleoside. An exchange of an A nucleoside in a central position of a
selfcomplementary homo-DNA oligonucleotide with the general formula ddGlc[(UA)n] resulted in a
much stronger influence on the homo-DNA duplex stability compared to the A-D exchange near the 4'
end: For the 14-mer ddGlc[(UA)3UD(UA)3] an inter- or intramolecular duplex formation was found
dependant on the oligonucleotide concentration. An investigation of an A-D exchange on the stability of
the reverse Hoogsteen A-A pairing resulted in no enthalpic destabilization by an A-D exchange:
Compared to the octamer ddGlc[A8] even an enthalpic stabilization was found if two reverse Hoogsteen
A-A base pairings were replaced by two A-D base pairings (ΔH -208 kJ/mol (ddGlc[A8]); ΔH -322
kJ/mol ddGlc[A2DA5]), although the enthalpic stabilization was overcompensated by an entropic
destabilization (ΔS -520 J/(mol*K) (ddGlc[A8]); ΔS -917 J/(mol*K) ddGlc[A2DA5]). Also in the
nonamer ddGlc[UD8], in which all A nucleosides were replaced against D nucleosides, an interaction
was still detectable. iii Further investigations were performed with non selfcomplementary
oligonucleotides of the general formula ddGlc[CAUA-X1-GUGA] und ddGlc[UCAC-X2-UAUG].
Comparisons of the Watson-Crick A-U (X1 = A; X2 = U) base pairing with the corresponding D-U base
pairing (X1 = D, X2 = U) were performed. Further studies were performed to study the influence of a
A-D exchange in the following base pairings A-A (X1 = A; X2 = A to X1 = D; X2 = A); A-C (X1 = A;
X2 = C) and A-G (X1 = A; X2 = G). All these investigations resulted in a enthalpic destabilization and
entropic stabilization of the duplex formation.
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ABSTRACT OF THE DISSERTATION 
Synthesis of Carbon-Analogues of 2,4-Diaminopyrimidine and 2-Oxo-4-Aminopyrimidine 
Homo-DNA Nucleosides 
 
Study of Homo-DNA Oligonucleotides Containing Carbon-Analogues of the 2,4-
Diaminopyrimidine Nucleotide 
by 
Michael Löpfe 
University of Zurich, 2008 
Professor Jay S. Siegel, Chair 
 
This doctoral work is divided into two sections: the first part deals with the synthesis 
of carbon-analogues of 2,4-diamonpyrimidin homo-DNA nucleosides and 2-oxo-4-
aminopyrimidin homo-DNA nucleosides. In the second part homo-DNA-oligonucleotides 
containing carbon-analogues of the 2,4-diaminopyrimidine homo-DNA nucleoside were 
investigated. 
Starting from known stabilities of exocyclic amino nucleosides (EAN’s) a model 
compound was designed to increase the stability of these compounds. By replacing the 
exocyclic nitrogen by a carbon the unstable aminohemiacetal was replaced by a stable cyclic 
ether. Due to the fact that EAN’s undergo a furanose-pyranose isomerization and the pyranose 
is thermodynamically favored species, a pyranoside analogue of DNA, the homo-DNA was 
evaluated. In the first part of the thesis a series of homo-DNA-carbon-nucleosides were 
prepared from tris-O-acetyl-D-glucal. The key step of the synthesis was the diastereoselective 
v 
  
 
  
preparation of the β-C-glycoside, as shown below. The β-C-glycoside was accessible by a 
rearrangement from the α-C-glycoside under Lewis acidic conditions. 
 
In the second part of the thesis the carbon-analogue of the 2,4-diaminopyrimidine-
homo-DNA-nucleoside was incorporated by solid phase synthesis in homo-DNA-
oligonucleotides. It was shown that an adenine(A)-2,4-diaminopyrimidine(D) exchange near 
the 4’ end in the self complementary octamer ddGlc[UX(UA)3] did not result in a enthalpic 
destabilization of the Watson-Crick A-U base pairing (∆H -165 kJ/mol (D); -163 kJ/mol (A)). 
The entropic destabilization was explained by the increase of rotational degrees of freedom of 
the D-nucleoside compared to the A-nucleoside. An exchange of an A nucleoside in a central 
position of a selfcomplementary homo-DNA oligonucleotide with the general formula 
ddGlc[(UA)n] resulted in a much stronger influence on the homo-DNA duplex stability 
compared to the A-D exchange near the 4’ end: For the 14-mer ddGlc[(UA)3UD(UA)3] an 
inter- or intramolecular duplex formation was found dependant on the oligonucleotide 
concentration. 
An investigation of an A-D exchange on the stability of the reverse Hoogsteen A-A 
pairing resulted in no enthalpic destabilization by an A-D exchange: Compared to the octamer 
ddGlc[A8] even an enthalpic stabilization was found if two reverse Hoogsteen A-A base 
pairings were replaced by two A-D base pairings (∆H -208 kJ/mol (ddGlc[A8]);  ∆H -322 
kJ/mol ddGlc[A2DA5]), although the enthalpic stabilization was overcompensated by an 
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entropic destabilization (∆S -520 J/(mol*K) (ddGlc[A8]); ∆S -917 J/(mol*K) ddGlc[A2DA5]). 
Also in the nonamer ddGlc[UD8], in which all A nucleosides were replaced against D 
nucleosides,  an interaction was still detectable. 
Further investigations were performed with non selfcomplementary oligonucleotides 
of the general formula ddGlc[CAUA-X1-GUGA] und ddGlc[UCAC-X2-UAUG]. 
Comparisons of the Watson-Crick A-U (X1 = A; X2 = U) base pairing with the corresponding 
D-U base pairing (X1 = D, X2 = U) were performed. Further studies were performed to study 
the influence of a A-D exchange in the following base pairings A-A (X1 = A; X2 = A to X1 = 
D; X2 = A); A-C (X1 = A; X2 = C) and  A-G (X1 = A; X2 = G). All these investigations 
resulted in a enthalpic destabilization and entropic stabilization of the duplex formation. 
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ZUSAMMENFASSUNG DER DISSERTATION 
 
Synthese von Kohlenstoff-Analogen des 2,4-Diaminopyrimidin und 2-Oxo-4-
Aminopyrimidin Homo-DNA Nukleosides.  
 
Untersuchung von Homo-DNA Oligonukleotiden welche ein Kohlenstoff-Analogon des 2,4-
Diaminopyrimidin beinhalten 
von  
Michael Löpfe 
Universität Zürich, 2008 
Prof.  Dr. Jay S. Siegel, Vorsitz 
 
Die vorliegende Doktorabeit ist in zwei Abschnitte gegliedert: Die Synthese von 
Kohlenstoff-Analogen von 2,4-Diaminopyrimidin homo-DNA Nukleosiden und 2-Oxo-4-
aminopyrimidin homo-DNA Nukleosiden einerseits sowie die Untersuchung von Homo-
DNA-Oligonukleotiden, die das Kohlenstoff-Analogon des 2,4-Diaminopyrimidin homo-
DNA Nukleosids beinhalten. 
 Ausgehend von bekannten Untersuchungen zu Stabilitäten von exozyklischen 
Aminonukleosiden (EAN’s) wurde eine Modellverbindung entworfen, in welcher ein für die 
Instabilität der Verbindungen verantwortlicher Stickstoff durch ein Kohlenstoff ersetzt wird 
und somit die Aminoacetalgruppe durch einen stabilen cyclischen Ether ersetzt wurde. 
Aufgrund der Tatsache dass EAN‘s zu einer Furanose-Pyranose Isomerisierung tendieren und 
im thermodynamischen Gleichgewicht bevorzug als Pyranose vorliegen, wurde ein 
pyranosides Analogon der DNA, die sogenannte homo-DNA untersucht. Im ersten Teil der 
Arbeit wurde ausgehend von Tris-O-acetyl-D-glucal eine Serie von homo-DNA-C-
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Nukleosiden hergestellt.  Der zentrale Punkt der Synthese war die diastereoselektive 
Herstellung des β-C-Glycosids, das durch eine in situ Umlagerung vom α-C-Glycosid unter 
Lewis-Säurenkatalyse erhalten wurde.  
 
Im zweiten Teil der Arbeit wurde das gemäss obiger Synthese erhaltene Kohlenstoff 
Analogon des 2,4-Diaminopyrimidin-homo-DNA Nukleosids (D) mittels Festphasensynthese 
in homo-DNA Oligonukleotide eingebaut. Es wurde gezeigt, dass im selbstkomplementären 
Oktamer ddGlc[UX(UA)3] der Einfluss eines Adenin(A)-D Austausches nahe des 4‘-Endes 
des Oligos zu keiner enthalpischen Destabilisierung der Watson-Crick Basenpaarung führt 
(∆H -165 kJ/mol (D); -163 kJ/mol (A)). Eine gefundene entropische Destabilisierung erklärt 
sich durch erhöhte Rotationsfreiheitsgrade des D-Nukleosids gegenüber dem A-Nukleosid. 
Durch eine Integration des D-Nukleosids in die Mitte eines selbstkomplementären 
Oligonucleotides und somit das Aufeinandertreffen zweier U-D Basenpaarungen erfolgt eine 
drastische Beeinflussung der Duplexstabilität: Für das selbstkomplementäre 14-mer 
ddGlc[(UA)3UD(UA)3] wurde eine von der Oligonucleotidkonzentration abhängige inter- 
bzw. intramolekulare Duplexbildung gefunden. 
Eine Untersuchung eines A-D Austausches auf die Stabilität der reverse Hoogsteen A-
A Paarung zeigte, dass auch diese Baasenpaarung keine enthalpische Destabilisierung durch 
einen A-D Austausch erfährt: Gegenüber dem Oktamer ddGlc[A8] trat beim Austausch zweier 
A-A gegen A-D Paarung eine enthalpische Stabilisierung auf (∆H -208 kJ/mol (ddGlc[A8]);  
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∆H -322 kJ/mol ddGlc[A2DA5]), welche allerdings durch eine entropische Destabilisierung 
überkompensiert wurde (∆S -520 J/(mol*K) (ddGlc[A8]); ∆S -917 J/(mol*K) ddGlc[A2DA5]). 
Zusätzlich wurde gezeigt, dass selbst im extremen Fall des ddGlc[UD8], in welchem alle A 
gegen D ausgetauscht wurden, noch eine Interaktion auftritt. 
Weitere Untersuchungen nicht selbstkomplementärer Oligonucleotide der allgemeinen 
Form ddGlc[CAUA-X1-GUGA] und ddGlc[UCAC-X2-UAUG] wurden durchgeführt. Dabei 
wurde sowohl ein Vergleich eines Watson-Crick A-U (X1 = A; X2 = U) Basenpaares mit dem 
ensprechenden D-U (X1 = D, X2 = U) wie auch ein A-D Austausch in den folgenden 
Basenpaarungen A-A (X1 = A; X2 = A zu X1 = D; X2 = A); A-C (X1 = A; X2 = C) sowie A-G 
(X1 = A; X2 = G) untersucht. Diese Untersuchungen resultierten alle in einer enthalpischen 
Destabilisierung und einer entropischen Stabilisierung der Duplexbildung bei einem A-D 
Austausch. 
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1. Introduction 
 
„Wir wollen nicht nur wissen wie die Natur ist (und wie ihre Vorgänge ablaufen), sondern 
wir wollen auch nach Möglichkeit das vielleicht utopisch und anmassend erscheinende Ziel 
erreichen, zu wissen, warum die Natur so und nicht anders ist“ [Albert Einstein].1 [We not only 
want to know how nature is (and how her processes are carried through), but also want to reach, if 
possible, a goal which may seem utopian and presumptuous, namely, to know why nature is such 
and not otherwise]. 
 
1.1 Biological functions of nucleosides, nucleotides and nucleic acids2 
 
Nucleic acids were first isolated in 1869 by Miescher in Hoppe-Seyler’s laboratory at the 
University of Tubingen, Germany, from the nuclei of leukocytes found on discarded surgical 
bandages,3 and the presence of nucleic acids in other cells was demonstrated within a few years. 
The tetranucleotide hypothesis4 by Levene was only widely accepted in the 1930s and 1940s. This 
hypothesis predicted that nucleic acids have a monotonously repeating sequence of all four bases 
and were, therefore, not suspected of having a genetic function.  
In 1928, Griffith, a British medical officer made a startling discovery: injecting a mixture 
of heat-killed virulent S pneumococci (Diplococcus pneumoniae) and non-pathogenic R 
pneumococci in mice resulted in death of most of the mice.5 S pneumococci were found in the 
blood of the dead mice, indicating a transformation from the otherwise innocuous R pneumococci 
to the S form, induced by the coinjected heat-killed S pneumococci. However, the nature of the 
transforming principle remained unclear. 
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Fig. 1  Avery’s pneumococci. Large glistening colonies are virulent S-type pneumococci resulting 
from transformation of non-pathogenic R-type pneumococci (smaller colonies) by DNA from 
heat-killed S pneumococci.6 
 
In 1944, Avery, MacLeod, and McCarty reported that the transforming principle is DNA.6 The 
conclusion was based on the observation that the transforming principle had all the physical and 
chemical properties of DNA, contained no detectable protein, was unaffected by enzymes that catalyze 
the hydrolysis of proteins and RNA, but was totally inactivated by treatment with an enzyme that 
catalyzes the hydrolysis of DNA. 
Chargaff, at the end of the 1940s, refuted the tetranucleotide hypothesis by accurate 
determination of DNA base ratios and thereby indicated that DNA could be a complex molecule 
that is a requirement for genetic functions. 7  
Brinster demonstrated in 1982 that eukaryotes are also subject to transformation by DNA.8 
By microinjection of DNA bearing the gene for rat growth hormone into the nuclei of fertilized 
mouse eggs and implantation of these eggs into the uteri of foster mothers. The resulting 
transgenic mice had high levels of rat growth hormone in their serum and grew to nearly twice the 
weight of their normal littermates. 
Today it is known that nucleotides are biologically ubiquitous substances. Besides their 
central role in both the storage and expression of genetic information as monomeric units of 
nucleic acids, they participate in many biochemical processes:2 
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 3  
1.) Nucleoside triphosphates (especially ATP) are the end products of the majority of energy-
releasing pathways and the substances whose utilization drives most energy-requiring 
processes. 9 
2.) Many pathways are partially regulated by the levels of nucleotides (ATP, ADP) and 
certain nucleotides function as intracellular signals that regulate the activities of numerous 
metabolic processes.10 
3.) In many enzymatic reactions nucleotide derivatives, such as nicotinamide adenine 
dinucleotide, 11 flavin adenine dinucleotide, or coenzyme A, are required participants. 
4.) As components of the ribozymes, nucleotides are catalytically active.12 
 
1.2 DNA structure  
 
1.2.1 Nucleosides and nucleotides2,13 
 
Nucleic acids consist of a linear array of monomers, called nucleotides. Nucleotides are 
the phosphate esters of nucleosides. The phosphate group may be bonded to the C5’- (5’-
nucleotide) or to the C3’-hydroxygroup (3’-nucleotide). Nucleotides are constructed of three 
components: a nitrogen-containing heterocyclic base (major purines: adenine (A) and guanine (G), 
major pyrimidines: cytosine (C), uracil (U) (U occurs mainly in RNA) and thymine (T) (5-
methyluracil, occurs mainly in DNA), a pentose sugar (D-ribose in RNA, 2-deoxy-D-ribose in 
DNA), and a phosphate residue. The pentose is locked into a five-membered furanose ring by the 
bond from the C1’ of the sugar to N1 of C, U, T or to N9 of A or G. This bond is on the same side 
of the sugar ring as the C4’-C5’ bond and is defined as a β-glycosylic linkage (vs. α-glycosylic 
linkage with the C4’-C5’ bond and the nucleobase on different sides of the sugar ring) (Fig. 2). 
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                 A                               G                                    C                         T 
 
Fig. 2 Structures of the four major deoxynucleosides found in DNA: deoxyadenosine (A), 
deoxyguanosine (G), deoxycytidine (C) and deoxythymidine (T) in their dominant tautomeric 
forms with the IUPAC numbering systems for purines, pyrimidines and the 2-deoxy-D-ribose. 
 
1.2.2 Physical properties of nucleosides and nucleotides 
 
1.2.2.1 Ionization13  
 
The acid-base behavior of nucleotide is an important physical characteristic, because the 
acid-base behavior determines the charge and also the tautomeric structure which is responsible 
for the donation and acceptance of hydrogen bonds (Table 1).  
 
Base (site of protonation) Nucleoside 3’-Nucleotide 5’-Nucleotide 
Adenine (N1) 3.5 3.7 3.9 
Cytosine (N3) 4.2 4.4 4.6 
Guanine (N7) 3.3 - - 
Guanine (N1) 9.4 9.8 10.0 
Thymine (N3) 9.9 - 10.5 
Uracil (N3) 9.4 10.0 10.1 
 
Table 1 pKa values for bases in nucleosides and nucleotides (concentration 5-5 M to 10-5 M, data 
relate to 20° C and zero salt concentration)14 
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All of the bases are uncharged in a pH range of 5-9. The nucleotide phosphates possess 
pKa values of around 1 and 7 (in the case of the monoester) for the first and second deprotonation, 
respectively. The three amino bases, A, C, and G, become protonated on one of the ring nitrogens 
rather than the exocyclic amino group.15  
 
1.2.2.2 Tautomerism of bases 
 
Heterocyclic molecules in solution frequently yield a mixed population of species in rapid 
equilibrium when hydrogen atoms attached to nitrogens are able to migrate to other, free nitrogens 
or to keto oxygens within the same molecule.16 This kind of tautomerism depends mostly on the 
dielectric constant of the solvent and the pKa of the respective heteroatoms.17 By tautomeric 
changes, uracil and guanine, in the enol form, simulate cytosine and adenine, and cytosine and 
adenine in the imino form may substitute for uracil and guanine (Fig. 3). 
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Fig. 3 Keto-enol and amine-imine tautomerism in nucleoside bases (arrows denoted A and D 
symbolize acceptor and donor site, respectively). 
 
Since this kind of metamorphosis of hydrogen bond acceptor and donor site would be 
problematic for a self-replicating system, this tautomerism has been intensively studied by UV, 
IR, NMR, crystallographic,18,17 and quantum chemical methods.19 The results can be summarized 
in the following way: the main tautomeric forms of the naturally occurring bases are the amino 
and the keto configuration (Fig. 2). 
 
1.2.2.3 Sugar-phosphate chain conformation 
 
The conformational structure of a nucleotide within a nucleic acid is defined by the 
torsion angles α,  β, γ, δ, ε, ζ in the phosphate backbone, ν0 to ν4 in the furanose ring, and χ for 
the glycosylic bond (Fig.4). Many of these torsion angles are interdependent, resulting in a 
simpler description of the nucleotides, defined by four parameters: the sugar pucker, the syn-anti 
conformation of the glycosylic bond, the orientation of C4’-C5’, and the shape of the phosphate 
ester bonds. 
The puckering of the furanose ring is described by the major displacement of C2’ and C3’ 
from the plane defined through C1’-O4’-C4’. If the endo displacement of C2’ is greater than the 
exo displacement of C3’, the conformation is called C2’-endo and so on (the endo face of the 
furanose is on the same side as C5’ and the nucleobase; the exo face is on the opposite side to the 
base) (Fig.4, right). Because these sugar puckers are located in the north (N) and south (S) 
domains of the pseudorotation cycle of the furanose ring, C2’-endo is also called S(outh) and C3’-
endo N(orth). The energy barrier of the N and S conformation is less than 20 kJ/mol, resulting in a 
rapid equilibrium in solution, which follows the path of pseudorotation with O4’-endo as the 
transition state. 20 
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Torsion angle Atoms involved 
α (n-1)O3’-P-O5’-C5’ 
β P-O5’-C5’-C4’ 
γ O5’-C5’-C4’-C3’ 
δ C5’-C4’-C3’-O3’ 
ε C4’-C3’-O3’-P 
ζ C3’-O3’-P-O5’(n+1) 
  
χ O4’-C1’-N1-C2 (pyrimidines) 
 O4’-C1’-N9-C4 (purines) 
ν0 C4’-O4’-C1’-C2’ 
ν1 O4'-C1’-C2’-C3’ 
ν2 C1’-C2’-C3’-C4’ 
ν3 C2’-C3’-C4’-O4’ 
ν4 C3'-C4’-O4’-C1’ 
 
Fig.4  Notation of torsion angle (according to IUPAC) for polynucleotide chains20 and structures 
for the C2’-endo (S) and C3’-endo (N) preferred sugar puckers. 
 
The plane of the nucleobase is almost perpendicular to that of the sugar. The bases may 
occupy two principal orientations. The anti conformer has the smaller H-6 (pyrimidine) or H-8 
(purine) atom above the sugar ring, while the syn conformer has the larger O-2 (pyrimidine) or N-
3 (purine) in that position. For pyrimidines it is only possible to occupy a narrow range of anti 
conformations while purines are found in a wider range of anti conformations which can even be 
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extended into the high-anti range (for 8-azapurines such as formycin)21 (Fig. 5). One exception to 
the general preference for anti conformation is reported: guanine prefers the syn glycoside in 
mononucleotides, in alternating oligomers like dRib[CpGpCpG], and in Z-DNA.22 
 
 
O
HO
HO
N
N
NH2
O
O
O
HO
N
N
H
N OH2N
PO
O--O
anti-dC syn-dGMP  
 
Fig. 5 Anti and syn conformational ranges for glycosylic bonds (χ) in pyrimidine (left) and purine 
(right) nucleosides and anti conformation of deoxycytidine (lower left) and syn conformation of 
deoxyguanosine-5’-phosphate (lower right).23 
 
For the C4’-C5’ bond, the favoured conformers are the synclinal (sc) and antiperiplanar 
(ap) rotamers. For pyrimidine nucleosides, +sc is preferred, while, for purine nucleosides, +sc and 
ap are equally populated. However, in the nucleotides, the 5’-phosphate reduces the 
conformational freedom and the dominant conformer is +sc (for γ) (Fig. 6). For the syn guanine, a 
value in the ap region was found.22  
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Fig. 6 Preferred nucleotide conformations: +sc for C4’-C5’ (left); ap for C5’-O5’ (centre); and 
ap/-ac for C3’-O3’ (right). 
 
Phosphate diesters are tetrahedral at phosphorus and show antiperiplanar conformations 
for the C5’-O5’ bond. Similarly, the C3’-O3’ lies in the antiperiplanar to anticlinal range, 
resulting in the use of a virtual bond concept, in which the chains P5’-O5’-C5’-C4’ and P3’-O3’-
C3’-C4’ can be analysed as rigid, planar units linked at phosphorus and at C4’. 
 
1.2.2.4. Primary structure of DNA 
 
Early work from Klein and Thannhauser established that the primary structure of DNA 
has each nucleoside joined by a phosphodiester from its 5’-hydroxyl group to the 3’-hydroxyl 
group of one neighbour and by a second phosphodiester from its 3’-hydroxyl group to the 5’-
hydroxyl of its other neighbour.24 There are no 5’-5’ or 3’-3’ linkages in regular DNA primary 
structure. This observation means that the uniqueness of a given DNA primary structure resides 
solely in the sequence of its bases. 
 
1.2.2.5 Secondary structure of DNA 
 
In 1953, Watson and Crick determined the structure of B-DNA by x-ray diffraction 
patterns (the counter ion being an alkali metal such as Na+ and the relative humidity > 92%).25 R. 
Dickerson determined, in 1980, the first X-ray crystal structure of a B-DNA 
(dGlc[CGCGAATTCGCG]) at near-atomic (1.9 Å) resolution.26 If the relative humidity reduced 
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to 75%, B-DNA undergoes a reversible conformational change to the A-DNA. By solving the 
crystal structure of the self-complementary hexanucleotide dGlc[CGCGCG], Wang and Rich 
found a left-handed double helix (Table 2) in 1979, as the first reported example of Z-DNA.27  
 
 A-DNA B-DNA Z-DNA 
Helical sense Right-handed Right-handed Left-handed 
Diameter ~26 Å ~20 Å ~18 Å 
Base pairs per helical turn 11.6 10 12 (6 dimers) 
Helical twist per base pair 31° 36° 
9° for pyrimidine-purine 
steps; 51° for purine-
pyrimidine steps 
Helix pitch (rise per turn) 34 Å 34 Å 44 Å 
Helix rise per base pair 2.9 Å 3.4 Å 7.4 Å per dimer 
Base tilt normal to the helix 
axis 20° 6° 7° 
Major groove Narrow and deep Wide and deep Flat 
Minor groove Wide and 
shallow Narrow and deep Narrow and deep 
Sugar pucker C3’-endo C2’-endo 
C2’-endo for 
pyrimidines; C3’-endo 
for purines 
Glycosidic bond Anti Anti 
Anti for pyrimidines;  
syn for purines 
 
Table 2 Structural features of ideal A-, B-, and Z-DNA.28 
 
1.2.2.6 Hydrogen bonding motifs29 
 
Under the assumption that at least two hydrogen bonds must form to produce a stable base 
pair, the four bases substituted at the glycosyl nitrogens (N1 In pyrimidine and N9 in purine) can 
be arranged in 28 different ways. The 28 base pairs are grouped in Fig. 7 according to interactions 
between like and different bases in the purine-purine and pyrimidine-pyrimidine series, followed 
by purine-pyrimidine pairs. In each group, the orientation of the glycosyl C1’-N linkage can be 
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either unrelated by symmetry elements (asymmetric) or related by dyads (twofold axis) located 
perpendicular to or within the base-pair planes. 
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Fig. 7 All 28 possible base pairs for A, G, U(T), and C involving at least two hydrogen bonds. 
Nitrogen atoms displayed as filled circles, glycosyl bonds as thick lines with R indicating ribose 
C1’ atom. Symmetry elements for the orientation of the glycosyl C1’-N linkage  and  are 
twofold rotation axes vertical to and within the plane of the paper.30 
 
In oligonucleotides, the symmetry elements are of special interest, because they relate not 
only the glycosidic bonds, but also the attached sugar-phosphate backbone. 
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2. Problem outline 
 
A chemical rationalisation of the DNA structure should follow the methodology proposed 
by Eschenmoser:31 two criteria should be taken into consideration: first, the relationship between 
the structure and its biological function; and second, the structure’s potential for constitutional 
self-assembly.  
Many papers have been published concerning the question why nature chooses ribose (and 
2’-desoxyribose) as sugar backbones.32 For the purine- and pyrimidinebases, they only refer to the 
possibility of their prebiotic origin.31  
An open question is if other prebiotic accessible bases could also form base pairs with 
comparable strength and selectivity to the Watson-Crick base pairing in normal DNA. This 
question should be addressed in the same systematic way as the question why ribose and 2’-
desoxyribose is selected for the backbone of RNA and DNA from all the praebiotic accessible 
sugars. 
Today, it is known that cytidine is the least stable of the four nucleosides because of its 
tendency to undergo spontaneous deamination (hydrolysis) to uridine (t ½ = 340 yr at pH 7 and 
25°).33 With this experimental knowledge, a three-base codon derived from 2,4-
diaminopyrimidine (D) as a single source and its hydrolysis products, cytosine (C) and uracil (U), 
was postulated: “By building a glycosidic bond through an exocyclic amino group a D nucleoside 
would be isosteric to A, complementary to U and a progenitor of C and U. By formation of the 
glycosidic bond in a C nucleoside by an exocyclic amine a fourth nucleoside (E) could be formed. 
E would be a harbinger of the modern G with a possible base pairing with C.” (Fig. 8)34 
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Fig. 8 Hydrolysis cascade from diaminopyrimidine (D) to C to U (top) and 
pairing of D with U and E with C in a DNA system (bottom). 
 
This proposal immediately leads to two questions: 
1.) How stable are these exocyclic amino nucleosides (EANs) against the previously described 
anomerisation, isomerisation and cleavage of the nucleobase? 35   
 
Chapter 2: Problem outline 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 18  
 
 
Scheme 1 Possible mechanism of isomerisation (red arrows), anomerisation (black arrows) and 
cleavage of the nucleobase (blue arrows). 36 
 
2.) Are these EAN’s capable of forming pseudo-Watson-Crick hydrogen bonds comparable in 
strength and selectivity with the ones formed by the naturally occurring nucleobases? 
Many investigations have been conducted to determine stability parameters of EANs (rates 
of isomerisation, anomerisation, and cleavage of the nucleobase), in particular for FapydA and 
FapydG (see 3.1.3.). 37 Much less data is available in the literature concerning base-pairing 
properties of EANs, 38 due to their short lifetime, which requires calculations, the design of model 
systems or novel synthetic strategies. 
The goal of this project was to design, prepare, and investigate a model system giving 
data for the base pairing properties of EANs and especially producing data on base-pairing 
properties of compounds 1 and 2 (Fig. 9).  
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Fig. 9 Exocyclic amino nucleosides of interest. 
 
For the development the model system see chapter 4.1.  
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3. State of knowledge 
 
3.1. Exocyclic amino nucleosides 
 
3.1.1. Biological significance of exocyclic amino nucleosides (EANs) 
 
As a result of oxidative damage in natural DNA, EANs occur from purine nucleosides in 
the form of imidazole ring-opened formamidopyrimidines (fapydA derived from adenosine, 
fapydG derived from guanosine) and have been implicated in mutagenesis.39 Clitocine (6-amino-
5-nitro-4-(β-D-ribofuranosylamino)pyrimidine), a secondary fungal metabolite, first isolated from 
the mushroom Clitocybe inverse in 1986 by Kubo et al.40 exhibited strong insecticidal activity 
against the pink bollworm Pectinophora gossypiella. Later, it was found that clitocine has also 
strong cytostatic effect towards several leukaemia cell lines and is an inhibitor of adenosine 
kinase.41 Synthetic EANs like 4-substituted 8-(D-ribofuranosylamino)pyrimido[5,4-d]pyrimidines 
show antitumor and antiviral properties (Fig. 10).42 
 
 
 
Fig. 10 Examples of exocyclic amino nucleosides (EANs). 
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3.1.2. Hydrolysis (deamination) of 2,4-diaminopyrimidine and cytosine 
 
The  temperature-rate profile for the hydrolysis of cytosine to uracil was initially reported 
in 1972 by Garret and Tsau,43 (Fig. 11, left) after Shapiro and Klein had found that the 
nucleobase cytosine and the nucleoside cytidin undergo a hydrolysis to uracil and uridine, 
respectively.44 This deamination occurred under reaction conditions, which did not cause 
deamination in adenosine or guanosine. Lindahl and Nyberg discovered that the deamination rates 
of cytosine residues in single-stranded DNA, poly-d[C] and dCMP at pH 7.4 are comparable, 
though the cytosine residues in native double stranded DNA are deaminated at < 1% of the rate 
observed for dCMP or poly-d[C].45 The hydrolysis of 2,4-diaminopyrimidine, studied in 1998 by 
Levy and Miller (Fig. 11, right), resulted in a mixture containing cytosine, isocytosine and 
uracil.46 
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Fig. 11 Observed hydrolysis processes (upper part) and Arrhenius plot for the decomposition of 
A, U, G, C, T (left) and xanthine, hypoxanthine, 2,4-diaminopyrimidine (right); (reported at pH 
7.0).46 
 
3.1.3. Available stability data for EANs concerning anomerisation, furanose-
pyranose isomerisation, and cleavage of the nucleobase 
 
Recent studies on triazine EANs performed by Hysell et al.36 exhibited following effects: the 
stability of a triazine exocyclic amino nucleoside differ according to electron-deficiency of the 
nucleobase.  3 decomposes within 15 min in water, though 4 was stable in a D2O-THF-d8 solution 
(Fig. 12). 
 
 
Fig. 12 Examples of triazine EANs indicating the influence of electron-deficiency of the aromatic 
system on the stability in solution. 
 
Further 1H-NMR studies with 5β  demonstrated that the anomerisation to 5β, 5α occurred 
rapidly relative to the furanose-pyranose isomerisation (to 6β, 6α). Nevertheless, the pyranose 
isomers 6β,  6α represent, as it was similarly reported for the formamidopyrimidines FapydA35b 
and FapydG,35a the thermodynamically favoured products. Relative to the anomerisation, the 
cleavage of the nucleobase is a slow process (Fig. 13).  
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Fig. 13 Anomerisation, isomerisation and cleavage of the nucleobase for the triazine EAN 5β  in 
D2O, pH = 6.0, followed by 1H-NMR of the anomeric protons at (a) t = 0, (b) t = 1h, (c) t = 9h, (d) 
t = 30h.36 
 
It was observed that the rate of isomerisation was increased at lower pH, as expected from 
the proposed mechanism: 5β had a half-life of 10 h, 5 d, and more than 10 d at pH 6.0, 7.0, and 
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8.0, respectively. Although it was found that 5β was stable at pH = 11.0, the more electron-rich 
system 3 degraded within 15 min even at pH 11.0. 
The isomerisation of 5β is slower in MeOH compared to H2O; no isomerisation was 
observed for 5β in the aprotic solvents DMSO, acetonitrile, and acetone. The electron rich 
compound 3 also isomerised in aprotic polar solvents. Protection of the primary hydroxy at C5’ of 
3 as triisopropylsilylether resulted in a decrease of decomposition rate, explained by the loss of a 
possible intramolecular proton transfer or internal H-bonding assistance. 
A recent study of the FapydG lesion was done by Burgdorf and Carell,37b studying EAN 
7β as a model for the FapydG lesion (Fig. 10, Fig. 14). The authors point out that their results 
(half life for 7β of 37.8 h and 65.2 h for 7α, respectively in CH3CN/H2O 1:1 at 50° C concerning 
the cleavage of the nucleobase) indicate a higher stability of the FapydG lesion than reported in an 
earlier publication by Berger and Cadet.35a  
 
 
            
                  7β, 7α 
 
 
 
 
 
Fig. 14 Model compound 7β for the FapydG lesion (left) and HPLC-chromatogram of a 7β/7α 1:1 
mixture in CH3CN/H2O 1:1 at 50° C over 24 h (right). 
 
The experimental observations from Hysell et al.,36 indicate that rates for all 
decomposition processes (anomerisation, isomerisation and cleavage of the nucleobase) are 
dependent from four parameters: 
1.) higher rates of decomposition in more electron-rich aromatic systems 
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2.) higher rates in protic solvents, compared to aprotic, polar solvents 
3.) higher rates with unprotected hydroxy at C5’ 
4.) higher rates with decreasing pH. 
A comparison of 7β with the FapydG lesion shows that all changes made in the model of 
Burgdorf et al. should result in a higher stability compared to FapydG: the acetyl protecting group 
results in a more electron-deficient system. The solvent used was CH3CN/H2O 1:1 (compared to 
H2O used by Berger and Cadet) and the hydroxyl group at C5’ was protected as a silylether. 
Therefore the higher stability from 7β compared to the results from Berger and Cadet may be 
explained by the results of Hysell et al. 
 
3.1.4. Synthetic design for base pairing experiments of EANs. 
 
For the synthesis of oligonucleotides containing EANs, it has to be considered that the 
isomerisation, anomerisation, and cleavage of the nucleobase (see. 3.1.3.) can be avoided. This 
topic has been addressed in three different approaches: the first attempt was described by 
Greenberg and coworkers for the fapydG47 and fapydA47b lesion: Greenberg and coworkers 
applied a reverse β-cyanoethyl phosphoramidite (chain growth in the 5’→3’ direction) with a 
dinucleotid-phosphoramidite as building block. This approach uses the fact that the instability of 
EANs is less pronounced in di- and oligonucleotides than mononucleosides and mononucleotides, 
allowing Greenberg and coworkers to introduce anomeric mixtures of fapydG and fapydA in an 
oligonucleotide chain (Fig. 15). 
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Fig. 15 Dinucleotide of FapydG (left) and FapydA (right) for reversed 5’→3’ oligonucleotide 
synthesis. 
 
The second approach was also described by Greenberg and coworkers. This approach 
increases the stability of the glycosidic bond by an exchange of the exocyclic nitrogen, 
participating in the glycosidic bond by a carbon. By calculations48 and experiments,47b it was 
shown that oligonucleotides containing C-nucleotides as model for the FapydG and FapydA lesion 
do not have significantly changed base pairing properties compared to natural N-nucleotides. This 
method allows for the selective insertion of a defined anomer by standard β-cyanoethyl 
phosphoramidite chemistry (chain growth in the 3’→5’ direction) (Fig. 16).  
 
 
 
Fig. 16 FapydA-C-phosphoramidite (left) and FapydG-C-phosphoramidite (right) for standard β-
cyanoethyl phosphoramidite chemistry by Greenberg and coworkers. 
 
The third approach, described by Carell and coworkers,49,38a is a variation of the second 
approach by Greenberg and coworkers described above: the glycosidic bond is strengthened by a 
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replacement of the oxygen in the furanose ring by a carbon, resulting in a replacement of the 
furanose against a cyclopentane. As already described for the second approach, this approach also 
allows for the selective insertion of a defined anomer by standard β-cyanoethyl phosphoramidite 
chemistry (chain growth in the 3’→5’ direction). However, this approach has only been applied to 
the preparation of a model for the FapydG but not the FapydA lesion (Fig. 17). 
 
 
 
Fig. 17 FapydG-cyclopentane-phosphoramidite as building block of a model compound for the 
FapydG lesion by Carell and coworkers.38a, 49 
 
3.2 Known pyranose nucleic acid systems 
 
Eschenmoser and coworkers reported on the synthesis and characterisation of systems 
with pyranose-sugars and the regular purine- and pyrimidine-bases (adenine, guanine, thymine 
(uracil), cytosine).50,32b They reported that from the eight possible diastereomeric hexoses with 
(6’→4’) connectivity (these systems have, in their backbone, six covalent bonds per monomer 
unit (as RNA and DNA)) neither the β-allo- (A) nor the β-altro- (B) nor the β-
glucopyranosyl(6’→4’)-system (C) shows base pairing properties comparable in strength and 
selectivity with the base pairing in RNA or DNA oligonucleotides (Fig. 18). 
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Fig. 18 Members of the family of β-D-hexopyranosyl-(6’→4’)-oligonucleotides. 
 
In the unnatural 2’,3’-dideoxy(6’→4’)glucopyranosyl-system, a base pairing, which was 
stronger than the base pairing in DNA or RNA oligonucleotides, was found.32c The difference in 
base pairing strength was rationalised by steric hindrance between the equatorial 2’-OH group of a 
pyranosyl subunit and the neighbouring nucleobase. This hypothesis was tested by the synthesis 
of the 2’-deoxy-β-D-allopyranosyl (3’-OH, 2’-H) and the 3’-deoxy-β-D-allopyranosyl (2’-OH, 3’-
H) systems. The former showed strong base pairing whereas the latter showed only weak base 
pairing (Fig. 19).51,50,32b Recent results from the first reported x-ray structure of a homo-DNA 
octamer duplex (ddGlc[CGAATTCG]2) indicated that hydroxy groups attached to the 2’,3’-
dideoxyglucopyranose of several residues in the various configurations display short contacts to 
either atoms from adjacent base, sugars, or the phosphate group: Egli et al. point to overcrowding 
of the backbone as the most likely reason for the inability of fully hydroxylated hexopyranose-
based nucleic acid analogues to form stable duplexes.52 
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Fig. 19 Pyranose oligonucleotides. 
 
3.3 Base pairing in the 2’,3’-dideoxy(6’→4’)glucopyranosyl (homo-DNA)-
system 32c 
 
 
 
Fig. 20 Constitution and configuration of homo-DNA oligonucleotides compared to DNA 
oligonucleotides. 
 
In the homo-DNA system (Fig. 20), a different base pairing pattern (compared to DNA) is 
observed: 
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oligonucleotide Tm [°C] ∆H [kcal/mol] 
Τ ∗ ∆S (25 °C) 
[kcal/mol] ∆G [kcal/mol] 
Hyperchromicity 
(wavelength) [%] 
ddGlc[A6] 47 (15 µM) -39.4 -30.2 -9.2 7 (260 nm) 
ddGlc[(AT)6] 59  (9.3 µM) -60.2 -47.1 -13.1 25 (260 nm) 
d[(AT)6] 24  (8.9 µM)  -65.2 -59.7 -5.5 35 (260 nm) 
ddGlc[G6] 38  (20 µM) -45.2 -36.8 -8.4 13 (250 nm) 
ddGlc[G6], 
ddGlc[C6] 
61  
(50 µM) -39.5 -28.6 -10.9 22 (280 nm) 
ddGlc[(CA)6] 29  (8.3 µM) -53.0 -45.1 -7.9 12 (260 nm) 
 
Table 3  Thermodynamic data of homo-DNA- (ddGlc) and DNA-oligonucleotides.32c 
 
Adenine pairs with adenine. Different from the DNA hexamer dRib[A6], the ddGlc[A6] 
showed a duplex formation deducible from changes in UV- and CD-spectroscopy. Analogous to 
DNA-oligonucleotides the melting temperature (Tm) of ddGlc[An] (n =6, 10, 12) is dependant on 
the salt concentration and increases in a range from 0.015 to 1.5 M NaCl with increasing salt 
concentration (dTm/dln(c)-pitch of +2°/M) but less pronounced than for DNA-oligonucleotides 
(+8°/M).29 Increasing concentrations of urea decrease the Tm value, similar to that seen for DNA 
oligonucleotides. 
Adenine pairs with thymine (but weaker than with adenine). The addition of 
ddGlc[T6] did not influence the UV-melting curve of ddGlc[A6]. The observation of A-T pairing 
resulted from alternating, self-complementary sequences ddGlc[(AT)n] (n = 3, 4).  
Guanine pairs with guanine. The hexamer ddGlc[G6] shows intermolecular self-pairing 
properties similar to ddGlc[A6]. 
Guanine pairs with cytosine (stronger than with itself). Different from the addition of 
ddGlc[T6] to ddGlc[A6] the self-pairing complex ddGlc[G6] is broken up by the addition of 
ddGlc[C6]. Phenomenologically, the ddGlc[purin]—ddGlc[purin] complexes can be differentiated 
from ddGlc[purin]—ddGlc[pyrimidine] pairing-complexes through different hyperchromicity 
ranges: UV-melting curves of ddGlc[purin]—ddGlc[purin] duplexes typically show 
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hyperchromicity values (at 260 nm for ddGlc[An] —ddGlc[An] and 250 nm for ddGlc[Gn]—
ddGlc[Gn], respectively) of less than < 13%, during ddGlc[purin]—ddGlc[pyrimidine] duplexes 
possess hyperchromicity values of > 20% (at 260 nm for  ddGlc[(AT)n]—ddGlc[(AT)n] and 280 
nm for ddGlc[Gn]—ddGlc[Cn]). 
Adenine pairs with cytosine (but weaker than with thymine). In ddGlc[(AC)n], an 
oligonucleotide with sufficient chain length (n > 4), a duplex formation was observed, in contrast 
to the corresponding DNA oligonucleotide dRib[(AC)n]. The melting temperatures of 
ddGlc[(AC)n]-pairing complexes were, at the same concentration, about 20-30 °C lower than the 
corresponding ddGlc[(AT)n] complexes, but still higher than the corresponding DNA 
oligonucleotides dRib[(AT)n]. 
DdGlc[purine]-ddGlc[pyrimidine] and ddGlc[purine]-ddGlc[purine] prefer antiparallel 
strand orientation. Purine-pyrimidine paired duplexes of the homo-DNA series are 
thermodynamically more stabile than the corresponding duplexes in the DNA series, due to 
entropic (and not enthalpic) reasons (Table 3).  
Homo-DNA sequences do not cross-pair with complementary sequences containing DNA-
, RNA- nor any other oligonucleotide analogue backbone that has been identified to date.53  
Recent results from the first reported X-ray structure of a homo-DNA oligonucleotide 
showed that the backbone-base inclination (Fig. 21) determines the relative polarity of paired 
strands in duplexes (antiparallel versus parallel) and the potential for cross-pairing between 
different nucleic acid systems:52 Nucleic acid-pairing systems with significant positive or negative 
inclinations are essentially unable to form parallel arrangements involving two or more 
oligonucleotides and reverse Watson-Crick base pairs. A difference of 20° or more in the 
backbone-base inclination exhibited by two oligonucleotide systems would render cross pairing 
impossible. 
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Fig. 21 Backbone-base inclination: ηB defined as angle between vectors P-CM and ntpβ with (α) 
best plane through the basen, (β) plane normal to α containing P and CM (base’s centre of mass), 
(tpβ) orthogonal projection on plane  of vector P-Pn+1 at position P, (ntpβ) vector orthogonal to 
tpβ in plane β with P as origin.52 
 
In all following parings all base conformations are anti. The adenine-adenine pairing in 
the homo-DNA series occurs according to the reverse Hoogsteen-mode with an antiparallel strand 
orientation. The adenine-thymine pairing in homo-DNA oligonucleotides is formed in the Watson-
Crick mode with an antiparallel strand orientation. The guanine-guanine pairing in homo-DNA 
prefers antiparallel strand orientation. The guanine-cytosine pairing in homo-DNA prefers a 
Watson-Crick mode (as the A-T pairing) with antiparallel strand orientation. The constitution of 
the adenine-cytosine has not been proven, but experimental results indicate a reverse Hoogsteen 
pairing (Fig. 22): A decrease of melting-temperature with decreasing pH and a complete loss of 
pairing by replacement of the adenine by 7-C-adenine was observed. This experimental results 
excluded a Watson-Crick pairing of a protonated adenine with cytosine (would be stronger with 
lower pH) and a reversed Watson-Crick (N7 is not involved in pairing, replacement of N7 with C 
would not influence base pairing)). 
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Fig. 22 Constitution of homo-DNA-pairing (from upper left to bottom right): adenine-adenine, 
adenine-thymine, guanine-guanine, guanine-cytosine and adenine-cytosine. 
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4. Own work 
 
4.1. Development of a model system 
 
EANs undergo a furanose-pyranose isomerisation in which the pyranose isomers are the 
thermodynamically favored species for triazine EANs36 as well as for diaminopyrimidine EANs35 
(see 3.1.3). This observation led us to choose a pyranose nucleic acid analogue, 2’,3’-
dideoxy(6’→4’)glucopyranosyl (homo-DNA), as a model system for base pairing studies 
(Scheme 2). For a stabilization of the instable glycosidic bond in the EAN (anomerisation, 
isomerisation and cleavage of the nucleobase) an approach was applied, first reported by 
Greenberg and coworkers.47b to study the pyrimidine EANs, FapydA and FapydG, replacing the 
exocyclic nitrogen by a carbon (Scheme 2), allowing the study of the base pairing properties of a 
stable species in the absence of an isomerisation- and anomerisation equilibrium. 
 
 
 
Scheme 2 Development of a model system for base pairing studies. 
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4.2. Retrosynthetic analysis 
 
 
Scheme 3 Retrosynthetic analysis of nucleosides 10 and 11. 
 
10 and 11 represent the products of condensation of guanidine and urea with β-
ketoaldehyde 12, or a β-ketoaldehyde equivalent, respectively (Scheme 3). Due to the poor 
nucleophilicity of urea (→problems for the condensation), it should be possible to prepare 2-
oxopyrimidine-nucleoside 11 from 10 by activation of the amino group as a diazonium ion 
followed by hydrolysis. 
In β-ketoaldehyde 12, the protecting groups R have to be chosen to survive basic 
conditions, which are necessary for the condensation, making ester protecting groups (for example 
acetyl- or benzoyl-protecting groups) unsuitable for this purpose. 
β-ketoaldehyde 12 should be prepared in an aldol-type reaction from ketone 13. In the key 
step of the synthesis, ketone 13 has to be prepared diastereoselectively as the β-anomer from 
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glycoside 14. Because it was reported from Eschenmoser and coworkers for the Vorbrüggen-
nucleoside synthesis of a non C(1) activated pyranoside,32a and recently also for C-glycosylations 
of pyranoses in C(1) activated glycosides by Woerpel and coworkers,54 that the configuration at 
C(1) did not affect the diastereoselectivity of the nucleosidation and C-glycosylation, in either 
case, we planed the synthesis of glycoside 14 as an anomeric mixture. 
Glycoside 14 should be prepared from 3,4,6-tris-O-acetyl-D-glucal by a Ferrier rearrangement, resulting in 
a 2,3-enopyranoside, from which 14, as precursor in the C-glycosylation, should be obtained after 
hydrogenolytic reduction of the double bond and protecting group manipulations.  
 
4.3. Synthesis 
 
4.3.1 Synthesis of C-glycosides 
 
3,4,6-tris-O-acetyl-D-glucal 15 was converted by a Ferrier rearrangement,55,32a to the 
methyl-4,6-di-O-acetyl-α/β-D-erythro-hex-2-enopyranoside 16 with a diastereomeric ratio 
16α/16β = 8:1 (according to integration of GC and 1H-NMR data) in 94% yield (Scheme 4). The 
following hydrogenation with Pd(C) in acidic MeOH resulted in saturated pyranoside 17 (17α/17β 
= 8:1, GC, 1H-NMR) in over 80% yield. Basic hydrolysis of 4,6-bisacetate 17 with 2 N NaOH in 
THF/MeOH/H2O 5:4:1 at 0 °C, or with the strongly basic anion exchange resin IRA 400 (or IRA 
402) in MeOH, resulted in pyranoside-4,6-diol 18 in 98% (2 N NaOH), 95% (IRA 400), and 93% 
(IRA 402) yields, respectively. C(1) activation under acidic conditions with AcOH, H2SO4 gave 
access to the 1,4,6-tris-O-acetylpyranoside 19 in 76% yield (19α/19β = 5:1, GC).56 
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Scheme 4 Synthesis of glycosides 17-19, and 21 from 3,4,6-tris-O-acetyl-D-glucal according to 
Ferrier (top) and Isobe (bottom), respectively. 
 
A slightly different strategy for the synthesis of 1,4,6-trisacetate 19 from 3,4,6-tris-O-
acetyl-D-glucal by Jiang and Isobe,57 also starting with a Ferrier rearrangement, yielded hex-2-
eno-pyranoside 20 (20α/20β = 9:1 (GC)) in over 90% yield. Hydrogenation to the fully saturated 
4,6-bisacetate with Pt(C) yielded in over 95% as α-D/β-D = 9:1 anomeric mixture (GC, 1H-NMR) 
pyranoside 21. The following C(1) activation the 1,4,6-trisacetate 19 under Lewis acidic 
assistance with ZnCl2 proceeded in only 23% yield (α-D/β-D = 7:1 (GC)) with the C(1)-OH 
pyranoside as side product, making the procedure of Ferrier and Prassad superior for the 
preparation of C(1) activated pyranoside 19. 
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Scheme 5 Synthesis of 4,6-bis-O-benzoyl-pyranoside 22 and 4,6-bis-O-benzylpyranoside 23 and 
1-OAc-4,6-bis-O-benzyl-pyranoside 24. 
 
Esterification with benzoyl chloride  in pyridine resulted in bis-O-benzoylpyranoside 22 
(yield 83%, 22α/22β = 14:1 (GC, 1H-NMR). Bis-O-benzylpyranoside 23 was obtained from 18 in 
THF with benzyl bromide (yield 86%, 23α/23β = 7:1 (GC)) (Scheme 5). The synthesis of 1-OAc-
4,6-bis-O-benzyl-pyranoside 24 from 1-OMe-pyranoside 23, under similar reaction conditions 
already applied in the preparation of 1,4,6-trisacetate 19, could not be optimized to a yield better 
than 31%; increasing the reaction time resulted in cleavage of the benzyl protecting groups under 
the strongly acidic reaction conditions (AcOH, H2SO4 (cat.)). A decrease in the reaction time 
resulted in recovery of starting material. All attempts to activate C(1) in pyranoside 23 as α-
halogenoether (α-chloro- and α-bromoether) failed (results not shown). 
The silylenolether of acetone was prepared from acetone, Me3SiCl and NaI in a procedure 
described by Cazeau et al.58 Under the coupling conditions to form C-glycosides (1.2 eq 
silylenolether of acetone, 1.4 eq distilled SnCl4 (bulb-to-bulb-distillation), dry CH3CN), the C(1) 
activated pyranoside 19 resulted in the generation of undesired α-C-glycoside 25α (25α/25β = 
66/34, 1H-NMR) as the major anomer (yield 78%) (Table 4).  
 
Chapter 4: Own work 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 39  
 
Substrate Product R1 R2 Temp. [°C] Additive α/β Yield Reaction time 
17 25 Ac Me 25 - 47/53 44% 6 h 
17 25 Ac Me 25 3 Å MS 71/29 53% 6 h 
19 25 Ac Ac -78 - 66/34 78% 2 h 
22 26 Bz Me 25 - 69/31 76% 6 h 
22 26 Bz Me 25 3 Å MS 77/23 49% 6 h 
23 27 Bn Me 25 - 18/82 51% 6 h 
23 27 Bn Me 25 3 Å MS 69/31 63% 6 h 
23 27 Bn Me 25 - 12/88 17% 21 h 
 
Table 4 Formation of C-glycosides 25-27. 
 
25α and 25β were separated by preparative column chromatography (SiO2, Et2O/hexane 
3:1) and the structure was assigned by COSY and NOESY experiments: all expected 1,3-diaxial 
NOEs in the separated anomers 25α and 25β  were observed. In 25β NOEs between HC(1) and 
Hax.C(3), Hax.C(3) and HC(5) and more importantly between HC(1) and HC(5) (an NOE not 
detected for 25α) were observed (Fig. 23, upper right). In 25α NOEs resulting from an inverted 
chair conformation were observed between HC(1) and 1 HC(3), 1 HC(3) and both H2C(6) and also 
between HC(1) and both H2C(6) (an NOE not detected for 25β) (Fig. 23, top left and middle).  
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Fig. 23 Observed NOEs for separated α- and β-anomers of 25 and 27 (top) with characteristic 
NOEs between HC(1) →H2C(6) for the α-anomer and HC(1)→HC(5) for the β-anomer, part of 
the NOESY of 25α (middle) and determination of the diastereoselectivity by integration of 1H-
NMR data (1H of C(1)CH2CO) (for 27, 26 ). 
 
Inspired by the Vorbrüggen version59 of the Hilbert-Johnson-method60 for the synthesis of 
nucleosides, the coupling to C-glycosides was also carried out from pyranosides 17, 22, and 23 
without C(1) activation. When 1.2 eq silylenolether of acetone were used, the non C(1) activated 
pyranosides 17, 22, and 23 were treated with distilled SnCl4 in dry CH3CN and the following 
results were obtained (Table 4): Bis-O-acetyl-pyranoside 17 produced C-glycoside 25 after 6 h at 
25 °C in 44% yield as a diastereomeric mixture (25α/25β = 47/53 (1H-NMR)); 22 gave a 
diastereomeric ratio α-D/β-D 69/31 (1H-NMR) in 76% yield; and 23 gave an α-D /β-D ratio of 
18/82 (1H-NMR) in 51% yield. The determination of the diastereoselectivity of 27α/27β was 
performed by integration of 1H-NMR signals of 1 H of C(1)CH2CO and separation of the anomers 
(CC on SiO2), followed by peak assignment with COSY and NOESY experiments of the separated 
anomers as described above for 25α. In the case of the bis-O-benzoyl-pyranoside 26, the 
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separation of the anomers was unsuccessful and the structure was elucidated according to the 
3J(HC(4), HC(5)) coupling constant (Fig. 24), which was for the 26β-anomer and 25β-anomer 
between 10.2 and 10.5 Hz, as expected. Further confirmation of the structure was obtained by the 
δ 13C (13C-NMR) of C(1)-CH2-CO, which were between 49.0 and 49.4 ppm for all β-anomers 
(25β, 26β, 27β) and 47.1 and 47.7 ppm for the α-anomers (25α, 26α, 27α), respectively. 
 
 
 
Fig. 24 1H chemical shifts of HC(4), 3J(HC(4), HC(5)) coupling constants (in Hertz) and 13C 
chemical shifts of C(1)-CH2-CO for 25, 26 and 27. The values were obtained in the case of 25 and 
27 from separated α-D/β-D anomers, assigned by COSY and NOESY experiments, and used for 
the determination of anomers 26α, 26β (see text). 
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The addition of 3 Å molecular sieves to the reaction increased the α-D/β-D ratio: α-D/β-D 
ratios found with (without) sieves were 71/29 (47/53) for 17, 77/23 (69/31) for 22, and 69/31 
(18/82) for 23. These results indicate that the methanolate, formed during the oxoniumion 
formation, has an influence on the diastereoselectivity of the reaction. Increasing the time of the 
reaction from 6 h to 21 h resulted in an slightly increased diastereoselectivity (α-D/β-D 12/88 vs. 
18/82) and a decreased yield (17% vs. 63%) for 23. These results indicate that 27α rearranges 
under the reaction conditions to the thermodynamically favorable 27β-anomer. Further evidence 
for an in situ α to β rearrangement and the influence of a protic solvent came from the following 
experiment (Fig. 25). To a diastereomeric mixture 27α/27β = 71/29 in dry CH3CN was added 1.4 
eq distilled SnCl4. After 6 h at 25 °C nearly no anomerisation occurred (27α/27β = 61/39). When 
the 27α/27β = 71/29 mixture was subjected to the same reaction conditions in CH3CN/MeOH 
20:1, efficient epimerization resulted in a diastereomeric ration 27α/27β  = 34/76.  
 
                           
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25 Anomerisation of 27α to 27β, followed by 1H-NMR of C(1)CH2-CO at (a) t = 0, (b) t = 6 
h in CH3CN, (c) t = 6 h in CH3CN/MeOH 20:1. 
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  The experimental evidence led to the hypothesis that the in situ epimerization follows this 
mechanism (Scheme 6):61 The methanolate formed during the oxonium ion formation, induces the 
formation of the Sn-enolate. Due to stabilization by intramolecular chelation to the oxygen of the 
pyranose ring, the Z-enolate is formed, resulting in a syn chair-boat conformation. By a retro-
Michael reaction, cleavage of the C(1)-O bond occurs, followed by a change in conformation. 
From the anti chair-boat conformation, the β-C-glycoside is formed by a Michael reaction. This 
rearrangement is less effective in the case of the ester protected sugars (17, 22) compared to the 
ether-protected sugar 23, probably due to a possible complexation of Sn4+ to the ester groups 
(Scheme 6).  
 
 
 
O
BnO
OBn
O
O
BnO
OBn
O
10 eq Zn(OAc)2
12 eq NaOMe,
MeOH, rt, 26h
61%
27 /27 = 71:29 27 /27 = 34:66  
 
Scheme 6 Proposed mechanism of the anomerisation (top) and zinc(II)-mediated epimerization 
according to Zou and coworkers (bottom). 
 
A 71/29 mixture of 27 was epimerized to 33/67 in 61% yield with a zinc(II)-mediated 
epimerization, reported by Zou and coworkers (Scheme 6).62 Of all the routes to key intermediate 
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27β the synthesis from bis-O-benzylpyranoside 24 was the most suitable one, due to the 
diastereoselectivity (27α/27β = 18/82), the possibility of a preparative separation of the anomers 
27α and 27β by column chromatography on SiO2, and the acceptable yield (56%). Additionally 
the preparation of 27β by C-glycosylation did not need C(1) activation when starting from 23. 
This strategy allowed us to prepare 27β on multi-gram scale. 
 
4.3.2 Synthesis of homo-DNA-C-nucleosides 
 
Derivatives of N,N-dimethylformamide (DMF) are known to react with a variety of 
activated methylene compounds to yield the corresponding enamino derivatives directly.63 These 
enamino derivatives are activated β-ketoaldehyde equivalents (1,3-dielectrophiles), and as 
reported by Schmidt and Hoffmann, they undergo condensation with dinucleophiles (hydrazine, 
acetamidine and guanidine) to form pyrazole, 2-methyl- and 2-amino-pyrimidines, respectively.64  
Because the commercially available N,N-dimethylformamide dimethyl acetal (DMF-
DMA) 28 resulted only in poor conversion of ketone 27β to the enaminoketone, the more reactive 
tert-butoxybis(dimethylamino)methane (Bredereck’s reagent) 29 was prepared from DMF in three 
steps according to a procedure first described by Bredereck and coworkers.65 DMF  was 
methylated with an equimolar amount of dimethylsulfate to give the O-methylated methylsulfate 
30,66 which was used without purification for the synthesis of N,N,N’,N’-
tetramethylformamidinium-methylsulfate 31, due to reported purification problems (for 30) 
(Scheme 7).66  
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Scheme 7 DMF-DMA 28 and synthesis of Bredereck’s reagent 29 from DMF. 
 
N,N,N’,N’-tetramethylformamidinium-methylsulfate 31 was obtained from 30 by 
treatment with a saturated solution of Me2NH in benzene as colorless low melting solid,67 which 
was converted to Bredereck’s reagent 29 with KtBuO in Et2O. 29 was purified by distillation (p = 
11 mbar, t = 60 °C).68  
27β was converted to the two regioisomeric enaminoketones 32 and 33 with Bredereck’s 
reagent 29 in toluene. Condensation with guanidinium sulfate (or guanidinium chloride) provided 
a mixture of homo-DNA-β-C-nucleosides 34 and 35 in a 3:1 ratio (for both guanidinium sulphate 
and guanidinium chloride) with a yield of 63% (58% with guanidinium chloride) (from 27β ). 
Homo-DNA-C-alkyl-nucleoside 34 was separated from homo-DNA-C-aryl-nucleoside 35 by 
column chromatography on neutral Al2O3 (Brockmann activity III). Attempts to separate 34 and 
35 on SiO2 failed. From mixed fractions of 34 and 35, enriched in 35 (34/35 = 1:2), pure 35 was 
obtained by recrystallisation from EtOAc/hexane 2:1, due to the good crystallization properties of 
homo-DNA-C-aryl-nucleoside 35. No occurrence of anomerisation under the basic reaction 
conditions of the condensation was deduced by COSY and NOESY experiments of C-nucleoside 
34 (NOEs: HC(1’)/HC(6’)→Hax.C(3’), Hax.C(2’)→HC(4’)/HC(5’), and HC(5’)/HC(4’)→Hax.C(3’). 
In contrast, a process of deprotonation of the acidic carbonyl-α-protons followed by a ring-
opening of the pyranose ring was reported by Hoffmann and Schmidt for the α-anomer of the 
corresponding O-benzylated glucopyranosyl-ketone (Fig. 26).64  
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Hydrogenolytic deprotection of homo-DNA-C-nucleosides 34 and 35 failed under various 
conditions (Pd(C) or Pd(C) with up to 60% Pdblack (precipitated Pd) in MeOH/EtOAc 3:1). 
Protection of the primary amine in 34 as the isobutyric amide69 or as the benzyl-amide32a did not 
facilitate the deprotection of the bis-O-benzylether. Ultimately, homo-DNA-C-nucleosides 34 and 
35 were deprotected to the 4’,6’-diols 10 and 36, following a procedure by Hart et al.,70 under 
Lewis acidic conditions with BBr3 in CH2Cl2 with a yield of 75% (10) and 79% (36), respectively. 
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Fig. 26 Synthesis of fully unprotected homo-DNA-β-C-nucleosides 10 and 36 from β-C-glyco-
pyranoside 27β  and observed NOEs in the NOESY experiment for 34 excluding a known 
anomerisation reported by Hoffmann and Schmidt under basic condensation conditions (top).64 1H-, 
and NOESY spectrum of 34 (bottom). 
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condensation under the same reaction conditions and produced higher ratios of the homo-DNA-C-
aryl-nucleoside vs. homo-DNA-C-alkyl-nucleoside as mixtures with -OEt substitutents at C(2) of 
the pyrimidine, resulting from an SNAr reaction with the base as nucleophile (Table 5). This 
observation was applied in a second strategy to prepare 2-oxo-homo-DNA-C-alkyl-nucleoside 11 
from the corresponding 2-O-benzyl-pyrimidine derivative, which should be prepared by a one-pot 
reaction (condensation, SNAr reaction) in NaOBn/BnOH. Due to poor condensation yields (10 to 
26%) for both S-methylisothiourea hemisulfate and O-methylisourea hemisulfate and the preferred 
formation of the undesired homo-DNA-C-aryl-nucleoside, this alternative strategy for the 
synthesis of homo-DNA-C-alkyl-nucleoside 11 was discarded (Table 5). No condensation was 
observed with urea. 
 
 
 
 
 
Chapter 4: Own work 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 50  
X- Nucleophile 
Solvent/ 
base 
Aryl-C-
nucleoside/alkyl-
C-nucleoside 
Yield (from 
27β) R
2
 
0.5 SO42- 
 
EtOH/ 
NaOEt 
1:3 (isolated) 63% NH2 
Cl- 
 
EtOH/ 
NaOEt 
1:3 (isolated) 58% NH2 
0.5 SO42- 
 
EtOH/ 
NaOEt 
3:2 (1H-NMR) 26% OEt 
0.5 SO42- 
 
EtOH/ 
NaOEt 
3:1 (1H-NMR) 15% OEt 
0.5 SO42- 
 
BnOH/ 
NaOBn 
4:1 (1H-NMR) 10% OBn 
- 
O NH2
NH2
 
EtOH/ 
NaOEt 
- - - 
 
Table 5 Condensation of enaminoketones 32 and 33 with O-methyl isourea hemisulfate, S-
methylisothiourea hemisulfate and urea, respectively. 
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Fig. 27 1H-NMR (peaks assigned according to COSY experiment) (top), and observed NOE 
between HC(1’)-HC(5’) (bottom) important for the assignment of β-configuration for homo-
DNA-β-C-alkyl-nucleoside 10 (all spectra were measured in d4-MeOD at 300 K and 500 Mhz). 
 
To exclude the possibility that an anomerisation of homo-DNA-β-C-alkyl-nucleoside 10 
had occurred under the strongly Lewis acidic conditions necessary for the deprotection of the 
bisbenzylether in 34 COESY and NOESY experiments of 10 were performed. They supported the 
β-D-configuration by displaying the characteristic HC(1’)→HC(5’) NOE (Fig. 27). 
The same strategy was applied for the determination of the fully deprotected homo-DNA-
β-C-aryl-nucleoside 36. The characteristic HC(1’)→HC(5’) NOE of the β-D-configuration was 
observed here as well (Fig. 28). 
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Fig. 28 1H-NMR (peaks assigned according to COSY experiment) (top), and observed NOE 
between HC(1’)-HC(5’) (bottom) important for the assignment of β-configuration for homo-
DNA-β-C-aryl-nucleoside 36 (all spectra measured in D2O at 300 K and 600 Mhz). 
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Homo-DNA-β-C-aryl-nucleoside 36 was crystallized from D2O, resulting in colorless 
needles suitable for X-ray crystal structure analysis. In the crystal of 36 two conformations, 
different in the torsion angles χ (O(9/29)-C(1/21)-C(10/30)-C(11/31)) and γ (O(7/27)-C(6/26)-
C(5/25)-C(4/24)), occur in a 1:1 ratio. In conformer 36A (Fig. 29) the values for  χ and γ  are -
165.5°, -161.6° (antiperiplanar); in the other conformer B, -54.0° and 58.1 (synclinal), 
respectively. Intermolecular contacts between the bases in 36 occur with conformational 
recognition: the nucleobase of conformer 36A forms exclusively two hydrogen bonds to two 
nucleobases of nucleosides with the same conformation. Conformer 36B only forms four 
hydrogen-bonds to two nucleobases of nucleosides with the same 36B conformation.  Further 
intermolecular contacts occur between HO(7) of conformer A and HO(28) of conformer B, and 
between HO(8) of conformer A and HO(27) of conformer B, forming twelve-membered loops and 
extended …36A…36B…36A…36B… chains. The x-ray structure of of 36 proved the β-
configuration of 36, which had also been determined by NOESY experiments (Fig. 29).  
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Fig. 29 X-ray structures of conformer 36A (top left) and 36B (top right) of homo-DNA-β-C-aryl-
nucleoside 36 and packing of 36 (bottom) with conformer 36A in green and 36B in blue, 
respectively. 
 
Under basic hydrolysis conditions (10 N NaOH in H2O), reasonable amounts of the 
corresponding pyrimidine-2-ones 11 and 37 were not obtained from homo-DNA-β-C- nucleosides 
10 nor 36, although the product was detected in solution by ESI-MS (Scheme 8). Acidic 
diazotation with NaNO2, according a procedure described by Schulz and Pfleiderer,71 failed for 
both the benzyl-protected homo-DNA-β-C-alkyl-nucleoside 34 and the homo-DNA-β-C-aryl-
nucleoside 35, so did many other acidic diazotations. The first method successfully applied in the 
conversion of 34 to the corresponding 2-iodopyrimidine-nucleoside 38 was a procedure of 
Loren,72 which used an isopentylnitrite in benzene with I2, as an iodine-radical donor, trapping the 
intermediately formed pyrimidine-2-radical (Scheme 9). The yield of the reaction was increased 
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from 21% to 33% by replacing I2 with diiodomethane as iodine-radical donor, according to a 
procedure described by Nair and Richardson.73 This preparation of 2-iodo-pyrimidine-nucleosides 
was also successfully applied in the case of the homo-DNA-β-C-aryl-nucleoside 35 with a yield of 
36% for the 2-iodopyrimidine-β-C-aryl-nucleoside 39. In the synthesis of 2-iodopyrimidine-β-C-
alkyl-nucleoside 38, the deaminated product 40 was isolated as a side product. To exclude the 
possibility of radical hydrogen abstraction from the benzylic position of the benzyl protecting 
groups, we prepared from the fully deprotected homo-DNA-β-C-alkyl-nucleoside 10, according to 
a procedure of Martini and Bredereck,74 the bis-O-acetylated derivative 41 in 63% yield, which 
was converted to the 2-iodopyrimidine-nucleoside 42 according the procedures described for 38 
and 39. Although the yield could be increased in the synthesis of 42 (47%), compared to the bis-
O-benzyl-analogue 38 (33%), the deaminated nucleoside 43 was also observed in the preparation 
of 41. 
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Scheme 8 Synthesis of 2-iodo-homo-DNA-β-C-alkyl-nucleoside 38 and 2-iodo-homo-DNA-β-C-aryl-
nucleoside 39. 
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Scheme 9 Mechanism of the formation of the 2-iodo-pyrimidine nucleosides according to Nair 
and Richardson.75 
 
Solvolysis of 2-iodopyrimidin-C-alkyl-nucleoside 38 and 2-iodopyrimidin-C-aryl-
nucleoside 39 in with NaOH in BnOH following a procedure by Camaioni et al.76 resulted in good 
yields (79% for 38 and 82% for 39) of the corresponding 2-O-benzylpyrimidin-C-alkyl- and -C-
aryl-nucleosides 44 and 45. Applying the conditions reported above for the deprotection of 34 and 
35 resulted in fully deprotected 2-oxopyrimidine-homo-DNA-β-C-alkyl-nucleoside 11 and -C-
aryl-nucleoside 37 with yields of 79% and 84%, respectively (Scheme 10).  
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Scheme 10 Preparation of fully unprotected 2-oxopyrimidin-homo-DNA-β-C-alkyl-nucleoside 11 
and -C-aryl-nucleoside 37. 
 
To exclude the occurrence of an anomerisation of 2-oxopyrimidine-homo-DNA-β-C-alkyl-
nucleoside 11 and C-aryl-nucleoside 37 under the strongly Lewis acidic conditions necessary for 
the deprotection of the trisbenzylether in 44 and 45, respectively, COSY and NOESY experiments 
were performed for 11 and 37. The characteristic HC(1’)→HC(5’) NOES for the β-D-
configuration was observed for both nucleosides (Fig. 30, Fig. 31). 
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Fig. 30 1H-NMR (peaks assigned according to COSY experiment) (top), and observed NOE 
between HC(1’)-HC(5’) (bottom) important for the assignment of β-configuration for 2-
oxopyrimidine-homo-DNA-β-C-alkyl-nucleoside 11 (all spectra were measured in d6-DMSO at 
300 K and 600 Mhz). 
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Fig. 31 1H-NMR (peaks assigned according to COSY experiment) (top), and observed NOE 
between HC(1’)-HC(5’) (bottom) important for the assignment of β-configuration for 2-
oxopyrimidine-homo-DNA-β-D-C-aryl-nucleoside 37 (all spectra were measured in d4-MeOD at 
300 K and 600 Mhz). 
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4.3.3 Synthesis of homo-DNA-nucleosides with natural nucleobases  
 
The synthesis of the homo-DNA-nucleosides with natural nucleobases followed by some 
modifications the methodologies described by Eschenmoser and coworkers,32a with the key step 
being a Hilbert-Johnson-method60 for nucleoside-synthesis, modified by Vorbrüggen and 
coworkers.59a This variant of the nucleoside synthesis forms the nucleosidic bond between the 
sugar and the per-silylated heterocyclic base under Lewis acid catalysis and does not require any 
activated leaving group at the anomeric centre. Because it is reported that the configuration at the 
anomeric centre of 17 influenced neither the product distribution nor the yields of the nucleoside 
formation, 17 was used as an anomeric mixture. 
The persilylated heterocyclic bases were prepared in situ in the reaction mixture. In a 
typical experiment for the preparation of a pyrimidine-nucleoside 48, uracil was suspended in a 
solution of methyl pyranoside 17 in dry CH3CN. After adding an excess of silylating reagents 
(hexamethyldisilazane (HMDS) and chloro(trimethyl)silane (Me3SiCl)) followed by SnCl4, which 
resulted in a homogenous reaction mixture, the reaction was heated to 45°C for 20 h. This 
procedure resulted in β-D-nucleoside 48 as the major product (55%) with 14% of the 
corresponding α-D-anomer 49 (Scheme 11) after aqueous work-up and separation of the anomers 
by column chromatography. The corresponding cytosine derivatives were prepared in an 
analogous approach by silylating commercially available N4-benzoylcytosine in situ with N,O-
bis(trimethylsilyl)acetamide (BSA) in a solution of pyranoside 17 in CH3CN followed by the 
addition of SnCl4 and heating to 50° C for 2 h, resulting in a chromatographically separable β-
D/α-D-mixture in a total yield of 57%, with the thermodynamically more stable β-D-anomer being 
the major product. As a side product from the reaction mixture 7% of enolether 52 was isolated. 
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Scheme 11 Vorbrüggen nucleoside synthesis for the preparation of the β-D-anomers of homo-
DNA-uracil and homo-DNA-cytosine-nucleosides 48 and 50, respectively. 
 
N6-benzoyladenine and N2-isobutyrylguanine were prepared from adenine and guanine, 
respectively, according procedures described by Bullock et al.77 for adenine and Benner and 
coworkers for guanine.78 BzCl (or isobutyric anhydride) was added to a suspension of adenine in 
pyridine or guanine in N,N-dimethylacetamide at rt. The reaction was heated to 120 °C (150 °C) 
for 2 h. Aqueous workup, followed by recrystallisation from boiling EtOH/H2O 1:1, resulted in 
72% N6-benzoyladenine and 85% N2-isobutyrylguanine (Scheme 12). 
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Scheme 12 Preparation of N6-benzoyladenine and N2-isobutyrylguanine according to Bullock et al.77  
and Benner and coworkers.78 
 
The preparation of the β-D-homo-DNA-purine nucleosides 53β and 54β was more 
challenging than the preparation of the β-D-homo-DNA-pyrimidine nucleosides 48 and 50 
(Scheme 13): homo-DNA-adenine-nucleoside 53 was prepared from a solution of 22 and N6-
benzoyladenine in CH3CN by the addition of hexamethyldisilazane/Me3SiCl, followed by SnCl4, 
which resulted in a homogenous solution that was worked up after a reaction time of 20 h at rt 
(Scheme 13). After column chromatography, a 53β/53α 74:26 mixture was obtained in a yield of 
53%. Further attempts to separate the anomers 53β and 53α by chromatography and 
crystallization failed. Homo-deoxyguanosine 54 was prepared from the in situ per-silylated N2-
isobutyrylguanine with dibenzoylpyranoside 22 under CF3SO3SiMe3 catalysis in refluxing 
CH3CN. The reaction resulted in a mixture of N9-β-D/N9-α-D/N7-β-D in an 80:14:6 ratio with a 
total yield of 37%. Both couplings to the β-D-homo-DNA-purin-nucleosides resulted in formation 
of enolether 56 as side product, most likely resulting from an intramolecular stabilization of the 
intermediate oxonium ion. 
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Scheme 13 Vorbrüggen nucleoside synthesis for the preparation of the of homo-DNA-adenine and 
homo-DNA-guanine-nucleosides 53 and 54, respectively (top) and determination of the N9-β-
D/N9-α-D/N7-β-D-ratio for 54 (55) by integration of HC(1’) (1H-NMR) (bottom). 
 
The acetyl protecting groups from pyrimidine nucleoside 48 were removed by treatment 
with NH3/MeOH (Scheme 14) in 91% yield. In the case of the homo-deoxycitidine derivative 50, 
the acetyl protecting groups were selectively removed with 0.2 N NaOH at 0° in 25 min, directly 
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forming the N4-protected precursor 58 necessary for oligonucleotide synthesis in a yield of 82%. 
N6-benzoyl-homo-deoxyadenosine 59 was obtained under the same deprotection conditions 
applied for the preparation of 58. The α-D- and β-D-anomers of the adenine-nucleoside 59 were 
separated by recrystallisation from boiling MeOH, resulting in pure-β-D-homo-deoxyadenosine 59 
in a 58% yield. After deprotection of the N9-α-D/N9-β-D/N7-β-D mixture of the homo-guanosine 
54β/54α/55β derivatives, the N7-β-D-isomer was separated from N9-α-D/N9-β-D-isomers by 
chromatography resulting in an anomeric mixture of 60β/60α  = 83/17.  
 
 
Scheme 14 Deprotection of the homo-DNA-nucleosides 48, 50, 53 and 54. 
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4.3.4 Synthesis of phosphoramidites of homo-DNA-nucleosides 
 
The precursors 61-64 of the phosphoramidites 65-68 were prepared according to reported 
synthesis protocols.79 Treatment of homo-uridine 57 with chloro(4,4’-
dimethoxytriphenyl)methane ((MeO)2TrCl) in pyridine with 4-(dimethylamino)pyridine (DMAP) 
as acylating catalyst and a tertiary amino base resulted selectively in the primary hydroxy-
alkylated dimethoxytrityl derivative 61. For the benzoylcytosine-, benzoyladenine- and 
isobutyric-guanosine derivatives 58-60, tetrabutylammonium perchlorate ((Bu4N)ClO4) was used 
as acylating catalyst as described by Beaucage and coworkers,80 because Eschenmoser and 
coworkers reported that DMAP only resulted in low yielding dimethoxytritylation (Scheme 15) in 
these cases.32a In the case of the guanosine derivative 60, the dimethoxytritylether formation on 
the primary hydroxy group allowed a separation of the two anomer: 64β was separated from 
64α by chromatography on SiO2. 
 
 
 
 
Starting 
material Nucleobase Catalyst Reaction time Yield product 
57 uracil DMAP/Et3N 3.5 h 75% 61 
58 Bz4cytosine (Bu4N)ClO4 1 h 81% 62 
59 Bz6adenine (Bu4N)ClO4 1 h 91% 63 
 
DMAP = 4-(dimethylamino)pyridine  
 
O
HO
OH
base
(MeO)2TrCl
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pyridine, rt
O
HO
ODMTr
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Scheme 15 Synthesis of homo-DNA-DMTr-derivatives 61-64 from 4’,6’-diols 57-60. 
 
The dimethoxytrityl precursors 61-64 were converted to the (2-
cyanoethyl)phosphoramidites 65-68 with chloro(2-cyanoethoxy)(diisopropylamino)phosphine and 
Hünig’s-base. The crude phosphoramidites 65-68 were, after aqueous workup and flash-
chromatography on basic silica (addition of Et3N), reprecipitated several times from rapidly 
stirred dichloromethane (resp. EtOAc)/hexane (to remove traces of Et3N that might inactivate the 
acidic activator used for the oligonucleotide-synthesis). Phosphoramidites 65-68 were obtained in 
65-90% yield as 1:1 diastereomeric mixtures (1H and 31P-NMR) (Scheme 16). 
 
 
Starting 
material Nucleobase Solvent Yield product 
61 uracil CH2Cl2 84% 65 
62 Bz4cytosine THF 87% 66 
63 Bz6adenine THF 78% 67 
64 Ibz2guanine THF 67% 68 
 
Scheme 16 Preparation of phosphoramidites 65-68. 
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4.3.5 Synthesis of controlled pore glass (CPG) derivatised homo-DNA-nucleosides 
 
Activated esters 69-72 were prepared from the dimethoxytrityl derivatives 61-64 by an 
reaction with succinic anhydride in pyridine, followed by an esterification of the remaining 
carboxylic acid function with 4-nitrophenol in the presence of N,N’-dicyclohexylcarbodiimide 
(DCC) in good yields (Scheme 17). The 4-nitrophenylesters 69-72 were selectively detected on tlc 
plates by the observation that these compounds undergo a hydrolysis at 120°C, forming the yellow 
4-nitrophenol. Spraying with the acidic mostain reagent (see Exp. Part) resulted in an immediate 
deprotection of the DMTr-protecting group and formation of the orange 4,4’-(dimethoxy)trityl-
cation (λmax. 498 nm) (Scheme 17, bottom). Another heating step to 180°C changed the color to 
brown, a color also observed for other sugar containing compounds with mostain reagent. 
Activated esters 69-72 were immobilized on “controlled pore glass” (CPG) covered with 
alkylamino-groups. In first attempts, a 500 Å pore size, highly loaded (140 µmol/g) long chain 
alkylamine-CPG (LCAA-CPG) resin (3-prime) with a grain size of 75-125 µm was used. This 
LCAA-CPG had the disadvantage that it was necessary to perform filtration over P4-glas-filter 
funnels (pore size 10-16 µm), resulting in a slow filtration. This problem was circumvented by 
using a 500 Å pore size LCAA-CPG with a larger grain size of 125-175 µm (SynGen) and a lower 
loading capacity (60-80 µmol/g) making faster filtrations with P3-glass filter funnels (pore size 
16-40 µm) possible. All reported loading capacities in Scheme 17 refer to the SynGen-LCAA-CPG 
with the larger particle size. The highly loaded LCAA-CPG (smaller particle size) was coated 
with higher loading capacities (typically values > 45 µmol/g were found for the 3-prime-LCAA-
CPG (data not shown)). The loading of the support was performed in a reaction of the activated 
esters 69-72 with a suspension of LCAA-CPG in DMF/dioxane/Et3N during 20-24 h at rt. During 
the addition of the solution containing the 4-nitrophenylesters 69-72, the suspension immediately 
turned yellow, due to the formation of 4-nitrophenol. Capping the remaining free amino groups on 
the LCAA-CPG as amides with Ac2O/DMAP in pyridine for 10-90 min resulted in the homo-
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DNA-derivatised, capped LCAA-CPG-solid supports. If free primary amino groups were detected 
on the support by a ninhydrin tests according to a procedure described by Kaiser et al.81 for the 
protein synthesis, another capping step with Ac2O/DMAP in pyridine was performed. This step 
was repeated until the ninhydrin test showed negative results. 
 
 
 
 
 
 
 
 
 
 
Scheme 17 Preparation of polymer-bound protected homo-deoxyribonucleosides. Loading 
capacities (µmol/g) were obtained, as measured by photometric trityl assay (top) and selective 
detection of 4-nitrophenylesters (69-72) on tlc plates (bottom). 
 
120° C mostaine 180°C
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The loadings of the supports were determined by a photometric determination of the 
concentration of the 4,4’-(dimethoxy)trityl cation (λmax. 498 nm, ε498 = 70000),  produced from a 
defined aliquot of the derivatised support under acidic catalysis (0.1 M TsOH in CH3CN or 2% 
dichloroacetic acid in CH2Cl2) (Fig. 32).79  
 
 
 
 
 
 
 
 
 
 
Fig. 32 Example of a UV-spectrum of the 4,4’-dimethoxytrityl-cation obtained from deprotection 
of derivatised LCAA-CPG-support under acid catalysis, showing a strong absorption at 498 nm 
(ε498 = 70000). 
 
4.3.6 Synthesis of phosphoramidites of homo-DNA-C-nucleosides 
 
The conversion of completely deprotected homo-DNA-C-alkyl- and homo-DNA-C-aryl-
nucleosides 10 and 36 into the N-benzoyl-derivatives 73 and 74 was performed in a one pot 
reaction referring to known methods.79 Silylation of the free OH-groups with Me3SiCl in pyridine 
at 0°, followed by benzoylation of the NH2-functionality with BzCl and a deprotection of the bis-
trimethylsilylethers with aq. NH3, resulted in N-benzoylated homo-DNA-C-alkyl-nucleoside 73 
and N-benzoylated homo-DNA-C-aryl-nucleoside 74 with yields of 80 and 59%, respectively 
(Scheme 18).  
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Scheme 18 Synthesis of N-benzoyl-homo-DNA-C-alkyl- and N-benzoyl-homo-DNA-C-aryl-
nucleosides 73 and 74. 
 
The nucleosides 75 and 76 were prepared according to reported synthetic protocols.79 
Treatment of homo-DNA-C-alkyl-nucleoside 73 with chloro(4,4’-dimethoxytriphenyl)methane 
((MeO)2TrCl) in pyridine with tetrabutylammonium perchlorate ((Bu4N)ClO4) as acylating 
catalyst resulted in selective alkylation of the primary hydroxy as dimethoxytrityl derivative 75.80 
Attempts to apply  4-(dimethylamino)pyridine (DMAP) as acylating catalyst resulted in poor 
conversion in the case of homo-DNA-C-alkyl-nucleoside 73, as it was already described by 
Eschenmoser and coworkers (Scheme 19) for other N-amide-protected homo-DNA-nucleosides, 
especially benzoylcytosine-, benzoyladenine- and isobutyric-guanosine-derivatives 58-60.32a  The 
homo-DNA-C-aryl-nucleoside 74 was converted to the dimethoxytrityl-derivative 76 under 
similar conditions as those applied to 73 with (Bu4N)ClO4 as acylating catalyst. Both conversions 
proceeded in yields of over 80%. 
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Scheme 19 Synthesis of the 4,4’-dimethoxytrityl derivatives of homo-DNA-C-alkyl- and homo-
DNA-C-aryl-nucleosides 75 and 76. 
 
The dimethoxytrityl precursors 75, and 76 were converted to the (2-
cyanoethyl)phosphoramidites 77, and 78 with chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
and Hünig’s-base. The crude phosphoramidites 77, and 78 were, after aqueous workup and flash-
chromatography on basic silica (addition of Et3N), reprecipitated three times from rapidly stirred 
dichloromethane/hexane. (2-cyanoethyl)phosphoramidites. 77 and  78 were obtained in 54% yield 
as 1:1 diastereomeric mixtures (according to 1H- and 31P-NMR) (Scheme 20). 
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Scheme 20 Conversion of dimethoxytrityl-derivatives 75, and 76 to (2-
cyanoethyl)phosphoramidites 77, and 78. 
 
4.3.7 Oligonucleotide synthesis 
 
Oligonucleotides in amounts >3 µmol were prepared by manual solid-phase synthesis 
according to reported procedures79 with application of (2-cyanoethyl)phosphoramidites as 
monomer units and 5-(ethylthio)-1H-tetrazole as activator. Small scale oligonucleotide 
preparations <1 µmol (typically 0.2 µmol or 0.4 µmol) for characterisation, UV-melting curve 
studies, CD and neg. ESI- resp. MALDI-TOF-MS were performed with (2-
cyanoethyl)phosphoramidites on a DNA-synthesizer (Expedite NAS 8905, Applied Biosystems), 
using a protocol developed for DNA synthesis and successfully applied for homo-DNA 
synthesis.32a Our protocol varied from the standard specification according to Applied Biosystems 
in the coupling times, which were increased for some couplings (see Experimental part), the 
activator (the more acidic and more potent 5-(ethyltio)-1H-tetrazol instead of 1H-tetrazol was 
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used)  and in later synthesis the concentration of (2-cyanoethyl)phosphoramidites in later 
synthesis (0.05 M compared to 0.1 M), allowing a reduction of the (2-cyanoethyl)phosphoramidite 
used for purging the lines (Scheme 21). The chain construction cycle consisted of four steps:  
1.) Acidic cleavage of the DMTr-protecting group and release of the 6’-OH-group of the 
support-bound nucleoside (respectively oligonucleotide). 
2.) Coupling with the 5-(ethylthio)-1H-tetrazol activated (2-cyanoethyl)phosphoramidite. 
3.) Capping of uncoupled 6’-OH-groups with Ac2O. 
4.) Oxidation of the phosphite to the phosphate with an aqueous I2-solution. 
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1.) deprotection: 3% trichloroacetic acid in CH2Cl2,40s , wash
2.) coupling: 0.1M phosphoramidite (10 eq) in CH3CN,
0.5M 5-(ethylthio)-1H-tetrazol (30 eq) in CH3CN, 1.5 to 5 min, wash
3.) capping: 7% 1-methylimidazole in
THF/ 2,6-dimethylpyridine/ Ac2O 15:1:1, 30s, wash
4.) oxidation: 0.1 M I2 in THF/pyridine/H2O 4:1:0.1, 50s wash
5.) deprotection: 3% trichloroacetic acid in CH2Cl2, 40s, wash
6.) conc. NH3-solution, 20h, 55°.
1.) deprotection: 2% dichloroacetic acid in CH2Cl2, 2min, wash
2.) coupling: phosphoramidite (8 eq.), 30 eq 5-(ethylthio)-1H -tetrazol,
CH3CN, 1h, wash
3.) capping: DMAP, Ac2O, 2,6-dimethylpyridine, THF, 5 min, wash
4.) oxidation: I2, THF/H2O/2,6-dimethylpyridine 2:2:1, 1 min, wash
5.) deprotection: 2% dichloroacetic acid in CH2Cl2, 2min, wash
6.) conc. NH3-solution, 20h, 55°.
Expedite NAS 8905, DNA synthesizer
chain
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the support
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Scheme 21 Oligonucleotide synthesis cycle for Expedite NAS 8905 DNA synthesizer (Applied 
Biosystems) and manual oligonucleotide synthesis (right), Expedite NAS 8905 DNA synthesizer 
(Applied Biosystems) (middle, left), and apparatus constructed for manual oligonucleotide 
synthesis (bottom, left). 
 
Coupling yields were determined according to the photometric dimethoxytrityl cation 
assay (Fig. 32) and were typically >97% for the automated homo-DNA synthesis. In the manual 
homo-DNA synthesis a coupling yield of >98% was observed. After finishing chain elongation, 
the deprotection process was initiated by cleavage of the 6’-terminal dimethoxytrityl group, 
followed by a release from the support and cleavage of all nucleobases- and phosphate-protecting 
groups with concentrated NH3-solution at 55° C for 20 h resulting in homo-DNA-
oligodeoxyribonucleotides as crude materials. The purity of these homo-DNA-oligonucleotides 
was determined by reversed-phase (RP) C18-HPLC (C18-Waters Spherisorb ODS2, 5 µm, 250x4.6 
mm) using a linear gradient of CH3CN in 0.1 M aqueous (Et3NH)OAc, pH 7.0 or DEAE-ion 
exchange (IE) HPLC (Nucleogen-DEAE 60-7, Macherey-Nagel) with a linear KCl-gradient in 20 
mM KH2PO4, pH 6.0, in H2O/CH3CN 4:1. If necessary, oligonucleotides were purified by an 
identical HPLC-method. It was shown by MALDI-TOF-MS of several homo-DNA-
oligonucleotides prepared with poor coupling yields (about 80%) that C18-RP- and DEAE-ion 
exchange-HPLC allow a separation of mixtures containing homo-DNA-oligonucleotides, which 
only differentiate in chain length in a single nucleotide. Pure homo-DNA oligonucleotide 
sequences were purified by precipitation from 70% EtOH / 30 % 0.3 M  Na-acetate in H2O, pH = 
4.8. 
First attempts to analyze homo-DNA-oligonucleotides were performed with negative 
electrospray ionisation (ESI)-MS, producing good results for the monoanionic dinucleotide 
ddGlc[U2]. However, polyanionic homo-DNA species with the general formula 
ddGlc[AaBbCcDdEe], Σa,b,c,d,e>2 gave results that were difficult to interpretate. The homo-DNA-
hexamer ddGlc[(UA)3], for example, showed numerous signals in the neg. ESI-MS, of which the 
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dianionic species [m+3H]2-, [m+2H+Na]2-, [m+2H+K]2-, [m+H+2Na]2- were the most intensive 
ones (Fig. 33, bottom).  
 
 
 
 
 
 
 
 
 
 
Fig. 33 Neg. ESI-MS of the dimer ddGlc[U2] (top) and the hexamer ddGlc[(UA)3] (bottom). 
 
For homo-DNA-oligonucleotides with the general formula ddGlc[AaBbCcDdEe], Σa,b,c,d,e>2, 
the method of choice for analysis was matrix-assisted laser desorption/ionization (MALDI) time-
of-flight (TOF) MS with a 6-aza-2-thiothymine (ATT) matrix.82 MALDI-TOF measurement under 
these conditions resulted, also for longer polyanionic homo-DNA sequences, in a main peak 
corresponding to the molecular monoanion of the oligomer (Fig. 34). 
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Fig. 34 MALDI-TOF MS (matrix: 6-aza-2-thiothymine) of the 9-mer ddGlc[UD8]. The main peak 
corresponds to the molecular monoanion of the corresponding oligomer. 
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Sequence 
Manual (m) or 
automatic (a) 
oligonucleotide-
synthesis 
Scale 
[µmol] Coupling time 
C18-RP-HPLC (buffer A/B) or 
Nucleogen DEAE 60-7-IE-
HPLC (buffer C/D), retention 
time 
MS analysis (method, calc., found) 
ddGlc[U2] m 3.5 60 min 0-20% B in 17min, tR = 13.9 min Neg. HR-ESI calc. [m]- 545.1285, found 545.1291 
ddGlc[U2] a 0.2 3 min 30 s 0-20% B in 17min, tR = 13.9 min Neg. ESI, calc. [m]- 545.1, found 545.1 
ddGlc[U3] a 0.2 3 min 30 s 0-30% B in 27 min, tR = 15.1 min  
ddGlc[U4] a 0.2 1 min 30 s 0-30% B in 27 min, tR = 15.2 min  
ddGlc [U6] a 0.2 3 min 30 s 0-50% B in 12 min, tR = 8.7 min  
ddGlc[4’(UA)36’] a 0.2 3 min 30 s 0-30% B in 27min, tR = 18.0 min
Neg. ESI, calc. [m+3H]2- 1829.4, found 1829.4 // 
calc. [m+2H+Na]2- 1851.4, found 1851.2 // 
[m+2H+K]2- 1867.3, found 1867.2 
ddGlc[4’(UA)46’] a 0.2 3 min 30 s 0-30% B in 25 min, tR = 18.5 min 
Neg. ESI, calc. [m+5H]2- 2460.5, found 2461.0 
//calc. [m+4H+Na]2- 2482.5, found 2482.3 // calc. 
[m+3H+2Na]2- 2504.5, found 2505.2 
ddGlc[C7] a 0.2 1 min 30 s 0-30% B in 25 min, tR = 16.4 min 
MALDI-TOF (Matrix ATT), calc. [m+5H]- 2058.4, 
found 2058.7 
ddGlc[G7] a 0.2 3 min 30 s  MALDI-TOF (Matrix ATT), calc. [m+5H]
-
 2338.5, 
found 2337.8 
ddGlc[4’UD86’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 20.8 min 
MALDI-TOF (Matrix ATT), calc. [m+7H]- 2649.7, 
found 2649.7 
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ddGlc[4’UAUD(UA)26’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 15.5 min 
MALDI-TOF (Matrix ATT), calc. [m+6H]- 2435.5, 
found 2435.5 
ddGlc[4’UD(UA)36’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 14.6 min 
MALDI-TOF (Matrix ATT), calc. [m+6H]- 2435.5, 
found 2435.3 
ddGlc[4’(UA)2UD(UA)26’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 17.6 min 
MALDI-TOF (Matrix ATT), calc. [m+8H]- 3066.6, 
found 3066.5 
ddGlc[4’(UA)3UD(UA)36’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 24.4 min 
MALDI-TOF (Matrix ATT), calc. [m+12H]- 4328.9, 
found 4329.2 
ddGlc[U8] a 0.4 1 min 30 s  15-75% D in 30 min, tR = 9.7 min 
MALDI-TOF (Matrix ATT), calc. [m+5H]- 2369.4, 
found 2369.2 
ddGlc[4’(UA)56’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 20.2 min 
MALDI-TOF (Matrix ATT), calc. [m+8H]- 3092.6, 
found 3092.6 
ddGlc[4’AADA56’] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 23.1 min 
MALDI-TOF (Matrix ATT), calc. [m+6H]- 2527.6, 
found 2527.5 
ddGlc[A8] a 0.4 1 min 30 s 15-75% D in 30 min, tR = 26.4 min 
MALDI-TOF (Matrix ATT), calc. [m+6H]- 2553.6, 
found 2553.5 
ddGlc[4’UCACAUAUG6’] a 0.4 1 min 30 s   
ddGlc[4’UCACCUAUG6’] a 0.4 1 min 30 s   
ddGlc[4’UCACGUAUG6’] a 0.4 1 min 30 s   
ddGlc[4’UCACUUAUG6’] a 0.4 1 min 30 s   
ddGlc[4’CAUADGUGA6’] a 0.4 1 min 30 s   
ddGlc[4’CAUAAGUGA6’] a 0.4 1 min 30 s   
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A =  0.1 M (HNEt3)OAc in H2O, pH 7.0    C =  20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0 
B =  CH3CN        D = 1 M KCl, 20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0 
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4.4 Base pairing studies 
 
In order to evaluate the influence of exchanging a homo-DNA-adenine nucleotide against the 
corresponding 2,4-diaminopyrimidine nucleotide both self-complementary and not self-
complementary homo-DNA sequences were investigated (Fig. 35).  
 
 
 
Fig. 35 homo-DNA adenine nucleotide (left) and C-analoga of a homo-DNA 2,4-diaminopyrimidine 
nucleotide (right). 
 
Within the studies of self-complementary homo-DNA sequences three questions were assessed: 
1.) In homo-DNA sequences with the general formula ddGlc[(AU)n] the influence of the adenine 
– 2,4-diaminopyrimidine exchange in Watson-Crick A-U base pairings was evaluated. 
2.) In self-complementary poly-adenine homo-DNA oligonucleotides the influence of adenine – 
2,4-diaminopyrimidine exchanges on reverse Hoogsteen A-A base pairings was evaluated. 
3.) In non self-complementary homo-DNA sequences with the general formula ddGlc[4’CAUA-
X-GUGA6’] and ddGlc[4’UCAC-Y-UAUG6’] the influence of an adenine – 2,4-
diaminopyrimdine exchange in position X with Y being uracil, adenine, cytosine and guanine 
was evaluated.  
 
4.4.1 Self-complementary sequences 
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4.4.1.1 Homo-DNA sequences with the general formula ddGlc[(AU)n] 
 
Because of the reported strong reverse-Hoogsten-base-pairing of ddGlc[An], with n>4  
(see 3.2.1) which could not be broken up by the addition of ddGlc[Tn], with n>4 as it was reported 
by Eschenmoser and coworkers,32c it had to be expected that, as the Watson-Crick A-T base-
pairing, also the Watson-Crick A-U-base-pairing in the homo-DNA-system would be detectable in 
self-complementary sequences like ddGlc[(AU)n], but not by addition of ddGlc[Un] to ddGlc[An]. 
For that reason was decided to make a comparison of a Watson-Crick adenine-uracil base pairing 
with a diaminopyrimidine-uracil base pairing in self-complementary oligonucleotides with the 
general formula ddGlc[(AU)n] in which a single adenine nucleotide was replaced by a 
diaminopyrimidine nucleotide. It was shown, as it will be reported in the next few paragraphs, that 
the influence of a single adenine-diaminopyrimidine exchange was especially influenced by two 
parameters:  
1.) the position of the modification: A replacement of an adenine nucleotide in a central 
position had a more disturbing influence on the duplex stability (expressed by Tm) compared to an 
adenine-dimaminopyrimidine exchange near the 4’-end of a homo-DNA-oligonucleotide.  
2.) for central adenine-diaminopyrimidine exchanges, a strong dependency of the melting 
behavior from the chain length was observed: The decamer ddGlc[(UA)2UD(UA)2] showed a 
decrease of Tm with increasing oligonucleotide concentration in solution. For the 14-mer 
ddGlc[(UA)3UD(UA)3] a decreasing Tm with increasing concentration was found for 
concentrations >6 µM. For concentrations <6 µM, no concentration dependency of the Tm was 
observed in the 14-mer ddGlc[(UA)3UD(UA)3] indicating intramolecular interaction. 
From the self-complementary (referring to antiparallel strand orientation) ddGlc[(UA)n] 
with n =3 and 4 melting curves were determined in 0.15 M NaCl, 0.01 M TrisHCl buffer, pH 7.0 
by temperature dependant UV- and CD-spectroscopy of solutions with different oligonucleotide 
concentrations. The oligonucleotide concentrations in solution were determined by a comparison 
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of the calculated sum of the extinction coefficients of all mononucleosides at λ = 260 nm with the 
measured optical density at this wavelength at a temperature T higher than the experimentally 
determined melting point for this oligonucleotide. Tm values were determined according to values 
obtained from UV-melting curves (if at the λmax value a strong CD signal was observed, Tm values 
were determined according to mean values obtained from UV- and CD-melting curves). Van’t 
Hoff-pairing enthalpies (∆H) and –entropies (∆S) were determined according to described 
methods83 by a linear correlation of the reciprocally Tm-values to the logarithm of the 
oligonucleotide concentration (see experimental part). An indication of the errors of the data was 
derived from the R2-factors of this linear regression (Fig. 36, Fig. 37). 
 
ddGlc[(UA)3] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Fig. 36 UV-melting curve of the hexanucleotide ddGlc[(UA)3] in 0.15 M NaCl 0.01 M TrisHCl, 
pH 7.0. The increasing hyperchromicity values with increasing oligonucleotid concentration 
indicate that the hexamer ddGlc[(UA)3] was already partially melted at the lowest measured 
temperature (t = 2.5 °C). 
 
In the temperature dependent UV-melting curve of the hexamer ddGlc[(UA)3] increasing 
hyperchromicity values for increasing oligonucleotide concentratrations were detected. The 3.0 
µM solution showed a hyperchromicity of 3 % (Fig. 36, blue melting curve), this value was 
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increased to 4.5 % for the 9.0 µM oligonucleotide solution (Fig. 36, black melting curve), 6 % for 
the 10.8 µM solution (Fig. 36, green melting curve) and reached 7.5 % for the highest measured 
28.1 µM solution (Fig. 36, red melting curve), indicating that even with the 28.1 µM solution the 
homo-DNA-oligonucleotide is partially melted at t = 2.5 °C, the lowest measured temperature 
(water based temperature control unit). This interpretation was confirmed by the observation that 
for the octanucleotide ddGlc[(UA)4] in a concentration range between 0.6 µM and 7.1 µM 
constant hyperchromicity values of about 17 % were obtained (Fig. 37, top). For the hexamer 
ddGlc[(UA)3] no calculation of Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) was 
performed, because the prerequisite for this determination is the observation of the completely 
unmelted duplex (method see83b,84). 
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[(UA)4] 0.6 12.0 16 (260 nm) 
ddGlc[(UA)4] 1.8 16.5 18 (260 nm) 
ddGlc[(UA)4] 6.0 22.0 17 (260 nm) 
ddGlc[(UA)4] 7.1 22.5 17 (260 nm) 
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ddGlc[(UA)4] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[(UA)4] -163 -452 -28.1 
 
Fig. 37 UV-melting curves of different oligonucleotide concentrations of the octanucleotide 
ddGlc[(UA)4] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0 (top), determined Tm values (average 
values obtained from UV- and CD-melting (data not shown)), hyperchromicities (middle), and 
linear regression 1/Tm vs. ln(c) resulting in ∆H and ∆S values (bottom). 
 
For the octamer ddGlc[(UA)4], a sigmoid melting curve was obtained with constant 
hyperchromicity values (of about 17 %) for an oligonucleotide concentration between 0.6 µM and 
7.1 µM (Fig. 37, middle). As expected for an intermolecular interaction, the Tm values were 
increased with increasing oligonucleotide concentrations in solution. The R2-value of 0.999 of the 
linear regression 1/Tm vs. ln(c) indicated a good fitting of the data and the determination of the 
Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S), resulted in ∆H = -163 kJ/mol and ∆S = -
452 J/(mol*K) (Fig. 37).  
In the self-complementary octamer ddGlc [UD(UA)3], a sigmoid melting curve was 
obtained with constant hyperchromicity values (of 10-11 %) for an oligonucleotide concentrations 
between 27.5 µM and 14.1 µM. With lower oligonucleotide concentrations than 14.1 µM, the 
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hyperchromicity values were decreased, indicating a partially melted duplex at the initial 
temperature 2.5 °C (data not shown). As expected for intermolecular duplex formation the Tm 
values were increased with increasing oligonucleotide concentration in solution. The R2-value of 
0.994 of the linear regression 1/Tm vs. ln(c) indicated a good fitting of the data and the 
determination of the Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S), resulted in ∆H = -
165 kJ/mol and ∆S = -485 J/(mol*K) (Fig. 38).  
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[UD(UA)3] 14.1 12.5 9 (260 nm) 
ddGlc[UD(UA)3] 18.4 13.8 10 (260 nm) 
ddGlc[UD(UA)3] 21.0 14.2 11 (260 nm) 
ddGlc[UD(UA)3] 27.5 15.3 11 (260 nm) 
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ddGlc[UD(UA)3] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0 in H2O
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[UD(UA)3] -165 -485 -20.5 
 
Fig. 38 UV-melting curves of different oligonucleotide concentrations of the octanucleotide 
ddGlc[UD(UA)3] in 0.15 M NaCl, 0.01 M TrisHCl, pH 7.0 (top), determined Tm values (values 
obtained from UV- melting) hyperchromicities (middle), and linear regression 1/Tm vs. ln(c) 
resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) (bottom). 
 
The comparison of the data obtained from the octamers ddGlc[(UA)4] and 
ddGlc[UD(UA)3] showed the following effects (Fig. 39): A decrease of the hyperchromicity 
values from about 17 % for ddGlc[(UA)4] to 10 % for ddGlc[UD(UA)4] was observed. The 
exchange of two Watson-Crick-adenine-uracil base pairs by two diaminopyrimidine-uracil base 
pairs, resulted in a weakening of the duplex stability at a concentration of 10 µM from 24.1 °C for 
ddGlc[(UA)4] to 11.0 °C for ddGlc[UD(UA)3] (calculated values according to the linear 
regression 1/Tm vs. ln (c) made for both oligonucleotides, for details see experimental part). This 
value corresponded to a weakening of duplex stability expressed by Tm of 6.5 °C per exchange of 
a single Watson-Crick adenine-uracil vs. a diaminopyrimidine-uracil base pair, under the 
assumption that also ddGlc[UD(UA)3] forms antiparallel oriented Watson-Crick base pairs, as it 
was shown for the dodecamer ddGlc[(UA)6].32  
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Although no direct Tm comparison between the octamer ddGlc [UD(UA)3] and the 
hexamer ddGlc[(UA)3] was accessible, due to the difficulty to observe the fully unmelted state in 
the hexamer ddGlc[(UA)3], it is clear that the duplex stability is higher in the octamer 
ddGlc[UD(UA)3], clearly indicating a diaminopyrimidine-uracil base pairing. 
 DdGlc[UD(UA)3] showed a broader melting region compared to ddGlc[(UA)4]. An 
evaluation of melting data obtained from melting curves of different oligonucleotide 
concentrations of both oligonucleotides showed that the lower duplex stability of 
ddGlc[UD(UA)3] compared to ddGlc[(UA)4] is only due to entropic reasons, but not to enthalpic 
reasons (Fig. 39). The replacement of two adenine-uracil Watson-Crick base pair against two 
diaminopyrimidine-uracil base pairs does not enthalpically destabilize the octamer 
ddGlc[UD(UA)3] compared to ddGlc[(UA)4].  
 
ddGlc[UD(UA)3] and ddGlc[(UA)4]  in 0.15 M NaCl, 0.01 M 
TrisHCl pH 7.0 in H2O
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[UD(UA)3] -165 -485 -20.5 
ddGlc[(UA)4] -163 -452 -28.1 
 
Fig. 39 UV-melting curves of the octanucleotides ddGlc[(UA)4] and ddGlc[UD(UA)3]in 0.15 M 
NaCl 0.01 M TrisHCl, pH 7.0. 
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It is tempting to speculate that this entropic destabilization is due to an increased 
flexibility of the nucleobase in the homo-DNA diaminopyrimidine nucleoside compared to the 
corresponding adenine nucleoside (Fig. 40). 
 
 
 
Fig. 40 Additional degrees of freedom of a C-analoga of a 2,4-diaminopyrimdine homo-DNA-
nucleotide (left) compared to the corresponding adenine nucleotide (right). 
 
The replacement of a homo-DNA adenine nucleotide against the corresponding 
diaminopyrimidine nucleotide in a central position had a much stronger influence on the homo-
DNA duplex stability than the replacement of a homo-DNA adenine nucleotide near the 4’-end of 
the homo-DNA-oligonucleotide: In the temperature dependent UV-melting curve of the octamer 
ddGlc[UAUD(UA)2] an increasing hyperchromicity value for increasing oligonucleotide 
concentration was detected: The 14.9 µM solution showed a hyperchromicity of 2 % (Fig. 41, 
blue melting curve), this value was increased to more than 3 % for the 22.7 µM and the  34.4 µM 
oligonucleotide solution (Fig. 41, black melting curve, green melting curve). This observation 
together with the low hyperchromicity values observed for ddGlc[UAUD(UA)2] compared to 
ddGlc[UD(UA)3] indicated that even with the 34.4 µM solution the homo-DNA-oligonucleotide 
was partially melted at t = 2.5 °C, the lowest measured temperature (water based temperature 
control unit). For the octamer ddGlc[UAUD(UA)2] no calculation of Van’t Hoff-pairing enthalpies 
(∆H) and –entropies (∆S) was performed, because the prerequisite for this determination is the 
observation of the completely unmelted duplex (method see83b,84) . 
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ddGlc[UAUD(UA)2] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in 
H2O
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Fig. 41 UV-melting curve of the octanucleotide ddGlc[UAUD(UA)2] in 0.15 M NaCl 0.01 M 
TrisHCl, pH 7.0. The increasing hyperchromicity values with increasing 
oligonucleotidconcentration indicate that the octamer was already partially melted at the lowest 
measured temperature (t = 2.5 °C). 
 
A comparison of the melting curves of the unmodified ddGlc[(UA)4] with 
ddGlc[UD(UA)3] and ddGlc[UAUD(UA)2] showed that the duplex destabilization of a 2,4-
diaminopyrimidine nucleotide is much stronger in a central position than near the 4’-end of the 
homo-DNA-oligonucleotide (Fig. 42). 
 
 
Chapter 4: Own work 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 91  
ddGlc[UD(UA)3], ddGlc[(UA)4] and ddGlc[UAUD(UA)2]  in 0.15 M 
NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Fig. 42 UV-melting curve of the octanucleotides ddGlc[(UA)4], ddGlc[UD(UA)3] and 
ddGlc[UAUD(UA)2] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0. 
 
The dramatic decrease of duplex stability by the incorporation of a 2,4-diaminopyrimidine 
nucleotide in a central position of the self-complementary homo-DNA octanucleotide 
ddGlc[(UA)4] let us investigate the destabilizing effect of central 2,4-diaminopyrimidine 
nucleotides in longer homo-DNA oligonucleotides. If the 2,4-diaminopyrimidine nucleotide was 
incorporated near the 4’-end of the homo-DNA oligonucleotide the duplex destabilization by the 
2,4-diaminopyrimidine nucleotide is only due to entropic but not due to enthalpic reasons. 
 The decamer ddGlc[(UA)5] was analyzed according to similar methods described for 
other homo-DNA oligonucleotides (see ddGlc[(UA)4]). A sigmoid melting curve was obtained for 
ddGlc[(UA)5] with hyperchromicity values between 13 % and 17 % for oligonucleotide 
concentrations between 24.4 µM and 3.0 µM (Fig. 43, middle). Tm values increased with 
increasing oligonucleotide concentration in solution. The R2-value of 0.997 of the linear 
regression 1/Tm vs. ln(c) indicated a good fitting of the data and the determination of the Van’t 
Hoff-pairing enthalpies (∆H) and –entropies (∆S), resulted in ∆H = -246 kJ/mol and ∆S = -704 
J/(mol*K) (Fig. 43).  
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ddGlc[(UA)5] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[(UA)5] 3.0 30.8 13 (260 nm) 
ddGlc[(UA)5] 5.6 32.4 16 (260 nm) 
ddGlc[(UA)5] 13.0 35.3 17 (260 nm) 
ddGlc[(UA)5] 24.4 37.4 14 (260 nm) 
 
ddGlc[(UA)5] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0 in H2O
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[(UA)5] -246 -704 -36.1 
 
Chapter 4: Own work 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 93  
Fig. 43 UV-melting curves of different oligonucleotide concentrations of the decanucleotide 
ddGlc[(UA)5] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0 (top), determined Tm values (values 
obtained from UV- melting) hyperchromicities (middle), and linear regression 1/Tm vs. ln(c) 
resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) (bottom). 
 
From the modified decamer ddGlc[(UA)2UD(UA)2] a slightly sigmoid melting curve was 
obtained with constant hyperchromicity values of 10 % for oligonucleotide concentrations 
between 30.0 µM and 6.2 µM. The decamer ddGlc[(UA)2UD(UA)2] showed a decrease of Tm with 
increasing oligonucleotide concentration in solution, clearly excluding an intermolecular homo-
DNA duplex formation (Fig. 44).  
 
ddGlc[(UA)2UD(UA)2] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in 
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[(UA)2UD(UA)2] 6.2 28.1 10 (260 nm) 
ddGlc[(UA)2UD(UA)2] 11.5 27.5 11 (260 nm) 
ddGlc[(UA)2UD(UA)2] 16.5 25.8 11 (260 nm) 
ddGlc[(UA)2UD(UA)2] 29.9 24.2 9 (260 nm) 
 
Fig. 44 UV-melting curves of different oligonucleotide concentrations of the decanucleotide 
ddGlc[(UA)2UD(UA)2] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0. 
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The hyperchromicity values of 10 % obtained for ddGlc[(UA)2UD(UA)2] were similar 
compared to hyperchromicity values obtained from ddGlc[UD(UA)3]. The incorporation of a 2,4-
diaminonucleotide in the middle of the oligonucleotide resulted in a much broader melting  region 
between 2.5 °C and 55 °C, compared to the sharp melting of ddGlc[(UA)5] (melting region 
between 20 °C and 50 °C, Fig. 45). 
 
ddGlc[(UA)5] and ddGlc[(UA)2UD(UA)2]  in 0.15 M NaCl 0.01 M 
TrisHCl pH 7.0 in H2O
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Fig. 45 UV-melting curves of the decamers ddGlc[(UA)5] and ddGlc[(UA)2UD(UA)2] in 0.15 M 
NaCl 0.01 M TrisHCl pH 7.0. 
  
The interesting behavior of decreasing Tm value with increasing oligonucleotide 
concentration in solution, observed in the decamer ddGlc[(UA)2UD(UA)2] led us to study the 14-
mer ddGlc[(UA)3UD(UA)3]. For this homo-DNA oligonucleotide, a sigmoid melting curve was 
obtained with hyperchromicity values between 10 % and 13 % for an oligonucleotide 
concentration between 16.0 µM and 4.0 µM (Fig. 46, middle). Similar hyperchromicity values 
were already obtained for the decamer ddGlc[(UA)2UD(UA)2]. The interesting behavior of 
decreasing Tm value with increasing oligonucleotide concentration, already observed in the 
decamer ddGlc[(UA)2UD(UA)2], was also observed in the 14-mer ddGlc[(UA)3UD(UA)3] for 
concentrations >6 µM. The decrease of the Tm values with increasing oligonucleotide 
concentration was more pronounced with the 14-mer ddGlc[(UA)3UD(UA)3] compared to the 
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decamer ddGlc[(UA)2UD(UA)2] (ddGlc[(UA)3UD(UA)3], c = 8.3 µM, Tm = 54.7 °C; c= 16 µM, 
Tm = 48 °C; ddGlc[(UA)2UD(UA)2] c = 6.2 µM, Tm = 28.1 °C, c = 16.5 µM, Tm = 25.8 °C). 
However in the case of the 14-mer ddGlc[(UA)3UD(UA)3] for concentrations smaller than 6 µM 
no further concentration dependency of the Tm values was observed. This experimental evidence 
indicated an intramolecular homo-DNA duplex formation in the 14-mer ddGlc[(UA)3UD(UA)3] 
with concentrations smaller than 6 µM. 
 
 ddGlc[(UA)3UD(UA)3] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[(UA)3UD(UA)3] 4.2 57.4 11 (260 nm) 
ddGlc[(UA)3UD(UA)3] 5.5 57.3 10 (260 nm) 
ddGlc[(UA)3UD(UA)3] 8.3 54.7 12 (260 nm) 
ddGlc[(UA)3UD(UA)3] 9.9 53.7  13 (260 nm) 
ddGlc[(UA)3UD(UA)3] 12.6 52.9 13 (260 nm) 
ddGlc[(UA)3UD(UA)3] 16.0 48.0 11 (260 nm) 
 
Fig. 46 UV-melting curves of different oligonucleotide concentrations of the oligonucleotide 
ddGlc[(UA)3 UD(UA)3] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0. 
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 This data could be explained by an exclusive intramolecular interaction for 
oligonucleotide concentrations smaller than 6 µM. With increasing oligonucleotide concentration, 
a competitive intermolecular duplex formation occurs (Fig. 47). 
 
Fig. 47 Inter- and intramolecular interaction of the 14-mer ddGlc[(UA)3UD(UA)3]. 
 
4.4.1.2 Homo-DNA sequences with the general formula ddGlc[An] 
 
As mentioned in chapter 3.2.1 homo-DNA-[An]-oligonucleotides with n > 5 undergo a  
reverse-Hoogsten base pairing. If an adenine nucleotide is replaced by a  2,4-diaminopyrimidine 
nucleotide a reverse-Hoogsten base pairing is still possible. A replacement of both adenine 
nucleotides by 2,4-diaminopyrimidine nucleotides still allows a 2,4-diaminopyrimidine-2,4-
diaminopyrimidine base pairing (Fig. 48).  
 
Fig. 48 Reverse Hoogsteen adenine-adenine, reverse Hoogsteen 2,4-diaminopyrimidine-adenine and 
2,4-diaminopyrimidine-2,4-diaminopyrimidine analogue of the reverse Hoogsteen base pairings. 
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For comparison data, the octanucleotide ddGlc[A8] was investigated. As expected for an 
intermolecular duplex formation the Tm values increased with increasing oligonucleotide 
concentration in solution. The R2-value of 0.998 of the linear regression 1/Tm vs. ln(c) indicated a 
good fitting of the data and the determination of the Van’t Hoff-pairing enthalpies (∆H) and –
entropies (∆S), resulted in ∆H = -208 kJ/mol and ∆S = -520 J/(mol*K) (Fig. 49). 
 
ddGlc[A8] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[A8] 19.0 66.5 7 (260 nm) 
ddGlc[A8] 11.9 64.5 7 (260 nm) 
ddGlc[A8] 7.1 62.0 7 (260 nm) 
ddGlc[A8] 4.2 60.0 7 (260 nm) 
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ddGlc[A8] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0 in 
H2O
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[A8] -208 -520 -52.9 
 
Fig. 49 UV-melting curve (at 260 nm) of different oligonucleotide concentrations of the 
oligonucleotide ddGlc[A8] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0 and determination of the 
Van’t Hoff-pairing enthalpies and – entropies.
 
 
By a replacement of all adenine nucleotides by 2,4-diaminopyrimidine nucleotides the 
following effects were observed. The melting curve of the nonanucleotide ddGlc[UD8] showed a 
much weaker interaction compared to the octanucleotide ddGlc[A8] (Fig. 50). The low signal to 
noise ratio was due to the low extinction coefficient of the the nonanucleotide ddGlc[UD8] (ε (290 
nm) 2300).  
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ddGlc[UD8] and ddGlc[A8] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Fig. 50 UV-melting curve (at 290 nm) of the nonanucleotide ddGlc[UD8] in 0.15 M NaCl 0.01 M 
TrisHCl, pH 7.0 compared to the UV-melting curve (at 260 nm) of the octanucleotide ddGlc[A8] 
in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0.
 
 
To study the influence of a replacement of single homo-DNA adenine nucleotide against a 
2,4-diaminopyrimidine nucleotide in the octamer ddGlc[A8] a study of the octamer ddGlc[A2DA5] 
was performed. In this oligonucleotide, two reverse Hoogsteen adenine-adenine base pairings are 
replaced against two 2,4-diaminopyrimidine-adenine base pairings. (Fig. 51).  
 
 
Fig. 51 Base pairing in the octamer ddGlc[A2DA5] 
 
The octamer ddGlc[A2DA5] showed a sigmoid melting curve with hyperchromicity values 
between 8 % and 11 % for oligonucleotide concentrations between 26.4 µM and 5.1 µM (Fig. 52, 
middle). As expected for intermolecular interactions the Tm values increased with increasing 
oligonucleotide concentration in solution. The R2-value of 0.943 of the linear regression 1/Tm vs. 
ln(c) indicated an acceptable fitting of the data and the determination of the Van’t Hoff-pairing 
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enthalpies (∆H) and –entropies (∆S), resulted in ∆H = -322 kJ/mol and ∆S = -917 J/(mol*K) (Fig. 
52).  
ddGlc[A2DA5] in 0.15 M NaCl, 0.01 M TrisHCl pH 7.0 in H2O
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[A2DA5] 26.4 47.7 9 (260 nm) 
ddGlc[A2DA5] 17.6 45.7 9 (260 nm) 
ddGlc[A2DA5] 9.5 43.8 11 (260 nm) 
ddGlc[A2DA5] 5.1 43.1 8 (260 nm) 
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[A2DA5] -322 -917 -48.3 
 
Fig. 52 UV-melting curves of different oligonucleotide concentrations of the octanucleotide 
ddGlc[A2DA5] in 0.15 M NaCl 0.01 M TrisHCl, pH 7.0 (top), determined Tm values (values 
obtained from UV- melting) hyperchromicities (middle), and linear regression 1/Tm vs. ln(c) 
resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) (bottom). 
 
A comparison of melting curves obtained for the octanucleotides ddGlc[A8] and ddGlc[A2DA5] 
showed a decrease of Tm from 64.5 °C for the octanucleotide ddGlc[A8] (concentration 11.9 µM) 
to  43.8 °C for ddGlc[A2DA5] (concentration 9.5 µM). As already observed in the octamer 
ddGlc[UD(UA)3] the destabilization of the octamer ddGlc[A2DA5] in comparison to the octamer 
ddGlc[A8] is only due to entropic reasons but not to enthalpic reasons. In the case of 
ddGlc[A2DA5] even an enthalpic stabilization compared to ddGlc[A8] was found (Fig. 53). 
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[A8] -208 -520 -52.9 
ddGlc[A2DA5] -322 -917 -48.3 
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Fig. 53 UV-melting curves of the octanucleotides ddGlc[A2DA5] and ddGlc[A8] in concentrations 
of 9.5 and 11.9 µM respectively (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) and Van’t 
Hoff-pairing enthalpies (∆H) and –entropies (∆S) (bottom). 
 
4.4.2 Non-self-complementary homo-DNA sequences with the general formula 
ddGlc[4’CAUA-X-GUGA6’], ddGlc[4’UCAC-X-UAUG6’] 
 
 For obtaining comparable data a study of the pairing behavior of a 1:1 mixture of the two 
unmodified homo-DNA oligonucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACUUAUG6’] was performed (Fig. 54). 
 
 
Fig. 54 Watson-Crick base pairing in the non self-complementary sequences 
ddGlc[4’CAUAAGUGA6’] and ddGlc[4’UCACUUAUG6’]. 
 
The nonamers ddGlc[4’CAUAAGUGA6’] and ddGlc[4’UCACUUAUG6’] showed a sigmoid 
melting curve with hyperchromicity values between 8 % and 10 % for oligonucleotide 
concentrations between 1.96 µM and 0.83 µM. 
The Tm values were increased with increasing oligonucleotide concentration in solution 
(Fig. 55). The R2-value of 0.985 of the linear regression 1/Tm vs. ln(c) indicated a good fitting of 
the data and the determination of the Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S), 
resulted in ∆H = -152.6 kJ/mol and ∆S = -366 J/(mol*K) (Fig. 55).  
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ddGlc[4'CAUA-A-GUGA6'] and ddGlc[4'UCAC-U-UAUG6'] in 0.15 M NaCl, 
0.01 M TrisHCl pH 7.0
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.96 44.0 6 (260 nm) 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.47 43.0 6 (260 nm) 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.1 41.0 7 (260 nm) 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] 0.83 39.5 11 (260 nm) 
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Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] -152.5 -365.7 -43.5 
 
Fig. 55 UV-melting curves of the nonanucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACUUAUG6’] in concentrations of 1.47 µM and 0.83 µM (values obtained in 0.15 M 
NaCl, TrisHCl pH 7.0) (top), determined Tm values (values obtained from UV- melting) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
  
 The corresponding nonamers incorporating a 2,4-diaminopyrimidine-nucleoside 
ddGlc[4’CAUADGUGA6’] and ddGlc[4’UCACUUAUG6’] resulted in following melting curves 
(Fig. 56). A weak hyperchromicity of 2 to 5 % was found for oligonucleotide concentrations 
between 2.61 µM and 1.10 µM. 
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Oligonucleotide Concentration [µM] Tm [°C] Hyperchromicity (wavelength) [%] 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] 2.61 45.0 2 (260 nm) 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.96 41.5 2 (260 nm) 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.47 38.7 3 (260 nm) 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] 1.10 36.5 5 (260 nm) 
 
ddGlc[4'CAUA-D-GUGA6'] and ddGlc[4'UCAC-U-
UAUG6'] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0
y = -0.000099764x + 0.001932909
R2 = 0.9905
3.12E-03
3.15E-03
3.18E-03
3.21E-03
3.24E-03
-13.2 -13 -12.8 -12.6 -12.4 -12.2 -12
ln (c) [mol/l]
1/
T
m
 [
K
-1
]
 
Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] -83.3 -149.6 -38.7 
 
Fig. 56 UV-melting curves of the nonanucleotides ddGlc[4’CAUADGUGA6’] and 
ddGlc[4’UCACUUAUG6’] in concentrations of 1.47 µM and 1.10 µM (values obtained in 0.15 M 
NaCl in TrisHCl pH 7.0) (top) and linear regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing 
enthalpies (∆H) and –entropies (∆S) (bottom). 
 
 Evaluation of the data as described for the nonanucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACUUAUG6’] resulted in following thermodynamic parameters: Van’t Hoff-pairing 
enthalpy ∆H = -83.3 kJ/mol and –entropy ∆S = -150 J/(mol*K). A comparison of melting curves 
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obtained for the nonamers ddGlc[CAUAAGUGA], ddGlc[UCACUUAUG] and 
ddGlc[CAUADGUGA], ddGlc[UCACUUAUG] showed a decrease of Tm from 41.0 °C from the 
adenine-uracil homo-DNA base pairing to 36.5 °C for the 2,4-diaminopyrimidine-uracil base 
pairing. (concentrations 1.10 µM) (Fig. 57). 
  
Comparison ddGlc[4'CAUA-A-GUGA6'], ddGlc[4'UCAC-U-UAUG6'] with 
ddGlc[4'CAUA-D-GUGA6'], ddGlc[4'UCAC-U-UAUG6'], c =1.10 µmol/L, in 0.15 
M NaCl, 0.01 M TrisHCl pH 7.0
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Fig. 57 Comparison of UV-melting of ddGlc[4’CAUAAGUGA6’], ddGlc[4’UCACUUAUG6’] and 
ddGlc[4’CAUADGUGA6’], ddGlc[4’UCACUUAUG6’], c = 1.10 µM, in 0.15 M NaCl, TrisHCl pH 
7.0. 
 
The same evaluations were performed for the following interactions of homo-DNA-2,4-
diaminopyrimidine nucleotide with the adenine, cytosine and guanine homo-DNA-nucleotide. 
Each base pairing A-A vs. D-A; A-C vs. D-C and A-G vs. D-G was evaluated. (Fig. 58). 
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Fig. 58 Homo-DNA-oligonucleotides investigated. 
 
 The resulting UV-melting, obtained Tm values, linear regressions 1/Tm vs. ln (c) and Van’t 
Hoff-pairing enthalpies (∆H) and –entropies (∆S)  are shown in Fig. 59 - Fig. 64. 
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ddGlc[4'CAUA-A-GUGA6'], ddGlc[4'UCAC-A-
UAUG6'] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0 
y = -0.0000401925x + 0.0027080793
R2 = 0.9702
3.21E-03
3.24E-03
3.27E-03
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K
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 
°C) [kJ/mol] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACAUAUG6’] 1.47 37.5 -206.9 -548.7 -43.3 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACAUAUG6’] 1.10 36 
 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACAUAUG6’] 0.83 35.5 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACAUAUG6’] 0.62 34.0 
 
Fig. 59 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACAUAUG6’] (values obtained in 0.15 M NaCl in TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
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 ddGlc[4'CAUA-D-GUGA6'], ddGlc[4'UCAC-A-UAUG6'] in 0.15 M NaCl, 0.01 M 
TrisHCl pH 7.0
-0.1
0.1
0.3
0.5
0.7
0.9
1.1
0 10 20 30 40 50 60 70 80 90 100
temperature [°C]
fr
ac
ti
o
n
 f
o
ld
ed
 [
θθ θθ
] 1.47 µmol/l
1.1 µmol/l
0.83 µmol/l
 
ddGlc[4'CAUA-D-GUGA6'], ddGlc[4'UCAC-A-
UAUG6'] in 0.15 M NaCl, 0.01 M TrisHCl, pH 7.0 in 
H2O
y = -0.0000748508x + 0.0022720430
R2 = 0.9932
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 
°C) [kJ/mol] 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACAUAUG6’] 1.96 39.0 -111.1 -240.9 -39.3 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACAUAUG6’] 1.47 37.0 
 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACAUAUG6’] 1.10 34.5 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACAUAUG6’] 0.83 33.0 
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Fig. 60 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUADGUGA6’] and 
ddGlc[4’UCACAUAUG6’] (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 
°C) [kJ/mol] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACCUAUG6’] 1.47 34.0 -448.3 -1342.1 -48.1 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACCUAUG6’] 1.10 33.5 
 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACCUAUG6’] 0.83 33.0 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACCUAUG6’] 0.62 32.5 
 
Fig. 61 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACCUAUG6’] (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
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ddGlc[4'CAUA-D-GUGA6'], ddGlc[4'UCAC-C-
UAUG6'] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0 
y = -0.0000654977x + 0.0024771412
R2 = 0.9822
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 
°C) [kJ/mol] 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACCUAUG6’] 1.96 31.0 -126.9 -302.9 -36.6 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACCUAUG6’] 1.47 28.5 
 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACCUAUG6’] 1.14 27.0 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACCUAUG6’] 0.62 24.0 
 
Fig. 62 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUADGUGA6’] and 
ddGlc[4’UCACCUAUG6’] (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
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ddGlc[4'CAUA-A-GUGA6'], ddGlc[4'UCAC-G-UAUG6'] in 0.15 M NaCl, 0.01 M 
TrisHCl pH 7.0
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 
°C) [kJ/mol] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACGUAUG6’] 1.47 34.4 -124.6 -288.1 -38.7 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACGUAUG6’] 1.10 32.0 
 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACGUAUG6’] 0.83 30.4 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACGUAUG6’] 0.62 29.0 
 
Fig. 63 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUAAGUGA6’] and 
ddGlc[4’UCACGUAUG6’] (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
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ddGlc[4'CAUA-D-GUGA6'], ddGlc[4'UCAC-G-
UAUG6'] in 0.15 M NaCl, 0.01 M TrisHCl pH  7.0
y = -0.000102394x + 0.001949142
R2 = 0.9915
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Oligonucleotide Concentration [µM] 
Tm 
[°C] 
∆H 
[kJ/mol] 
∆S 
[J/(mol*K)] 
∆G (T=25 °C) 
[kJ/mol] 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACGUAUG6’] 1.96 37.0 -81.2 -146.7 -37.2 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACGUAUG6’] 1.47 34.5 
 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACGUAUG6’] 1.10 31.0 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACGUAUG6’] 0.83 29.0 
 
Fig. 64 UV-melting curves (at 260 nm) of the nonanucleotides ddGlc[4’CAUADGUGA6’] and 
ddGlc[4’UCACGUAUG6’] (values obtained in 0.15 M NaCl, TrisHCl pH 7.0) (top left) and linear 
regression 1/Tm vs. ln(c) resulting in Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) 
(bottom). 
 
The Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) obtained for oligonucleotides with the 
general formula ddGlc[4’CAUA-X-GUGA6’], ddGlc[4’CAUA-Y-GUGA6’] are summarized in Fig. 
65. An adenine – 2,4- diaminopyrimidine exchange resulted in all observed cases in an 
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enthalpically destabilization and entropically stabilization of the duplex compared to the 
unmodified homo-DNA oligonucleotide. 
 
Oligonucleotide ∆H [kJ/mol] ∆S [J/(mol*K)] ∆G (T=25 °C) [kJ/mol] 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACUUAUG6’] -152.5 -365.7 -43.5 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACUUAUG6’] -83.3 -149.6 -38.7 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACAUAUG6’] -206.8 -548.7 -43.3 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACAUAUG6’] -111.1 -240.9 -39.3 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACCUAUG6’] -448.3 -1342.1 -48.1 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACCUAUG6’] -126.9 -302.9 -36.6 
ddGlc[4’CAUAAGUGA6’] 
ddGlc[4’UCACGUAUG6’] -124.6 -288.1 -38.7 
ddGlc[4’CAUADGUGA6’] 
ddGlc[4’UCACGUAUG6’] -81.2 -146.7 -37.2 
 
Fig. 65 Van’t Hoff-pairing enthalpies (∆H) and –entropies (∆S) of the oligonucleotides with the 
general formula ddGlc[4’CAUA-X-GUGA6’] and ddGlc[4’UCAC-Y-UAUG6’]. 
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5. Experimental Part 
 
1. General. Solvents were purified by distillation. Thin-layer chromatography (TLC): Merck TLC 
aluminum sheets, silica gel 60 F254, 2 mm or Machery-Nagel Alox plastic sheets, Aluminum oxide 
N/UV254, 0.2 mm.  Column chromatography (CC): Sigma-Aldrich Silica gel Merck Type 9385, 
230-400 mesh, 60 Å or Sigma-Aldrich aluminum oxide neutral type 507c, Brockmann I, 150 mesh 
inactivated with 4% H2O. High-performance liquid chromatography (HPLC): Shimadzu-10. M. p. 
Teston-DM-6300, values are uncorrected. IR Spectra: Perkin-Elmer-1600 FT-IR 
spectrophotometer; in KBr unless otherwise stated; absorption values in cm-1 and intensity (vs 
(very strong, 0–20% transmission), s (strong, 20-40% transmission), m (middle, 40-60% 
transmission), w (weak, 60-80% transmission)). 1H-(300 MHz) and 13C-NMR (75.5 MHz) Spectra: 
Bruker ARX-300 instrument; in CDCl3 at 300 K unless otherwise stated; δ in ppm relative to TMS 
(0.00 ppm), CHCl3 (7.26 ppm) or H3COH (3.31 ppm), coupling constants J in Hz. 13C-signal 
multiplicity from DEPT 90 and DEPT 135 spectra (Disortionless Enhancement by Polarization 
Transfer). Peaks assignment was performed by two-dimensional NMR experiments (COSY, 
HSQC, HMBC) and analogies. MS: Finnigan MAT-95 instrument for CI and EI; Finnigan TSQ-
700 triple quadrupole spectrometer for ESI; m/z (rel. %); Bruker Autoflex I spectrometer for 
MALDI-TOF; Elemental Analyses were performed on a Vario EL-instrument (Elementar).  
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5.1 Synthesis 
 
Isopropyl-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-erythro-hex-2-enopyranoside (20) 57 
 
   
 
To a solution of tri-O-acetyl-D-glucal (10.0 g, 36.7 mmol) in CH2Cl2 (100 ml) was added at rt 
propane-2-ol (14.0 ml, 11.0 g, 0.183 mol) and dropwise BF3*OEt2 (1.70 ml, 1.96 g, 13.8 mmol). 
After stirring for 22 h at rt, the reaction was quenched by the addition of aq. NaHCO3 sat. (200 ml) 
followed by solid NaHCO3 until no further foaming occurred. The organic phase was separated 
and the aqueous phase was extracted with CH2Cl2 (2 x 200 ml). The combined organic phase was 
washed with aq. NaClsat. (1 x 100 ml), dried (Na2SO4) and evaporated, yielding 9.78 g (35.9 
mmol, 98%, α-D/β-D = 9:1 (GC)) of 20 as a yellow oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.22 (Ce(SO4)2). 
 
1H-NMR (300 MHz, CDCl3): 5.99-5.79 (m, HC(3), HC(2)); 5.32-5.28 (m, HC(4)); 5.21 (d, J = 
1.5, HC(1), β-D); 5.14 (broad s, HC(1), α-D); 4.27-4.12 (m, CH2(6), H3CCHCH3); 4.03-3.95 (m, 
HC(5)); 2.10, 2.08 (2s, CH3(acetyl)); 1.25 (d, J = 6.3, CH3(iPr)); 1.18 (d, J = 6.1, CH3(iPr)). 
 
13C-NMR (75 MHz, CDCl3): 170.7, 170.2 (2s, 2 CO, α-D); 131.1, 125.7 (2d, C(2), C(3), β-D); 
128.7, 128.3 (2d, C(2), C(3), α-D); 93.1 (d, C(1),
 
β-D); 92.7 (d, C(1), α-D); 72.5 (d, CH(iPr), β-D); 
70.6 (d, CH(iPr), α-D); 70.1, 64.4 (2d, C(4), C(5), β-D); 66.6, 65.3 (2d, C(4), C(5), α-D); 63.4 (t, 
C(6), β-D); 63.0 (t, C(6), α-D); 23.4, 21.9 (2q, 2CH3(iPr), α-D); 21.6 (q, CH3(iPr), β-D); 20.9, 20.7 
(2q, 2CH3(acetyl), α-D).  
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EI-MS: 214.1 (5, [M-OiPr]+),  213 (13, [M-C2H3O2]+),  170 (18), 128 (100), 86 (96), 57 (14), 43 
(96, [H3CCO]+). 
 
Isopropyl-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-glucopyranoside (21)57 
 
     
 
20 (3.00 g, 11.0 mmol) was suspended with 10% Pt/C (153 mg) in EtOAc (61 ml) in a normal 
pressure hydrogenation apparatus. The suspension was evacuated and flushed with H2 (5 times). 
Stirring for 15 h at rt under a H2-athmosphere, filtration over celite and evaporation under reduced 
pressure resulted in 3.00 g (10.9 mmol, 99%, α-D/β-D= 9:1 (GC)) of 21 as a colourless oil. 
 
Rf (SiO2 ; Et2O/hexane 1:1) 0.40 (Ce(SO4)2). 
 
IR (film): 3465m, 2970vs, 2727w, 2474w, 2278w, 2107w, 2034w, 1937w, 1901w, 1740vs, 1657m, 
1440s, 1371vs, 1330s, 1234vs, 1177s, 1125vs, 1041vs, 995vs, 948s, 906w, 855m, 736m, 702w, 
665m, 647m, 605m, 584m, 525m, 490w. 
 
1H-NMR (300 MHz, CDCl3): 4.95 (broad s, HC(1)); 4.73 (dt, J = 10.1, 5.0, HC(4)); 4.26 (dd, J = 
11.9, 5.2, 1H of H2C(6)); 4.09 (dd, J = 11.9, 2.0, 1H of H2C(6)); 4.02-3.92 (m, HC(5)); 3.93 (mc, 
H3CCHCH3); 2.09, 2.05 (2s, CH3(acetyl)); 2.08-1.74 (m, H2C(3), H2C(2)) ; 1.23 (d, J = 6.3, 
CH3(iPr)) ; 1.15 (d, J = 5.9, CH3(iPr)). 
 
13C-NMR (75 MHz, CDCl3): 170.8, 170.0 (2s, 2CO, α-D), 99.5 (d, C(1), β-D), 99.1 (d, C(1), α-D); 
74.7, 68.5 (2d, C(4), C(5), β-D); 68.5, 67.9 (2d, C(4), C(5),
 
α-D); 63.4 (t, C(6),
 
β-D); 63.1 (t, C(6),
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α-D); 29.1, 23.8 (2t, C(2), C(3),
 
α-D); 23.1, 21.3 (2q, 2CH3(iPr), α-D); 21.0, 20.7 (2q, 2CH3(acetyl) 
, α-D). 
 
EI-MS: 215 (10, [M-H3CCOO]+), 99 (32), 86 (56), 43 (100, [H3CCO]+). 
 
Methyl-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-erythro-hex-2-enopyranoside (16)32a,55 
 
   
 
To a solution of 40.5 g (0.149 mol) of 3,4,6-tri-O-acetyl-D-glucal in 200 ml of toluene and 10 ml 
of MeOH at 0 °C was added 10 ml (8.70 g, 61.3 mmol) BF3*OEt2 dropwise over 8 min. After 
removing the ice bath, the reaction was stirred for 40 min. 290 ml of toluene was added, followed 
by NaHCO3 sat. (150 ml) and further solid NaHCO3 until no more foaming occurred. The org. 
phase was separated and the aq. phase was extracted with toluene (2 x 100 ml), the combined org. 
phases were dried (MgSO4) and evaporated under reduced pressure. The slightly yellow oil was 
dissolved in 200 ml MeOH stirred for 30 min at 40° C with 1 g activated charcoal, filtered over 
celite and evaporated to give 16 as a colourless oil: 34.2 g (0.140 mmol, 94 %, α-D/β-D = 8:1 
(GC, 1H-NMR)). 
 
Rf (SiO2 ; Et2O/hexane 1:1) 0.27 (Ce(SO4)2). 
 
IR (CHCl3): 3029m, 3010m, 2960m, 2935m, 2910m, 2830w, 1745vs, 1740vs, 1465w, 1450m, 
1440m, 1420m, 1405m, 1395m, 1370s, 1340w, 1250vs, 1185s, 1150m, 1135m, 1110m, 1070s, 
1050vs, 1020s, 965s, 910s, 870w, 830w, 710w, 660w, 645w, 605m. 
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1H-NMR (300 MHz, CDCl3): 6.02-5.81 (m, HC(2), HC(3)); 5.33 (dd, J = 9.6, 1.4, HC(4), α-D); 
5.20 (d, J = 1.4, HC(4), β-D); 5.04 (d, J = 1.4, HC(1), β-D); 4.93 (d, J = 1.2, α-D); 4.29-4.16 (m, 
H2C(6)); 4.11-4.05 (m, HC(5)); 3.47 (s, MeO, β-D); 3.45 (s, MeO, α-D); 2.11, 2.10, 2.09 (3s, 2 
Ac). 
 
13C-NMR (75 MHz, CDCl3): 170.6 (s, CO); 170.1 (s, CO); 130.1, 126.2 (2d, C(2), C(3), β-D); 
129.1, 127.6 (2d, C(2), C(3), α-D); 95.9 (d, C(1), β-D); 95.3 ((d, C(1), α-D); 72.7, 64.1 (2d, C(4), 
C(5), β-D); 66.8, 65.2 (2d, C(4), C(5), α-D); 63.3 (t, C(6), β-D); 62.9 (t, C(6), α-D); 55.8 (q, MeO, 
α-D); 55.2 (q, MeO, β-D); 20.8, 21.0 (2q, MeCO).  
 
EI-MS: 213 (2), 153 (4), 142 (13), 111 (15), 100 (100), 71 (12), 43 (34, [CH3CO]+). 
 
Methyl-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-glucopyranoside (17)32a,55 
 
  
 
To a solution of 35.1 g (0.144 mol) of 16 in 100 ml of MeOH and 1 ml of AcOH was added in a 
normal pressure hydrogenation apparatus 175 mg of 10% Pd(C). After twice evacuating and 
flashing with H2, the reaction was stirred for 8 h at 25° C, filtered over celite, evaporated, 
dissolved in 300 ml EtOAc, extracted with NaHCO3 sat. (1 x 150 ml), dried (MgSO4) and 
evaporated under reduced pressure, resulting in 29.0 g (0.118 mol, 82 %, α-D/β-D = 8:1 (GC, 1H-
NMR)) 17 as a slightly yellow oil. 
 
Rf (SiO2; Et2O/hexane 1:2) 0.35 (Ce(SO4)2). 
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IR (CHCl3): 3021m, 2950m, 2909w, 2853w, 2828w, 1734vs, 1455m, 1370m, 1302w, 1245vs, 
1235vs, 1180w, 1130m, 1105m, 1080m, 1063m, 1051s, 1040s, 996m, 976m, 959m, 925w, 897w, 
884w, 870w, 858w, 844w, 660w. 
 
1H-NMR (300 MHz, CDCl3): 4.77-4.63 (m, HC(4), β-D; HC(1), HC(4), α-D); 4.44 (dd, J = 8.5, 
2.0, HC(1), β-D); 4.28 (dd, J = 12.0, 5.2, 1H H2C(6), β-D); 4.26 (dd, J = 12.0, 5.3, 1H H2C(6), α-
D); 4.21-4.16 (m, 1H H2C(6), β-D); 4.11 (dd, J = 12.0, 2.3, 1H H2C(6), α-D); 4.03-3.96 (m, HC(5), 
β-D); 3.90 (ddd, J = 10.0, 5.3, 2.3, HC(5), α-D); 3.49 (s, MeO, β-D); 3.36 (s, MeO, α-D); 2.09, 2.05 
(2s, 2 Ac). 
 
13C-NMR (75 MHz, CDCl3): 170.8, 169.9 (2s, 2CO); 102.5 (d, C(1), β-D); 97.4 (d, C(1), α-D); 
68.6, 67.7 (2d, C(4), C(5), α-D); 68.1, 67.5 (2d, C(4), C(5), β-D); 63.3 (t, C(6), β-D); 63.1 (t, C(6), 
α-D); 56.4 (q, MeO, β-D); 54.5 (q, MeO, α-D); 29.3, 24.9 (2t, C(2), C(3), β-D); 28.7, 24.0 (2t, 
C(2), C(3), α-D); 20.9, 20.7 (2q, 2 MeCO). 
 
EI-MS: 215 (14), 144 (14), 101 (21), 84 (38), 58 (100), 43 (88, [CH3CO]+). 
 
ESI-MS: 269.1 (100, [m+Na]). 
 
HR-ESI-MS: calc. for C11H18O6Na1 ([m+Na]+)  269.1000; found 269.1001 
 
Acetyl-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-glucopyranoside (19)57 
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To a solution of 17 (2.00 g, 8.12 mmol) in 14 ml of AcOH was added 3.5 ml (3.80 g, 37.3 mmol) 
of Ac2O at 0 °C, followed by 0.4 ml of conc. H2SO4. After removal of the ice bath, the reaction 
was stirred for 6 min. The yellow solution was poured onto 200 ml of ice, extracted with CH2Cl2 
(2 x 100 ml), and the org. phase was washed with H2O (1 x 100 ml) and NaHCO3 sat. (1 x 100 ml), 
dried (Na2SO4) and evaporated, yielding 1.67 g (6.09 mmol, 76 %, α-D/β-D = 5:1 (GC)) of 19 as a 
colourless oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.24 (Ce(SO4)2). 
 
IR (film) 3650w, 3467w, 2960m, 1744vs (br.), 1655w, 1439m, 1369s, 1241vs, 1132s, 1087s, 
1044vs, 1004s, 953s, 918s, 735w, 605m, 540w. 
 
1H-NMR (300 MHz, CDCl3): 6.13 (broad s, HC(1), α-D); 5.78 (dd, J = 8.3, 2.4, HC(1), β-D); 4.80 
(dt, J = 10.0, 4.5, HC(4), α-D); 4.26 (dd, J = 12.0, 4.6, 1H H2C(6), α-D); 4.10 (dd, J = 12.0, 2.0, 
1H H2C(6), α-D); 4.02 (ddd, J = 10.0, 4.6, 2.0, HC(5), α-D); 2.12, 2.08, 2.06 (3s, 3 Ac); 1.96-1.64 
(m, H2C(3), H2C(2)). 
 
13C-NMR (75 MHz, CDCl3): 170.7, 169,7, 169.1 (3s, 3CO); 93.2 (d, C(1), β-D); 90.7 (d, C(1), α-
D); 75.4, 66.4 (2d, C(4), C(5), β-D); 70.7, 67.0 (2d, C(4), C(5), α-D); 62.8 (t, C(6), β-D); 62.6 (t, 
C(6), α-D); 27.7, 25.6 (2t, C(2), C(3), β-D); 27.5, 23.5 (2t, C(2), C(3), α-D); 20.9, 20.8, 20.6 (3q, 3 
MeCO). 
 
EI-MS: 215 (20, [M-CH3CO]+), 155 (9), 145 (48), 103 (27), 94 (52), 69 (44), 43 (100, [CH3CO]+). 
 
HR-ESI-MS: calc. for C12H18O7Na1 ([m+Na]+)  297.0950; found 297.0944. 
 
Azido-4,6-di-O-acetyl-2,3-dideoxy-α,β-D-glucopyranoside (81) 
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To a solution of 5.36 g (19.5 mmol) 19 in 210 ml of CH2Cl2 was added dropwise 5.2 ml (4.55 g, 
39.5 mmol) of azidotrimethylsilane, followed by 4.7 ml (5.76 g, 25.9 mmol) trimethylsilyl triflate. 
After stirring for 30 min at rt, the reaction mixture was cooled to 0°C and poured on water/ice 
(100 ml). The organic phase was separated and washed with 1 M HCl (1 x 40 ml), H2O (1 x 40 
ml), aq. NaClsat. (1 x 40 ml), aq. NaHCO3 sat. (1 x 40 ml), aq. NaClsat. (1 x 40 ml), dried (Na2SO4) 
and evaporated. CC (200 g SiO2, Et2O/hexane 1:2, 2% NEt3) yielded 4.56 g (17.7 mmol, 91 %, (α-
D/β-D= 1:1 (GC, 1H-NMR) of 81 as a slightly yellow oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.42 (Ce(SO4)2). 
Rf (SiO2; Et2O/hexane 1:2) 0.20 (Ce(SO4)2). 
 
IR (film): 3637w, 3466w, 3326w, 2958vs, 2878s, 2728w, 2463w, 2112vs (N3), 1742vs, 1742vs, 
1439vs, 1369vs, 1235vs, 1042vs, 1000vs, 973s, 947s, 905vs, 858vs, 739w, 706w, 648m, 626m, 
605s, 568m, 547w, 529w. 
 
1H-NMR (300 MHz, CDCl3): 5.42 (d-like, HC(1), α-D); 4.77-4.67 (m, HC(4), α-D, β-D, HC(1), β-
D); 4.31-4.14 (m, H2C(6), α-D, β-D); 4.06-4.00, 3.74-3.68 (2m, HC(5), α-D, β-D); 2.09, 2.07, 2.06 
(3s, 2CH3, α-D, β-D);  2.28-2.21, 1.93-1.56 (2m, H2C(3), H2C(2), α-D, β-D).  
 
13C-NMR (75 MHz, CDCl3): 172.3, 171.4 (2s, 2CO); 89.8 (d, C(1), β-D); 88.1 (d, C(1), α-D); 78.0, 
72.3, 68.7, 68.3 (4d, C(5), C(4), α-D, β-D); 64.4, 64.2 (2t, C(6), α-D, β-D); 30.8, 29.7, 28.7, 25.3 
(4t, C(3), C(2), α-D, β-D); 22.5, 22.3 (2q, 2 MeCO). 
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EI-MS: 215 (20, [M-N3]+), 155 (11), 113 (6), 95 (12), 67 (8), 43 (100, [CH3CO]+). 
 
ESI-MS: 280 ([M+Na]+). 
 
Azido-2,3-dideoxy-α,β-D-glucopyranoside (82)  
 
 
 
To a solution of 81 (1.00 g, 3.89 mmol) dissolved in MeOH (8 ml) were added 3.3 g of amberlite 
IRA 402 (washed with 50 ml 2 N aq. NaOH, 50 ml H2O, 50 ml MeOH) in one portion at rt. The 
reaction was stirred for 40 min at rt, filtered, evaporated under reduced pressure, yielding 612 mg 
(3.53 mmol, 91 %, α-D/β-D 1:1 (1H-NMR)) of 82 as highly viscous, colourless oil. 
 
Rf (SiO2; CH2Cl2/MeOH 5 :1) 0.56 (Ce(SO4)2). 
 
IR (film): 3374s, 2937s, 2874m, 2467w, 2109vs, 2044w, 1719w, 1661m, 1596w, 1456m, 1440m, 
1415m, 1373m, 1328m, 1240s, 1174w, 1100s, 1048vs, 1001m, 975s, 931m, 886w, 865m, 843w, 
831w, 736m, 702w, 664w, 626m, 568w. 
 
1H-NMR (300 MHz, d4-MeOD): 5.42 (br. s, HC(1), α-D); 4.75-4.69 (m, HC(1), β-D); 3.89-3.77, 
3.72-3.65, 3.62-3.55, 3.52-3.38, 3.35-3.28 (5m, HC(4), HC(5), H2C(6), α-D/β-D); 2.12-2.01, 1.91-
1.48 (2m, H2C(2), H2C(3), α-D/β-D). 
 
13C-NMR (75 MHz, d4-MeOD): 89.2 (d, C(1), β-D); 87.8 (d, C(1), α-D); 82.9, 77.0, 65.9, 65.8 (4d, 
C(4), C(5), α-D, β-D); 62.5, 62.3 (2t, C(6), α-D, β-D); 31.4, 30.7, 29.3, 27.4 (4t, C(2), C(3), α-D, β-
D). 
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CI-MS: 191.4 (49, [m+NH4]+), 163.1 (21), 148.1 (100), 146.1 (16), 131.1 (72, [m-N3]+), 112.1 
(10), 110.1 (17), 98.1 (8). 
 
ESI-MS: 196.0 (100, [m+Na]+), 185.0 (21), 155.0 (19). 
 
HR-ESI-MS: calc. for C6H11N3O3Na1 ([m+Na]+)  196.0698; found 196.0695. 
 
Azido-4,6-di-O-(tetraisopropyldisiloxane)-2,3-dideoxy-α,β-D-glucopyranoside (83)  
 
 
 
After drying for 4 h under high vacuum (p < 10-1 mbar) the diol 82 (502 mg, 2.90 mmol) was 
dissolved under sonication in 11.5 ml DMF. Imidazole (869 mg, 12.76 mmol) was added to the 
solution at rt followed by a dropwise addition of tetraisopropyldichlorosiloxane (1.0 ml, 3.19 
mmol) to the rapidly stirring solution within 15 min. The colourless solution was stirred at rt for 4 
h, and 1.7 ml CH3OH was added and the reaction was extracted with EtOAc (3 x 25 ml), the 
combined org. phases were dried (Na2SO4) and evaporated under reduced pressure. CC (20 g 
SiO2, Et2O/hexane 1:10, application of the compound with CH2Cl2) yielded 1.05 g (2.53 mmol, 
87%, α-D/β-D 1:1 (1H-NMR)) of 83 as a colourless oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.70 (Ce(SO4)2). 
Rf (SiO2; Et2O/hexane 1:10) 0.31 (Ce(SO4)2). 
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IR (film): 3325w, 2945vs, 2894m, 2868vs, 2725w, 2111vs, 1465s, 1439w, 1387m, 1325w, 1307w, 
1292w, 1264m, 1247m, 1182w, 1145m, 1091vs, 1035vs, 996vs, 943w, 919w, 885s, 861m, 846m, 
821w, 773w, 739m, 701w, 622w, 595w, 559w. 
  
1H-NMR (300 MHz, CDCl3): 5.42 (br. s., HC(1), α-D); 4.64 (dd, J = 10.1, 2.3, HC(1), β-D); 4.17 
(dd, J = 12.5, 2.0, 1H of H2C(6)); 4.12 (dd, J = 12.5, 2.2, 1H of H2C(6)); 3.95-3.80 (m, 4H of 
HC(4), HC(5), H2C(6)); 3.63-3.57 (m, 1H of HC(4), HC(5), H2C(6));  3.26-3.19 (m, 1H of HC(4), 
HC(5), H2C(6)); 2.13-2.04, 1.92-1.52 (2m, H2C(2), H2C(3)); 1.21-0.87 (m, 2 x 28H of 
SiCH(CH3)2). 
 
13C-NMR (75 MHz, CDCl3): 89.2 (d, C(1), β-D); 87.3 (d, C(1), α-D); 82.0, 76.1, 64.8, 64.3 (4d, 
C(4), C(5), α-D, β-D); 64.8, 64.3 (2t, C(6), α-D, β-D); 31.0, 30.4, 29.3, 27.3 (4t, C(2), C(3), α-D, β-
D);17.4, 17.3, 17.21, 17.19 (4q, H3C, α-D, β-D); 13.5, 13.3, 12.6, 12.5 (4d, SiCH). 
 
CI-MS: 433.3 (26, [m+NH4]+), 405.3 (23), 390.3 (51), 373.3 (100, [m-N3]+), 329.2(17), 278.2 
(12), 95.1 (15). 
 
ESI-MS: 438.3 (100, [m+Na]+), 413.4 (10), 397.3 (8). 
 
HR-ESI-MS: calc. for C18H37N3O4Na1Si2 ([m+Na]+)  438.2220; found 438.2225. 
 
Amino-4,6-di-O-(tetraisopropyldisiloxane)-2,3-dideoxy-α,β-D-glucopyranoside (84)  
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O
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To a solution of 400 mg (0.963 mmol) 83 in 8 ml of EtOH was added 180 mg of Lindlar’s catalyst at 
rt. After twice evacuating and flashing with H2 in a Parr-apartus (20 psi), the reaction was shaken 
for 2 h at 25 °C, filtered over celite, and evaporated under reduced pressure, resulting in 375 mg 
(0.962 mmol, 99 %) of 84 as a colourless foam. 
 
M.P. 116 °C 
 
Rf (SiO2; Et2O/hexane 1:2) 0.11 (Ce(SO4)2). 
 
IR (KBr): 3425br. s, 2945vs, 2894s, 2868vs, 1633w, 1496w, 1466s, 1386m, 1366w, 1311w, 
1294m, 1249m, 1219w, 1174m, 1142w, 1090vs, 1033vs, 1011vs, 991s, 974s, 934m, 918w, 902m, 
885vs, 844s, 775w, 699s, 661m, 594w, 554w. 
 
1H-NMR (300 MHz, CDCl3): 4.34 (dd, J = 10.1, 1.5, 1H); 4.22-4.04 (m, 1H); 4.10 (dd, J = 12.2, 
2.2, 1H); 3.88-3.68 (m, 4H); 3.14 (dt-like, 1H); 2.08-1.32 (m, H2C(2), H2C(3), 8H); 1.11-0.95 (m, 
2 x 28H of SiCH(CH3)2). 
 
CI-MS: 762.6 (58, [2m+H]+), 744.6 (100), 390.3 (32, [m+H]+), 373.3 (53, [m-NH2]+), 346.3 (15), 
329.2 (8), 278.3 (18). 
 
ESI-MS: 784.6 (33, [2m-NH3+Na]+), 762.5 (32, [2m-NH3+H]+), 405.3 (100, [m-NH2+HOCH3]+), 
390.3 (37, [m+H]+), 373.3 (67, [m-NH2]+). 
 
HR-ESI-MS: calc. for C36H75NO8Na1Si4 ([2m-NH3+Na]+)  784.4467; found 784.4476. 
 
Methyl-2,3-dideoxy-α-D-glucopyranoside (18)32a,55  
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To a solution of 17 (8.00 g, 32.5 mmol) dissolved in MeOH (60 ml) was added 26 g amberlite 
IRA 400 (washed with 300 ml 2 N aq. NaOH, 300 ml H2O, 200 ml MeOH) in one portion at rt. 
The reaction was stirred for 2 h at rt, filtered, and evaporated under reduced pressure, yielding 
5.02 g (31.0 mmol, 95 %) of 18 as a highly viscous colourless oil. 
 
Rf (SiO2; Et2O) 0.09 (Ce(SO4)2). 
 
IR (KBr) : 3195vs (br.), 2947s, 1651w, 1565m, 1404vs, 1271w, 1220w, 1209w, 1171w, 1129s, 
1075m, 1048vs, 1002w, 976m, 946w, 907w, 885w, 869w, 655w, 621w, 577w, 514w. 
 
1H-NMR (300 MHz, d4-MeOD): 4.65 (br. s, HC(1), α-D); 4.44 (dd, J = 8.7, 2.2, HC(1), β-D); 
3.87-3.84 (m, 1H H2C(6), β-D); 3.79 (dd, J = 11.8, 2.2, 1H H2C(6), α-D); 3.65 (dd, J = 11.7, 5.4, 
1H H2C(6), α-D); 3.50-3.43 (m, HC (5), HC(4), α–D ; HC (5), HC(4), β-D); 3.35 (s, MeO, α-D); 
1.84-1.64 (m, HC(2), HC(3), α-D ; HC(2), HC(3), β-D). 
 
13C-NMR (75 MHz, d4-MeOD): 98.5 (d, C(1), α-D); 75.1, 67.0 (2d, C(4), C(5), α-D); 54.6 (t, C(6), 
α-D); 30.1, 28.1 (2t, C(2), C(3), α-D). 
 
EI-MS: 131 (83, [M-OMe]+), 113 (13), 102 (93), 101 (100), 99 (78), 87 (22), 83 (15), 74 (30), 71 
(73), 69 (70), 67 (23), 61 (31). 
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[(1-methylethenyl)oxy]trimethyl silane 
 
 
 
 
To 3.7 ml (2.92 g, 50.3 mmol) of acetone was added 8.7 ml (6.33 g, 62.6 mmol) of NEt3 and 
stirred for 15 min at rt. 7.8 ml (9.80 g, 90.2 mmol) of freshly distilled (bulb-to-bulb-distillation) 
Me3SiCl was added dropwise, followed by a dropwise addition of a solution of 9.30 g (62.0 
mmol) NaI in 62 ml CH3CN. The reaction mixture was stirred for 25 min at rt. 50 ml pentane, 
followed by 30 ml of ice/water, was added and the org. phase was separated. The aq. phase was 
extracted with pentane (2 x 30 ml) and the combined org. phases were washed with H2O (1 x 40 
ml), dried (Na2SO4) and evaporated (until t = 35° C, p = 400 mbar), resulting in 5.12 g (39.3 
mmol, 78%) of silylenolether as a colourless liquid. 
 
1H-NMR (300 MHz, CDCl3): 4.07-4.04 (m, H2C=C); 1.78 (dd, J = 0.9, 0.4, CCH3); 0.21 (s, 
SiMe3).  
 
13C-NMR (75 MHz, CDCl3): 154.0 (s, H2C=C); 89.3 (t, H2C=C); 20.9 (q, CCH3); 2.0 (q, SiMe3).  
 
Methyl-4,6-di-O-benzyl-2,3-dideoxy-α-D-glucopyranoside (23) 
 
 
 
To a suspension of 18 (2.17 g, 13.4 mmol) in 50 ml of THF at 0 °C was added over 1 h NaH (1.30 
g, 50% in oil, 27.1 mmol) as solid in small portions. After stirring for 30 min at rt, Bu4NBr (50 
mg, 0.135 mmol) was added, followed by BnBr (3.2 ml, 26.9 mmol). After stirring for 2 h at rt, 
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the reaction was poured into 200 ml aq. NaHCO3 sat. and extracted with Et2O (3 x 100 ml). The 
combined org. phases were washed with H2O (2 x 100 ml), dried (Na2SO4) and evaporated. CC 
(300 g SiO2, Et2O: hexane 1:1) yielded 3.94 g (11.5 mmol, 86%, α-D/β-D = 7:1 (GC)) of 23 as a 
slightly yellow oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.38 (Ce(SO4)2). 
Rf (SiO2; EtOAc/hexane 3:2) 0.70 (Ce(SO4)2). 
 
IR (film): 3087w, 3063m, 3030m, 2935s, 2896s, 1952w, 1873w, 1811w, 1738w, 1604w, 1586w, 
1496m, 1453s, 1369s, 1325m, 1261m, 1222s, 1206s, 1177m, 1100 br. vs, 1027s, 959s, 909m, 
887w, 869w, 736vs, 697vs, 612w, 569w, 522w. 
 
1H-NMR (300 MHz, CDCl3): 7.37-7.21 (m, 10 arom. H); 4.72 (dd-like, HC(1), α-D); 4.67-4.38 (m, 
benz. H); 3.79-3.67, 3.57-3.52 (2m, HC(4), HC(5), H2C(6)); 3.49 (s, MeO, 0.45H,  β-D); 3.35 (s, 
MeO, 3.00H, α-D); 2.04-2.00 (m, 1H of H2C(3)); 1.86-1.70 (m, 1H of H2C(3), H2C(2)). 
 
13C-NMR (75 MHz, CDCl3): 138.5, 138.4 (2s, 2 arom. Cquart.);  128.2, 127.7, 127.5, 127.43, 
127.39 (5d, arom. C);  102.5 (d, HC(1), β-D); 97.4 (d, HC(1), α-D); 73.4, 70.6, 69.3 (3t, C(6), 
benz. C); 72.8, 71.2 (2d, C(4), C(5)); 56.2 (q, MeO, β-D); 54.3 (q, MeO, α-D); 29.7, 27.1 (2t, C(2), 
C(3)); 28.8, 23.9 (2t, C(2), C(3)).  
 
EI-MS: 113 (6), 97 (7), 91 (100), 81 (17), 65 (10), 51 (3). 
 
ESI-MS: 367 (3, [M+Na+2H]+), 366 (23, [M+Na+H]+), 365 (100, [M+Na]+).  
 
HR-ESI-MS: calc. for C21H26O4Na1 ([m+Na]+)  365.1729; found 365.1726. 
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Anal. calc. for C21H26O4 (342.43) : C 73.60, H 7.66; found C 73.62, H 7.41. 
 
Acetyl-di-O-benzyl-2,3-dideoxy-α,β-D-glucopyranoside (24) 
 
 
 
To a solution of 980 mg (2.86 mmol) 23 in 4.5 ml of AcOH at 0 °C was added, under vigorous 
stirring, 1.1 ml (1.20 g, 11.71 mmol) Ac2O followed by 130 µl (239 mg, 2.44 mmol) conc. H2SO4, 
the ice bath was removed and the yellow-brown solution stirred for 7 min at rt, poured on 5 ml ice 
water and solid NaHCO3 was added until no more foaming occurred. Extraction with Et2O (2 x 40 
ml), H2O (2 x 20 ml) and aq. NaHCO3 sat. (2 x 20 ml) followed by drying of the combined org. 
phases (Na2SO4) and evaporation resulted, after CC (34 g SiO2, Et2O/hexane 1:1), in 304 mg 
(0.821 mmol, 31%) of 24 as a highly viscous colourless oil. 
 
Rf (SiO2; Et2O/hexane 1:1) 0.17 (Ce(SO4)2). 
 
IR(film): 3088m, 3063s, 3030s, 3006m, 2937vs, 2867vs, 1954w, 1877w, 1809w, 1747vs (C=O), 
1605w, 1586w, 1469s, 1454vs, 1366vs, 1326m, 1310m, 1244vs, 1215vs, 1184vs, 1096br. vs, 
1028vs, 1005vs, 947vs, 905s, 876s, 820w, 737vs, 698vs, 606m, 535w, 462w.  
 
1H-NMR (300 MHz, CDCl3): 7.33-7.22 (m, arom H); 6.16-6.12 (br. s, HC(1), α-D); 4.67-4.38 (m, 
benz. H); 3.85 (ddd, J = 9.5, 3.6, 2.0, 1H of HC(4), HC(5), H2C(6)); 3.79-3.36 (m, 3 H of HC(4), 
HC(5), H2C(6)); 2.34-2.20, 2.13-2.04, 1.89-1.52 (3m, H2C(3), H2C(4); 2.08 (s, Ac, β-D); 2.07 (s, 
Ac, α-D). 
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13C-NMR (75 MHz, CDCl3): 169.4 (s, CO); 138.4, 138.2 (2s, arom. Cquart.); 128.3, 128.2, 127.8, 
127.63, 127.60, 127.5 (6d, arom. C);  91.4 (d, HC(1), α-D); 73.8, 72.1 (2d, C(4), C(5)); 73.4, 71.0, 
68.9 (3t, C(6), benz. C); 27.8, 23.6 (2t, C(2), C(3)); 21.1 (q, Ac). 
 
EI-MS: 116 (11), 98 (24), 91 (100, [PhCH2]+), 71 (97, [C6H5]+), 65 (19), 55 (5), 51 (6). 
 
ESI-MS: 393 (100, [M+Na]+). 
 
HR-ESI-MS: calc. for C22H26O5Na1 ([m+Na]+)  393.1678; found 393.1678. 
 
1-(4’,6’-di-O-benzyl-2’,3’-dideoxy-β-D-glucopyranosyl)-propan-2-one (27β) 
 
 
 
Freshly distilled SnCl4 (5.70 ml, 12.637 g, 48.51 mmol)  was added dropwise under Ar at rt to a 
well stirred solution of 23 (12.002 g, 35.05 mmol), silylenolether of acetone (5.920 g, 45.45 
mmol) in 600 ml dry CH3CN. After stirring for 6h at rt, the reaction was carefully poured into an 
ice-cold solution of 250 ml aq. NaHCO3 sat..  400 ml CH3CN were distilled out of the mixture. 
Extraction with Et2O (3 x 200 ml), followed by drying under high vacuum (1.2 * 10-1 mbar) for 
several hours, and CC (300 g SiO2, Et2O/hexane 1:1) yielded 5.113 g (13.88 mmol) β-D-anomer of 
27, 0.877 g (2.38 mmol) β-D-, α-D- mixture of 27, and 0.541 g (1.47 mmol) α-D-anomer 27 as 
slightly yellow oils (total yield 51%). 
 
Rf (SiO2 ; Et2O/hexane 2:1) 0.22 (Ce(SO4)2). 
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IR (film): 3410w, 3087w, 3062m, 3030m, 2934s, 2864vs, 1954w, 1876w, 1812w, 1714vs (CO), 
1605w, 1586w, 1496m, 1453s, 1437m, 1418m, 1367s, 1330m, 1315m, 1285m, 1206m, 1161s, 
1091br. vs, 1028s, 999s, 931w, 908m, 874w, 818w, 846w, 737vs, 698vs, 649w, 609w, 566w, 466w.   
 
1H-NMR (600 MHz, CDCl3): 7.34-7.21 (m, arom. H); 4.63-4.39 (m, benz. H); 3.78 (dddd, J = 
12.9, 7.4, 5.6, 2.0, HC(1)); 3.71 (dd, J = 10.7, 1.2, 1H from H2C(6)); 3.67 (dd, J = 10.7, 4.4, 1H 
from H2C(6)); 3.42-3.39 (m, HC(4), HC(5)); 2.75 (dd, J = 15.9, 7.1, 1H from C(1)CH2CO); 2.46 
(dd, J = 15.9, 5.6, 1H from C(1)CH2CO); 2.29-2.23 (m, HC(3)eq); 1.83-1.76 (m, HC(2)eq); 1.56-
1.43 (m, HC(3)ax); 1.38-1.32 (m, HC(2)ax). 
 
13C-NMR: (75 MHz, CDCl3): 207.0 (s, CO); 138.4, 138.3 (2s, arom. Cquart.); 128.23, 128.19, 
127.7, 127.6, 127.5, 127.4 (6d, arom. C); 80.5, 73,8, 72.9 (3d, C(1), C(4), C(5)); 73.3, 70.9, 69.6 
(3t, 2 OCH2-arom., C(6)); 49.4 (t, C(1)CH2CO); 30.9 (q, Me); 30.5, 29.1 (2t, C(2), C(3)). 
 
CI-MS: 386 (100, [M+NH4]+),  369 (15, [M+H]+), 277 (9, [M-C7H7]+), 206 (7), 189 (5), 91 (6, 
[C7H7]+).  
 
ESI-MS: 391.2 (100 [M+Na]+). 
 
HR-ESI-MS: calc. for C23H28O4Na1 ([m+Na]+)  391.1885; found 391.1890. 
 
Anal. calc. for C23H28O4 (368.47) : C 74.97, H 7.66; found C 74.95, H 7.62. 
 
1-(4’,6’-di-O-benzyl-2’,3’-dideoxy-α-D-glucopyranosyl)-propan-2-one (27α) 
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As described for 27β with 4.000 g (11.68 mmol) 23, 1.9 ml SnCl4 (4.212 g, 16.170 mmol), 2.016 
g (15.47 mmol) silylenolether of acetone in 200 ml dry CH3CN with 50 g 3Å molecular sieves 
resulted in a α-D/β-D    = 69/31 mixture of 27 (yield 2.71 g, 7.37 mmol, 63%). 
 
Rf (SiO2 ; Et2O/hexane 2:1) 0.20 (Ce(SO4)2). 
 
IR (film): 3486br. m, 3088m, 3063s, 3030s, 2935vs, 2865vs, 1955w, 1876w, 1812w, 1713vs, 
1661w, 1605w, 1586w, 1496s, 1453vs, 1362vs, 1313s, 1275s, 1206s, 1097br. vs, 1028s, 908m, 
852w, 819w, 737vs, 698vs, 608w, 532w.  
 
1H-NMR (300 MHz, CDCl3): 7.36-7.18 (m, 10 arom. H); 4.69-4.30 (m, 4 benz. H); 3.88-3.79, 
3.72-3.61, 3.51-3.38 (3m, 5H, HC(1), H2C(6), HC(4), HC(5)); 2.85 (dd, J = 15.7, 7.6, 1H of 
C(1)H2CCO); 2.50 (dd, J = 15.7, 5.9, 1H of C(1)H2CCO); 1.98-1.85, 1.81-1.62. 1.50-1.36 (3m, 
H2C(2), H2C(3)). 
 
 
13C-NMR: (75 MHz, CDCl3): 207.2 (s, CO); 138.4, 138.2 (2s, arom. C); 128.3, 127.8, 127.71, 
127.67, 127.57, 127.4 (6d, arom. C); 73.78, 72.0, 68.3 (3d, C(1), C(4), C(5)); 73.72, 70.6, 69.1 
(3t, 2 OCH2arom., C(6)); 47.1 (t, C(1)CH2CO); 30.8 (q, Me); 26.5, 24.0 (2t, C(2), C(3)). 
 
ESI-MS: 391.2 (100 [M+Na]+). 
 
HR-ESI-MS: calc. for C23H28O4Na1 ([m+Na]+)  391.1885; found 391.1890. 
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Methyl-4,6-di-O-benzoyl-2,3-dideoxy-α-D-glucopyranoside (22) 
 
 
 
To a solution of 18 (3.25 g, 20.1 mmol) in 16 ml of pyridine was added at 0 °C BzCl (6.50 ml, 
7.91 g, 56.3 mmol). After stirring for 6 h at rt, the pyridine was evaporated, the crude product was 
dissolved in 150 ml of EtOAc, washed with H2O (1 x 75 ml), aq. 1 M HCl (1 x 75 ml), aq. CuSO4 
(1 x 30 ml), aq. NaHCO3 sat. (1 x 75 ml), H2O (1 x 75 ml), dried (MgSO4) and evaporated. CC (200 
g SiO2, hexane/Et2O 2:1) yielded 6.16 g (16.6 mmol, 83%, α-D/β-D = 14:1 (GC, 1H-NMR)) of 22 
as a colourless solid. 
 
Rf (SiO2 ; Et2O/hexane 1:1) 0.26 (UV254, Ce(SO4)2). 
 
IR(film) 3606vs (br.), 2085m, 1787m, 1717vs, 1602vs, 1491w, 1451s, 1372w, 1356w, 1315w, 
1268s, 1225m, 1212m, 1176m, 1112s, 1069m, 1053s, 1026m, 1012m, 999m, 972w, 951w, 804w, 
778w, 709vs, 687s, 516w. 
 
1H-NMR (300 MHz, CDCl3): 8.06-8.01 (m, 4 arom. H); 7.58-7.51 (m, 2 arom. H); 7.47-7.38 (m, 2 
arom. H); 5.09 (dt, J = 10.1, 4.9, HC(4), α-D); 4.78 (t, J = 2.2, HC(1), α-D); 4.66-4.61 (m,  1H of 
H2C(6), β-D); 4.58 (dd, J = 11.8, 2.8, 1H of H2C(6), α-D); 4.47-4.41 (m, 1H of H2C(6), β-D); 4.40 
(dd, J = 11.8, 5.9, 1H of H2C(6), α-D); 4.24 (ddd, J = 9.7, 5.9, 2.6, HC(5), α-D); 3.51 (s, MeO, 
0.21H,  β-D); 3.42 (s, MeO, 3.00H, α-D); 2.21-2.13, 2.08-1.90 (2m, H2C(2), H2C(3)). 
 
13C-NMR: (75 MHz, CDCl3): 166.3, 165.4 (2s, CO); 129.9, 129.8 (2s, arom. C); 133.1, 132.9, 
129.6, 128.8, 128.3, 128.2 (6d, arom. C); 97.4 (d, C(1)); 68.9, 68.6 (2d, C(4), C(5)); 64.2 (t, C(6)); 
54.6 (q, MeO); 28.7, 24.1 (2t, C(2), C(3)). 
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ESI-MS: 393.1 (100, [M+Na]+). 
 
HR-ESI-MS: calc. for C21H22O6Na1 ([m+Na]+)  393.1314; found 393.1321. 
 
1-(4’,6’-di-O-benzoyl-2’,3’-dideoxy-α,β-D-glucopyranosyl)-propan-2-one (26) 
 
 
 
 
As described for 27 from 22 (1.00 g, 2.70 mmol), silylenolether (422 mg, 3.24 mmol), SnCl4 (0.44 
ml, 984 mg, 3.78 mmol) in 35 ml CH3CN (except that to the solution was added finely ground and 
dried (60 h, 180° C) 3 Å molecular sieves (1.60 g)). CC (40 g SiO2, Et2O/hexane 3:1) yielded 469 
mg (1.27 mmol, 47 %) of 26 as colourless oil (26α-D/26β-D= 7:3 (1H-NMR)). 
 
Rf (SiO2 ; Et2O/hexane 3:1) 0.20 (UV254, Ce(SO4)2). 
 
IR (film) 3426w, 3067w, 2958m, 2877w, 1719vs, 1602m, 1584m, 1492w, 1474w, 1451s, 1359m, 
1318s, 1275vs (br.), 1176m, 1113s, 1070s, 1052s, 1026s, 987m, 938m, 898m, 806w, 711vs, 686m, 
606w, 591w, 497w. 
 
1H-NMR (300 MHz, CDCl3): 8.08-7.99, 7.58-7.53, 7.47-7.40 (3m, arom. H); 5.11 (dt-like, HC(4), 
1.08H, α-D); 5.01 (dt, J = 10.5, 4.8, HC(4), 0.33H, β-D); 4.61-4.48, 4.42-4.24 (2m, H2C(6), 
HC(1)); 3.98-3.86 (m, HC(5)); 2.87 (dd, J = 15.5, 7.9, 1.00H, 1H from C(1)CH2CO, α-D); 2.76 
(dd, J = 15.9, 7.5, 0.34H, 1H from C(1)CH2CO, β-D); 2.56 (dd, J = 15.5, 5.5, 1H of C(1)CH2CO, 
α-D); 2.48 (dd, J = 16.0, 5.1, 1H of C(1)CH2CO, β-D); 2.40-2.38, 2.13-2.10, 2.04-1.93, 1.90-1.53 
(4m, H2C(2), H2C(3)). 
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13C-NMR: (75 MHz, CDCl3): 206.3 (s, H3CCO), 166.2, 165.6 (2s, 2OCO); 133.1, 133.0, 129.7, 
129.6, 128.32, 128.29 (6d, arom. C); 77.4, 74.1, 72.5, 69.0, 68.0, 67.9 (6d, C(1), C(4), C(5)); 64.3, 
62.7 (2t, C(6)); 49.0 (t, C(1)CH2CO, β -D);, 47.9 (t, C(1)CH2CO, α-D); 30.34 (q, Me); 30.33, 29.1, 
26.3, 24.3 (4t, C(2), C(3)). 
 
ESI-MS: 419 (100, [M+Na]+). 
 
HR-ESI-MS: calc. for C23H24O6Na1 ([m+Na]+)  419.1471; found 419.1477. 
 
1-(4’,6’-di-O-acetyl-2’,3’-dideoxy-β-D-glucopyranosyl)-propan-2-one (25β) 
1-(4’,6’-di-O-acetyl-2’,3’-dideoxy-α-D-glucopyranosyl)-propan-2-one (25α) 
 
As described for 27, with 100 mg (0.406 mmol) of 17. CC (20 g SiO2, Et2O: hexane 3:1) (to 
increase the solubility of the crude material, several drops of CH2Cl2 were added) yielded 25 mg 
(91.8 µmol, 23%) of the α-D-anomer of 25 and 24 mg (88.1 mmol, 22%) of the β-D-anomer of 25. 
 
O
AcO
AcO
O
 
 
Rf (SiO2 ; Et2O) 0.58 (UV254, Ce(SO4)2). 
 
IR (film): 3467 br. m, 2953m, 2871m, 1740vs, 1439m, 1372s, 1243vs, 1165m, 1110m, 1041s, 
995m, 910w, 871w, 650w, 605w, 573m, 539w. 
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1H-NMR (600 MHz, CDCl3): 4.65 (dt, J = 10.2, 4.8, HC(4)); 4.20 (dd, J = 12.0, 5.7, 1H of 
H2C(6)); 4.09 (dd, J = 12.0, 2.3, 1H of H2C(6)); 3.86-3.81 (m, HC(1));  3.36 (ddd, J = 9.9, 5.7, 
2.3, HC(5)); 2.75 (dd, J = 16.1, 7.2, 1H of C(1)CH2CO); 2.46 (dd, J = 16.1, 5.3, 1H of 
C(1)CH2CO); 2.24-2.19 (m, HC(3)eq); 2.06, 2.04 (2s, 2Ac);  1.85-1.75 (m, HC(2)eq); 1.56-1.49 (m, 
HC(3)ax) ; 1.48-1.42 (m, HC(2)ax). 
 
13C-NMR: (125 MHz, CDCl3): 206.7 (s, CO); 170.9, 170.1 (2s, 2 CO from Ac); 77.4, 74.0, 67.9 
(3d, C(1), C(4), C(5)); 63.5 (t, C(6)); 49.1 (t, C(1)CH2CO); 31.0 (q, H3CCOCH2); 30.3, 29.0 (2t, 
C(2), C(3)); 22.0, 20.9 (2q, 2CH3 from Ac). 
 
CI-MS: 290.2 (100, [M+NH4]+), 273.2 (18, [M+H]+). 
 
ESI-MS: 295.2 (100, [M+Na]+). 
 
HR-ESI-MS: calc. for C13H20O3Na1 ([m+Na]+)  295.1158; found 295.1156. 
 
O
AcO
AcO
O
 
 
Rf (SiO2 ; Et2O) 0.50 (UV254, Ce(SO4)2). 
 
IR (film): 3459 br. vs, 2083w, 1642s, 1441w, 1370w, 1255m, 1137w, 1042w, 968w, 733m, 607m. 
 
1H-NMR (600 MHz, CDCl3): 4.79-4.71 (m, HC(4));  4.34 (dd, J = 11.8, 6.9, 1H of H2C(6)); 4.29-
4.22 (m, HC(1)); 4.11 (dd, J = 11.8, 4.5, 1H of H2C(6)); 3.95-3.91 (m, HC(5)); 2.81 (dd, J = 15.7, 
7.9, 1H of C(1)CH2CO); 2.50 (dd, J = 15.7, 5.5, 1H of C(1)CH2CO); 2.08, 2.07 (2s, 2Ac); 2.00-
1.88 (m, 1HC(3)); 1.83-1.77 (m, 1HC(3)); 1.77-1.71 (m, 1HC(2)); 1.67-1.60 (m, 1HC(2)). 
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13C-NMR: (125 MHz, CDCl3): 206.3 (s, CO); 170.8, 170.3 (2s, 2 CO from Ac); 72.4, 67.8, 67.2 
(3d, C(1), C(4), C(5)); 62.0 (t, C(6)); 47.7 (t, C(1)CH2CO); 30.5 (q, H3CCOCH2); 26.2, 24.2 (2t, 
C(2), C(3)); 21.2, 20.8 (2q, 2CH3 from Ac). 
 
ESI-MS: 295.1 (100, [M+Na]+). 
 
HR-ESI-MS: calc. for C13H20O3Na1 ([m+Na]+)  295.1158; found 295.1156. 
 
N,N-dimethyl-formimidiumacid-methylester-methylsulfate (30) 
 
 
To 10 g (0.137 mol) dry DMF was added at rt 13 ml (17.2 g, 0.136 mol) Me2SO4 under Ar. The 
reaction was stirred for 30 min at rt and 3 h at 60° C. The slightly yellow solution was cooled to rt 
and the crude product 30 (27.2 g, 0.136 mol) was used without purification in the preparation of 
31. 
 
N,N,N’,N’-tetramethyl-formamidinium-methylsulfate (31) 
 
 
 
27.2 g (0.136 mol) of crude 30 was added dropwise over 45 min at rt to a saturated solution of 
Me2NH in 100 ml dry benzene (prepared by bubbling 26.2 g (0.584 mol) Me2NH through a stirred 
solution of 100 ml benzene at 0° C and carefully heating to rt). The reaction was heated to 80° C 
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for 1 h, cooled to rt and the lower, golden layer was separated, extracted with dry Et2O (2 x 50 ml) 
and dried under vacuum (p < 10-1 mbar) resulting in 22.0 g (0.104 mol, 76% from DMF) of 31 as 
a colourless low melting solid. 
 
Bredereck’s reagent (29) 
 
 
 
15.5 g (73.0 mmol) of 31 was added under Ar as solid during 1 h to a solution of 9.20 g (82.0 
mmol) KtBuO in 150 ml dry Et2O. The reaction was stirred for 1.5 h at rt. The yellow suspension 
was filtered and the solvent evaporated (t = 40° C, p = 500 mbar). Vacuum-distillation of the 
yellow oil (p = 11 mbar, t = 60 °C) resulted in 7.30 g (41.9 mmol, 57%) of Bredereck’s reagent 29 
as a colourless oil.  
 
1H-NMR (C6D6, 300 MHz): 4.08 (s, CH); 2.32 (s, 12H of 3NCH3); 1.18 (s, OC(CH3)3). 
 
13C-NMR (C6D6, 75 Mhz): 100.7 (d, CH), 72.0 (s, OC(CH3)3); 41.2 (q, NCH3); 29.0 (q, 
OC(CH3)3). 
 
2-amino-4-[(4’,6’-di-O-benzyl-2’,3’-dideoxy-β-D-glucopyranosyl)methyl]-pyrimidine (34β) 
2-amino-4-methyl-5-(4’,6’-di-O-benzyl-2’,3’-dideoxy-β-D-glucopyranosyl)-pyrimidine (35β) 
 
To a solution of 27β (1.00 g, 2.71 mmol) in 12 ml dry toluene (Acros, over molecular sieves) was 
added Bredereck’s reagent (0.84 ml, 705 mg, 3.93 mmol). After stirring for 22 h at 70 °C, cooling 
to rt, adding 0.84 ml (705 mg, 3.93 mmol) Bredereck’s reagent and stirring for 90 min at 110 °C, 
the crude enaminoketone was cooled to rt, evaporated and dried for 12 h under vacuum (p < 10-1 
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mbar). The enaminoketone was dissolved in 17 ml EtOH and added to a freshly prepared 1 M 
solution of NaOEt in EtOH (11 ml) and 1.16 g (5.36 mmol) guanidiniumsulfate, which had been 
stirred for 30 min at rt. The reaction was stirred for 6 h at 78 °C, evaporated, dissolved in CH2Cl2 
(50 ml), washed with H2O (30 ml), dried (Na2SO4) and evaporated. CC (40 g Al2O3 Brockmann 
activity III, EtOAc/hexane 2:1) yielded 0.289 g (0.552 mmol, 20%) 34β as a slightly yellow 
highly viscous oil, 0.428 g (0.817 mmol, 30%) 34β/35β 1.5:1 (1H-NMR) and 0.188 g (0.359 
mmol, 13%) 35β as a colourless solid.  
 
 
 
Rf (Al2O3; EtOAc/hexane 2:1) 0.25 (UV254, Ce(SO4)2). 
 
IR (film): 3337vs (br.), 3063m, 3030m, 2935m, 2863m, 2079w, 1955w, 1812w, 1631vs, 1578vs, 
1495m, 1459s, 1369m, 1341m, 1315w, 1265w, 1205m, 1100s, 1027m, 1001w, 907w, 880w, 800w, 
781w, 736s, 698s, 646w, 607w. 
 
1H-NMR (CDCl3, 600 MHz) 8.11 (d, 1H, J = 5.1 Hz, NCHarom.), 7.33-7.21 (m, 10H, arom. H), 
6.64 (d, J = 5.1 Hz, NCHCHarom.), 5.29 (br. s, NH2), 4.63-4.40 (m, 4H, benz. H), 3.76-3.71 (m, 1H 
of H2C(6’), HC(1’)), 3.66 (dd, J = 10.8, 4.8 Hz, 1H of H2C(6’)), 3.44-3.39 (m, HC(4’), HC(5’)), 
2.88 (dd, J = 14.0, 7.6 Hz, 1H of HC(1’)CH2-arom.), 2.68 (dd, J = 14.0, 5.1 Hz, 1H of 
HC(1’)CH2-arom.), 2.29-2.26 (m, HC(3’)eq.), 1.79-1.76 (m, HC(2’)eq.), 1.50-1.40 (m, HC(3’)ax., 
HC(2’)ax.). 
 
13C-NMR (CDCl3, 150 MHz): 169.1 (s, C(1’)CH2Carom); 162.1 (s, H2NCarom); 157.3 (d, NCHarom); 
138.5, 138.4 (2s, 2 OCH2Carom); 128.4, 128.3, 127.7, 127.6, 127.5 (5d, 5 Carom); 111.9 (d, 
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NCHCHarom); 80.7 (d, C(5’)); 76.3 (d, C(1’)); 73.3 (t, 1 OCH2-arom); 73.1 (d, C(4’)); 71.0 (t, 1 
OCH2-arom); 69.8 (t, C(6’)); 43.8 (t, C(1’)CH2-arom); 30.6 (t, C(2’)); 29.2 (t, C(3’)). 
 
ESI-MS: 458.1 (5, [m+K]+), 442.2 (6, [m+Na]+), 420.3 (100, [m+H]+). 
 
HR-ESI-MS: calc. for C25H30N3O3 ([m+H]+)  420.2287; found 420.2287. 
 
Anal. calc. for C25H29N3O3 (419.52) C 71.57 H 6.97; found C 71.62 H 6.94. 
 
 
 
Rf (Al2O3; EtOAc/hexane 2:1) 0.22 (UV254, Ce(SO4)2). 
 
IR (KBr): 3408vs (br.), 2941m, 2864w, 2084w (br.), 1635vs, 1469m, 1367w, 1313w, 1216w, 
1216w, 1074m, 1027w, 1000w, 909w, 798m, 735m, 697s.  
 
1H-NMR (CDCl3, 300 MHz): 8.24 (s, NCHarom); 7.32-7.28 (m, 10 arom. H); 5.05 (br. s, NH2); 
4.65-4.39 (m, 5H, benz. H, HC(1’)); 3.82-3.70 (m, 2H); 3.60 (ddd, J = 9.1, 4.9, 2.0, 1H); 3.54-
3.46 (m, 1H); 2.40 (s, H3CCarom); 1.97-1.91, 1.80-1.42 (2m, H2C(2’), H2C(3’)). 
 
13C-NMR (CDCl3, 75 MHz): 166.1 (s); 161.5 (s), 155.5 (d), 138.4, 138.2 (2s, 2 OCH2Carom); 
128.3, 128.2, 127.6, 127.5, 127.4 (5d, 5 Carom); 123.0 (s); 81.2, 74.6, 72.8 (3d); 73.3, 71.0, 69.8 
(3t); 30.5, 29.6 (2t, C(2), C(3)); 21.5 (q, H3CCarom). 
 
ESI-MS: 442.2 (100, [m+Na]+), 420.2 (34, [m+H]+). 
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Anal. calc. for C25H29N3O3 (419.52) C 71.57 H 6.97 N 10.02; found C 71.44 H 6.87 N 9.87. 
 
(2R, 3S)-2-(benzoylmethoxy)-3-(benzoylhydroxy)tetrahydropyrane (86) 
 
 
 
To a solution of 220 mg (0.650 mmol) unsaturated pyranoside 56 in 3 ml MeOH and 0.03 ml 
AcOH at rt was added 5 mg of 10% Pd(C). The solution was evacuated and flushed with H2 three 
times, stirred for 16 h under H2, and filtered over Celite. The solvent was evaporated under 
reduced pressure and the crude material was dissolved in 150 ml EtOAc, extracted with NaHCO3 
sat. (2 x 70 ml), NaCl sat. (1 x 50 ml), the combined aqueous phases were extracted with EtOAc (40 
ml) and the combined organic phases were dried over Na2SO4 and evaporated under reduced 
pressure, resulting in 218 mg (0.640 mmol) of 86 as colourless highly viscous oil. 
 
Rf (SiO2; EtOAc) 0.81 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CDCl3): 8.05-8.01 (m, 4 arom. H); 7.57-7.49 (m, 2 arom. H); 7.43-7.36 (m, 4 
arom. H); 5.11-5.02 (m, 1H of H2C(1), HC(4), HC(5)); 4.61 (dd, J = 11.9, 2.6, 1H of H2C(6)); 
4.38 (dd, J = 11.9, 5.7, 1H of H2C(6)); 4.05-4.00 (m, 1H of H2C(1), HC(4), HC(5)); 3.81 (ddd, J = 
8.4, 5.6, 2.6, 1H of H2C(1), HC(4), HC(5)); 3.48 (dt, J = 11.7, 2.6, 1H of H2C(1), HC(4), HC(5)); 
2.43-2.38 (m, 1H of H2C(2), H2C(3)); 1.94-1.60 (m, 3H of H2C(2), H2C(3)). 
 
13C-NMR (75 MHz, CDCl3): 171.0 (s, CO); 166.4, 165.5 (2s, arom. C); 133.1, 132.9, 129.93, 
129.86, 128.4, 128.3 (6d, arom. C); 77.7, 69.2 (2d, C(4), C(5)); 67.9, 64.4 (2t, C(1), C(6)); 29.4, 
24.9 (2t, C(2), C(3)). 
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CI-MS: 218.0 (24); 205.0 (10), 104.9 (100), 76.9 (21), 27.9 (5). 
 
ESI-MS: 368.1 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C20H20O5Na ([m+Na]+)  368.1208; found 368.1208. 
 
2-amino-4-[(2’,3’-dideoxy-β-D-glucopyranosyl)methyl]-pyrimidine (10) 
 
 
 
To a solution of 492 mg (1.17 mmol) 34β in 100 ml CH2Cl2 under N2 at 0 °C was added 4.7 ml of 
a 1 M solution of BBr3 in CH2Cl2 (4.70 mmol). After stirring for 3 min at 0 °C, the reaction was 
quenched by slowly adding 0.996 g  (9.397 mmol) Na2CO3 in 30 ml H2O, followed by 40 ml H2O. 
The pH was adjusted to 9 with 2 N NaOHaq, the aqueous phase was separated and the organic 
phase was extracted with H2O (30 ml). The combined aqueous phases were washed with CH2Cl2 
(30 ml) and evaporated under reduced pressure. CC (5 g SiO2, MeOH/CH2Cl2 1:4) yielded 210 mg 
(0.878 mmol, 75%) of 10 as colourless solid. 
 
Rf (SiO2; CH2Cl2/MeOH 4:1) 0.27 (UV254, Ce(SO4)2). 
 
UV(H2O) 292 (2325). 
 
IR (film) 3345vs (br.), 2937s, 2864s, 1627vs, 1583vs, 1567vs, 1468vs, 1383m, 1373m, 1343m, 
1216m, 1073s, 988w, 799w. 
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1H-NMR (500 MHz, D2O): 8.11 (d, J = 5.1, RNCHarom); 6.65  (d, J = 5.1, NCCHarom); 3.77 (dd, J 
= 11.5, 2.4, 1HC(6’)); 3.76-3.71 (m, HC(1’)); 3.74 (dd, J = 11.1, 5.2, 1HC(6’)); 3.42-3.35 (m, 
HC(4’)); 3.13 (ddd, J = 8.7, 5.5, 2.5, HC(5’)); 2.80 (dd, J = 14.0, 7.4 , 1H of HC(1’)CH2-arom.); 
2.66 (dd, J =13.9, 5.2, 1H of HC(1’)CH2-arom.); 2.10-2.04 (m, C(3’)Heq); 1.76-1.71 (m, C(2’)Heq); 
1.52-1.34 (m, C(3’)Hax, C(2’)Hax).  
 
13C-NMR (125 MHz, D2O): 170.8 (s, CH2Carom); 164.5 (s, H2NCarom); 158.9 (d, NCHarom); 112.2 
(d, NCHCHarom); 84.1 (d, C(5’)); 77.5 (d, C(1’)); 67.4 (d, C(4’)); 63.5 (t, C(6’)); 44.8 (t, 
C(1’)CH2-arom); 33.7 (t, C(3’)); 32.1 (t, C(2’)). 
 
ESI-MS: 262 (100, [m+Na]+), 240 (45, [m+H]+). 
 
HR-ESI-MS: calc. for C11H18N3O3 ([m+H]+)  240.1348; found 240.1347. 
 
2-amino-4-methyl-5-(2’,3’-dideoxy-β-D-glucopyranosyl)-pyrimidine (36) 
 
 
To a solution of 114 mg (0.218 mmol) 35 in 30 ml dry CH2Cl2 under N2 was added at 0 °C 1.1 ml 
of a 1 M BBr3 (1.1 mmol) solution in CH2Cl2. The reaction was stirred for 3 min at 0 °C, 
quenched by a dropwise addition of 17 ml H2O at 0 °C and the pH of the aq. phase was adjusted to 
11 with aq. NaHCO3 sat. and aq. 2 N NaOH, the aq. phase was evaporated, the remaining solid was 
dissolved in 20 ml MeOH, filtered and evaporated. CC (6 g Al2O3; CH2Cl2/MeOH 5:1) resulted in 
41 mg (0.171 mmol, 79 %) 36 as a colourless solid. 
 
Rf (SiO2 ; CH2Cl2/MeOH 5:1) 0.19 (UV254, Ce(SO4)2). 
Rf (Al2O3 ; CH2Cl2/MeOH 5:1) 0.41 (UV254, Ce(SO4)2). 
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IR(film): 3345vs (br.), 2937s, 2864s, 1627vs, 1583vs, 1567vs, 1468vs, 1383m, 1373m, 1343m, 
1216m, 1073s, 988w, 799w.  
 
1H-NMR (600 MHz, D2O): 8.21 (s, NCHarom.), 4.56 (dd, J = 11.4, 1.9, HC(1’)); 3.88 (dd, J = 12.3, 
2.3, 1H of H2C(6’)); 3.72 (dd, J = 12.3, 6.0, 1H of H2C(6’)); 3.60 (dt, J = 9.7, 4.8, HC(4’));  3.50 
(ddd, J = 9.4, 6.0, 2.3, HC(5’)); 2.26-2.21 (m, C(3’)Heq)); 1.96-1.92 (m, C(2’)Heq)); 1.88-1.81 (m, 
C(2’)Hax)); 1.71-1.65 (m, C(3’)Hax)). 
 
13C-NMR (150 MHz, D2O): 168.4 (s, H2NCarom); 161.4 (s, H3CCarom); 155.7 (d, HCarom); 122.1 (s, 
C(1’)Carom); 82.6 (d, C(5’)); 74.1 (d, C(1’)); 65.6 (d, C(4’)); 61.4 (t, C(6’)); 31.7 (t, C(3’)); 29.2 (t, 
C(2’)); 20.5 (q, H3C). 
 
ESI-MS: 262.1 (100, [M+Na]+), 240 .1(21, [M+H]+). 
 
HR-ESI-MS: calc. for C11H18N3O3 ([m+H]+)  240.1348; found 240.1348. 
 
2-benzoylamino-4-[(2’,3’-dideoxy-β-D-glucopyranosyl)methyl]-pyrimidine (73) 
 
 
 
To a suspension of 281 mg (1.173 mmol) 10 in dry pyridine at 0 °C was added dropwise 0.74 ml 
(636 mg, 5.864 mmol) Me3SiCl. After stirring for 30 min at 0 °C, 0.68 ml (824 mg, 5.864 mmol) 
benzoyl chloride was added dropwise to the solution at 0° C. The reaction was stirred for 2 h at rt, 
cooled to 0 °C and 2.4 ml H2O was added, stirred for 15 min followed by the addition of 2.6 ml 
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NH3 conc (25% in H2O, 13.4 M). After stirring for 30 min, the pyridine was evaporated, the product 
was dissolved in 30 ml H2O and washed with 10 ml Et2O. CC (12 g SiO2; CH2Cl2/MeOH 10:1 to 
CH2Cl2/MeOH 8:1) resulted in 321 mg (0.935 mmol, 80 %) 73 as a colourless foam. 
 
M.p. 65 °C. 
 
Rf (SiO2 ; CH2Cl2/MeOH 10:1) 0.35 (UV254, Ce(SO4)2). 
 
IR (KBr): 3416vs (br.), 2937w, 2865w, 2639w, 1690s, 1597vs, 1557m, 1527s, 1440vs, 1404m, 
1316w, 1267m, 1073m, 1027w, 796w, 712m, 650w, 624w, 578w.  
 
1H-NMR (300 MHz, d4-MeOD): 8.58 (d, J = 5.1, NCHarom); 8.08-7.97 (m, 2 COCCHarom); 7.68-
7.42 (m, 3 arom. H); 7.24 (d, J = 5.1, RNCHCHarom); 3.90-3.82 (m, HC(1’)); 3.77 (dd, J = 11.7, 
2.7, 1HC(6’)); 3.65 (dd, J = 11.7, 5.5, 1HC(6’)); 3.46-3.36 (m, HC(4’)); 3.15 (ddd, J = 8.6, 5.5, 
2.7, HC(5’)); 2.97 (dd, J = 13.8, 7.4, 1H of HC(1’)CH2-arom.); 2.91 (dd, J = 13.3, 2.9, 1H of 
HC(1’)CH2-arom.); 2.17-2.03, 1.82-1.74, 1.58-1.46 (3m, H2C(2’), H2C(3’)).  
 
13C-NMR (75 MHz, d4-MeOD): 171.5, 168.6, 159.1 (3s, CO, CH2Carom, NHCarom), 135.7 (s, 
(CO)Carom); 133.7, 130.8, 129.6 (3d, arom. C); 118.9 (d, NCHCHarom); 84.1 (d, C(5’)); 77.4 (d, 
C(1’)); 67.4 (d, C(4’)); 63.5 (t, C(6’)); 44.7 (t, C(1’)CH2-arom.); 33.7, 32.1 (2t, C(3’), C(2’)). 
 
ESI-MS: 366 (100, [m+Na]+), 344 (29, [m+H]+). 
 
HR-ESI-MS: calc. for C18H21N3O4Na ([m+Na]+) 366.1430; found 366.1428. 
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2-aminobenzoyl-4-methyl-5-(2’,3’-dideoxy-β-D-glucopyranosyl)-pyrimidine (74) 
 
 
 
To a suspension of 684 mg (2.86 mmol) 36 in 29 ml dry pyridine was added 1.80 ml (1.55 g, 
14.23 mmol) Me3SiCl dropwise over 5 min. The reaction was stirred for 30 min at 0 °C, 1.66 ml 
(2.01 g, 14.31 mmol) of BzCl was added dropwise at 0° C and the reaction was stirred for 2 h at 
24° C and cooled to 0° C. 5.8 ml ice cold water, followed by 6.3 ml (25%, 13.4M) NH3aq., was 
added and the reaction was stirred for 30 min at 0° C and evaporated under reduced pressure, 
dissolved in 100 ml H2O and extracted with Et2O (3 x 25 ml). The aqueous phase was evaporated 
and the resulting colourless solid was suspended under ultrasonic in MeOH (50 ml). The 
suspension was filtered and the colourless solid washed with MeOH (2 x 10 ml) and the MeOH 
evaporated. CC (12 g SiO2, CH2Cl2/MeOH 10:1) resulted in 582 mg (1.70 mmol, 59%) 74 as a 
slightly yellow foam. 
 
Rf (SiO2 ; CH2Cl2/MeOH 10:1) 0.25 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 10.89 (br. s., NHCO); 8.62 (s, HCarom); 7.98-7.94 (m, arom. H); 
7.64-7.43 (m, arom. H); 4.55 (m, HC(1’)); 3.78-3.73, 3.57-3.50, 3.49-3.36, 3.29-3.24 (4m, each 
1H of HC(4’), HC(5’), H2C(6’)); 2.08-2.05, 1-95-1.92 (2m, each 1H of H2C(2’), H2C(3’)); 1.71-
1.53 (m, 2H of H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, d6-DMSO): 167.6, 165.8 (2s, CO, HNCarom); 156.9 (s, CH3Carom); 155.3 (d, 
HC(6)); 134.3 (s, COCarom); 134.3, 132.7, 132.0 (3d, Carom); 83.8, 73.5, 65.0 (3d, C(5’), C(1’), 
C(4’)); 61.6 (t, C(6’)); 32.8, 30.5 (2t, C(2’), C(3’)); 21.4 (q, H3C). 
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ESI-MS: 366 (100, [m+Na]+), 344 (8, [m+H]+). 
 
HR-ESI-MS: calc. for C18H21N3O4Na ([m+Na]+) 366.1430; found 366.1426. 
 
(2R, 3S)-2-(hydroxymethoxy)-3-hydroxy-tetrahydropyrane (87) 
 
 
 
A solution of 240 mg (0.705 mmol) 86 was stirred for 24 h  in a saturated NH3 solution in CH3OH. 
The solvent was evaporated and the crude mixture was dissolved in H2O (40 ml), extracted with 
CH2Cl2 (3 x 20 ml), and the combined organic phases were extracted with H2O (30 ml). The combined 
aqueous phases were lyophilised, resulting in 73 mg (0.552 mmol, 78 %) of 87 as colourless highly 
viscous oil. 
 
Rf (SiO2 ; EtOAc) 0.13 (Ce(SO4)2). 
 
1H-NMR (300 MHz, d4-MeOD): 3.88-3.77 (m, 2H); 3.56 (dd, J = 11.6, 6.2, 1H); 3.36-3.26 (m, 
2H); 3.04 (ddd, J = 9.1, 6.2, 2.6, 1H); 2.06-2.00 (m, 1H of H2C(2), H2C(3)); 1.65-1.57 (m, 2H of 
H2C(2), H2C(3)); 1.45-1.32 (m, 1H of H2C(2), H2C(3)). 
 
13C-NMR (75 MHz, d4-MeOD): 84.3 (d); 68.6 (t); 67.6 (d); 63.5 (t); 33.7 (t); 26.7 (t). 
 
2-benzoylamino-4-{[2’,3’-dideoxy-6’-O-({4,4’-dimethoxytriphenyl}methyl)-β-D-
glucopyranosyl]methyl}-pyrimidine (75) 
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265 mg (0.772 mmol) 73, dried for 15 h under high vacuum (p < 10-1 mbar) was coevaporated 
with 1 ml pyridine, 317 mg (0.927 mmol) Bu4NClO4 and 314 mg (0.927 mmol) DMTrCl were 
added and dried for 1.5 h under high vacuum. 4 ml pyridine was added and the reaction was 
stirred for 2 h, 15 min at rt. 60 ml CH2Cl2 were added and the reaction was extracted with aq. 
NaHCO3 sat. (2 x 30 ml), aq. NaCl sat. (1 x 30 ml), dried (Na2SO4). CC (19 g SiO2; EtOAc) (for this 
application, a few drops of CH2Cl2 were added due to solubility reasons) resulted in 422 mg 
(0.654 mmol, 85 %) 75 as a colourless foam. 
 
M.P.: 150 – 155 °C. 
 
Rf (SiO2; EtOAc) 0.28 (UV254, Ce(SO4)2). 
 
IR (KBr): 3441vs (br.), 3061w, 2963m, 2936m, 2876m, 2043w, 1691m, 1604s, 1510s, 1440vs, 
1403m, 1383w, 1301m, 1250s, 1177m, 1094vs (br.), 1032s, 999w, 931w, 884w, 830w, 708m, 
623m, 597w, 583w, 515w. 
 
1H-NMR (300 MHz, CD2Cl2): 8.68 (br. s, NH); 8.52 (d, J = 5.1, RNCHarom); 7.73 (dd, J = 7.2, 1.4, 
2 arom. H); 7.60 (tt, J = 6.4, 2.2, 1 arom. H); 7.51-7.40 (m, 4 arom. H); 7.32-7.18 (m, 7 arom. H); 
7.07 (d, J = 5.1, RNCHCHarom); 6.79 (dd, J = 9.0, 1.2, 4 arom. H); 3.84-3.75 (m, 2H of HC(1’), 
HC(4’), HC(5’), H2C(6’)); 3.73 (s, MeO); 3.72 (s, MeO); 3.50-3-38, 3.36-3.28, 3,28-3.21 (3m, 
each 1H, 3H from HC(1’), HC(4’), HC(5’), H2C(6’)); 2.94 (d, J = 6.5, HC(1’)CH2-arom.); 2.12-
2.01, 1.84-1.76, 1.55-1.49 (3m, H2C(2’), H2C(3’)). 
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13C-NMR (75 MHz, CD2Cl2): 170.0, 165.2, 158.2 (3s, CO, CH2Carom, NHCarom), 158.9, 157.7 (2s, 
arom. C); 158.2 (d, NCHarom); 136.1, 136.0, 134.6 (3s, (CO)Carom, 2 arom. C); 130.3, 129.0, 128.3, 
128.2, 127.7, 127.1, 113.4 (7d, arom. C); 117.4 (d, NCHCHarom); 86.7 (s, COC(6’)); 80.7 (d, 
C(5’)); 76.4 (d, C(1’)); 68.6 (d, C(4’)); 65.4 (t, C(6’)); 55.4 (q, OMe); 44.0 (t, C(1’)CH2-arom.); 
32.5,  30.9 (2t, C(2’), C(3’)). 
 
ESI-MS: 668.3 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C39H39N3O6Na ([m+Na]+ 668.2737; found 668.2745. 
 
2-aminobenzoyl-4-methyl-5-{2’,3’-dideoxy-6’-O-([4,4’-dimethoxytriphenyl]methyl)-β-D-
glucopyranosyl}-pyrimidine (76) 
 
 
 
545 mg (1.59 mmol) 74, 647 mg (1.91 mmol) DMTrCl, and 653 mg (1.91 mmol) (Bu4N)ClO4 
were dried for 2 h under high vacuum (p < 10-1 mbar) and dissolved in 8 ml pyridine, resulting in 
a red, clear solution. The reaction was stirred for 2 h 30 min at rt and evaporated under reduced 
pressure (t = 30° C) to a volume of 1 ml. CH2Cl2 (60 ml) was added and the reaction was 
extracted with NaHCO3 sat. (2 x 30 ml), NaClsat. (30 ml), dried (Na2SO4) and evaporated under 
reduced pressure (t < 35° C). CC (SiO2, EtOAc, 1% NEt3) resulted in 76 as slightly yellow foam 
(914 mg, 1.42 mmol, 89%). 
 
M.P.: 130 – 133 °C. 
 
Rf (SiO2; EtOAc) 0.28 (UV254, Ce(SO4)2). 
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IR (KBr): 3426br. m, 3060w, 2964s, 2937s, 2877m, 1670m, 1607m, 1579m, 1509s, 1488s, 1473m, 
1445s, 1383m, 1302w, 1250s, 1178m, 1153w, 1093vs, 1032m, 999w, 930w, 886w, 829w, 791w, 
755w, 739w, 706w, 622s, 598w, 583w. 
 
1H-NMR (300 MHz, CD2Cl2): 8.72 (br. s, NH); 8.50 (s, HC(6)); 7.82 (dd, J = 8.7, 1.5, 2 arom. H); 
7.77-7.73 (m, 1 arom. H); 7.56-7.36 (m, 6 arom. H); 7.31-7.14 (m, 6 arom. H); 6.79-6.74 (m, 3 
arom. H); 4.45 (d-like, HC(1’)); 3.74-3.68 (m, 1H of HC(4’), HC(5’), H2C(6’)); 3.71 (s, MeO); 
3.71-3.54, 3.47-3.41, 3.36-3.25 (3m, 4H of HC(4’), HC(5’), H2C(6’)); 2.45 (s, H3CCarom); 2.15-
2.08, 1.95-1.85, 1.72-1.51 (3m, H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, CD2Cl2): 166.7, 165.3 (2s, CO, NHCarom); 158.9 (s, arom. C); 156.8 (s, 
CH3Carom); 155.8 (d, HC(6)); 136.1, 136.0, 134.8 (3s, (CO)Carom, 2 arom. C); 132.7, 132.1, 130.3, 
129.0, 128.8, 128.3, 128.2, 127.6, 127.1, 113.4 (10d, arom. C); 81.4, 74.7, 68.3 (3d, C(5’), C(1’), 
C(4’)); 65.4 (t, C(6’)); 55.5 (q, OMe); 32.6, 31.0 (2t, C(2’), C(3’)); 21.9 (q, CH3). 
 
ESI-MS: 668.3 (100, [m+Na]+). 
 
2-iodo-4-[(2’,3’-dideoxy-4’,6’-bis-O-benzyl-β-D-glucopyranosyl)methyl]-pyrimidine (38) 
 
 
 
To a solution of 34 (100 mg, 0.238 mmol) in 1.7 ml CH2I2 under N2 was added 0.64 ml (588 mg,  
4.77 mmol) isopentylnitrite. The reaction was stirred for 1 h at 85° C, cooled to rt and evaporated 
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under reduced pressure. CC (3 g SiO2, EtOAc/hexane 1:2) yielded 42 mg (0.0792 mmol, 33%) 38 
as a highly viscous oil. 
 
Rf (SiO2; EtOAc/Hexane 1:2) 0.21 (UV254, Ce(SO4)2). 
 
IR(film): 2928w, 2864w, 1718s, 1564s, 1527m, 1452m, 1383vs, 1367vs, 1327s, 1271m, 1157m, 
1097s, 739w, 699w.  
 
1H-NMR (300 MHz, CDCl3): 8.17 (d, J = 4.9, NCHarom); 7.33-7.23 (m, 11 arom. H); 4.61-4.40 (m, 
4 benz. H); 3.74-3.61 (m, HC(1’), H2C(6’)); 3.41-3.38 (m, HC(5’), HC(4’)); 2.94-2.80 (m, 
C(1’)CH2Carom); 2.31-2.26 (m, 1H of H2C(3’)); 1.81-1.76 (m, 1H of H2C(2’)); 1.56-1.42 (m, 2H of 
H2C(3’), H2C(2’)). 
 
13C-NMR (75 MHz, CDCl3): 170.4, 157.7, 128.2, 127.5, 127.4, 120.9, 80.4, 75.8, 73.2, 72.9, 70.9, 
69.8, 43.4 (t, C(1’)CH2Carom), 30.5, 29.1 (2t, C(3’), C(2’)). 
 
ESI-MS: 553.1 (100, [m+Na]+), 569.1 (15, [m+K]+). 
 
HR-ESI-MS: calc. for C25H27N2O3Na1I1 ([m+Na]+)  553.0964; found 553.0958. 
 
2-iodo-4-methyl-5-(2’,3’-dideoxy-4’,6’-bis-O-benzyl-β-D-glucopyranosyl)-pyrimidine (39) 
 
 
 
To a solution of 100 mg (0.238 mmol) 35 (dried for 14 h under high vacuum)  in 1.7 ml (5.64 g, 
21.1 mmol) CH2I2 under N2 was added at rt 0.64 ml (561 mg, 4.79 mmol) isopentylnitrite and the 
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reaction heated to 85° C for 1 h. Starting from 60 ° C, the generation of a gas was observed.  The 
reaction was cooled to rt, evaporated and traces of CH2I2 were removed at 55° C under high 
vacuum (p < 10-1 mbar) over 10 min. CC (5 g SiO2; EtOAc/hexane 1:2) resulted in 45 mg (84.8 
µmol, 36%) of 39 as a colourless solid. 
 
Rf (SiO2; EtOAc/Hexane 1:3) 0.15 (UV254, Ce(SO4)2) 
 
IR(KBr): 3443vs, 3087m, 3062m, 3029m, 2924s, 2865vs, 2257w, 1658vs, 1562vs, 1496s, 1453vs, 
1399s, 1364vs, 1323vs, 1261s, 1208s, 1099vs, 1027s, 909w, 809w, 737vs, 697vs, 609w. 
 
1H-NMR (300 MHz, CDCl3): 8.39 (s, NCHarom); 7.38-7.23 (m, 10 arom. H); 4.65-4.45 (m, 5H, 4 
benz. H, HC(1’)); 3.82-3.68 (m, 2H); 3.61 (ddd, J = 7.4, 5.0, 1.8, 1H); 3.54-3.44 (m, 1H), 2.48 (s, 
CH3); 2.44-2.36, 2.15-1.92, 1.71-1.57 (3m, H2C(3’), H2C(2’)). 
 
13C-NMR (75 MHz, CDCl3): 155.9 (d, NCHarom); 139.5, 132.4 (2s, C(1)Carom, H2CCarom); 128.3, 
128.2, 127.6, 127.5 (4d, CHarom); 81.3, 74.1, 72.4  (3d, C(5’), C(4’), C(1’)); 73.4, 71.1, 69.6 (3t, 
C(6’), 2CH2Carom); 30.7, 29.4 (2t, C(3’), C(2’)); 21.5 (q, CH3). NCI was not detected. 
 
ESI-MS: 553.1 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C25H27N2O3Na1I1 ([m+Na]+)  553.0964; found 553.0956. 
 
2-O-benzyl-4-[(2’,3’-dideoxy-4,’6’-bis-O-benzyl-β-D-glucopyranosyl)methyl]-pyrimidine (44) 
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A solution of 38 (126 mg, 0.238 mmol) in 8 ml dry CH3CN (Fluka, over molecular sieves), 48 mg 
(1.20 mmol) NaOH (dried under vacuum p < 10-1 mbar, 2 h) and 1.0 ml (1.05 g, 9.52 mmol) 
BnOH were stirred for 4.5 h at 80° C, cooled to rt, evaporated, dissolved in CH2Cl2 (20 ml), 
washed with aq. NH4Clsat. (1 x 10 ml), dried (Na2SO4) and evaporated. CC (3 g SiO2, 
MeOH/CH2Cl2 1:50) yielded 149 mg (0.291 mmol, 79%) 44. 
 
Rf (SiO2; CH2Cl2/MeOH 50:1) 0.67 (UV254, Ce(SO4)2) 
 
IR(film): 3686w (br.), 3030s, 2934s, 2862vs, 1581vs, 1558vs, 1496s, 1453vs, 1409vs, 1354vs, 
1318s, 1207m, 1085vs (br.), 1028m, 909m, 735m, 697s. 
 
1H-NMR (300 MHz, CDCl3): 8.33 (d, J = 5.0, NCHarom); 7.48-7.18 (m, 15 arom. H); 6.91 (d, J = 
5.0, NCHCHarom); 4.70-4.39 (m, 6 benz. H); 3.81-3.61 (m, HC(1’), H2C(6’)); 3.42-3.38 (m, 
HC(4’), HC(5’)); 2.96 (dd, J = 14.0, 7.5, 1H of C(1’)CH2Carom); 2.78 (dd, J = 14.0, 5.1, 1H of 
C(1’)CH2Carom); 2.33-2.24 (m, 1H of H2C(3’)); 1.81-1.62, 1.48-1.40 (2m, 1 H of H2C(3’), 
H2C(2’)). 
 
13C-NMR (75 MHz, CDCl3): 170.5 (s, NCOarom); 158.8 (d, NCHarom); 140.2, 140.0, 138.8 (3s, 3 
OCH2Carom); 128.5, 128.2, 127.9, 127.6, 127.4, 127.3, 126.9 (7d, CHarom); 115.3 (d, NCHCHarom); 
80.5, 76.2, 73.1 (3d, C(1’), C(4’), C(5’)); 73.2, 71.5, 70.0, 69.2 (4t, C(6’), 3 OCH2-arom.); 43.8 (t, 
C(1’)CH2-arom.); 30.6, 29.1 (2t, C(2’), C(3’)). 
 
ESI-MS: 533.2 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C32H34N2O4Na1 ([m+Na]+) 533.2416; found 533.2416. 
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2-O-benzyl-4-methyl-5-(2’,3’-dideoxy-4’,6’-bis-O-benzyl-β-D-glucopyranosyl)-pyrimidine (45) 
 
 
A solution of 39 (130 mg, 0.245 mmol) in 8 ml dry CH3CN (Fluka, over molecular sieve), 49 mg 
(1.225 mmol) NaOH (dried under vacuum p < 10-1 mbar, 2 h) and 1.0 ml (1.05 g, 9.52 mmol) 
BnOH was stirred for 4.5 h at 80° C, cooled to rt, evaporated, dissolved in CH2Cl2 (20 ml), 
washed with aq. NH4Clsat. (1 x 10 ml), dried (Na2SO4) and evaporated. CC (3 g SiO2, 
MeOH/CH2Cl2 1:50) yielded 103 mg (0.202 mmol, 82%) 45 as a slightly brown, highly viscous 
oil. 
 
Rf (SiO2; CH2Cl2/MeOH 50:1) 0.57 (UV254, Ce(SO4)2). 
 
IR(film): 3062s, 3030s, 2927vs, 2864vs, 2199w, 1953w, 1877w, 1587vs, 1560vs, 1496s, 1453vs, 
1431vs, 1356vs, 1310vs, 1207s, 1180m, 1099vs, 1076vs, 910m, 815w, 796m, 736s, 697vs, 609w. 
 
1H-NMR (300 MHz, CDCl3): 8.45 (s, NCHarom); 7.49-7.46 (m, 2 arom. H); 7.37-7.23 (m, 13 arom. 
H); 5.42 (s, NCOCH2); 4.65-4.45 (m, 4 benz. H); 3.83-3.69 (m, 2H); 3.61 (ddd, J = 11.2, 4.9, 1.9, 
1H); 3.56-3.46 (m, 1H); 2.48 (s, CH3); 2.43-2.35, 2.01-1.92, 1.78-1.59 (3m, H2C(3’), H2C(2’)). 
 
13C-NMR (75 MHz, CDCl3): 156.4 (d, NCHarom); 128.3, 128.2, 127.9, 127.7, 127.6, 127.5, 127.4 
(7d, arom. C); 81.3 (d); 74.5 (d); 73.3(t); 72.8 (d); 71.1(t); 69.8 (t); 68.7 (t); 30.7, 29.6 (2t, C(3’), 
C(2’)); 21.7 (q, CH3).  
 
ESI-MS: 533.2 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C32H34N2O4Na1 ([m+Na]+ 533.2416; found 533.2416. 
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4-[(2’,3’-dideoxy-4,’6’-bis-O-benzyl-β-D-glucopyranosyl)methyl]-pyrimidin-2-one (11) 
 
 
 
To a solution of 7 mg (13.7 µmol) 44 in 1.8 ml dry CH2Cl2 was added at 0°C 82 µl (82 µmol) of a 
1 M BBr3-solution in CH2Cl2. The reaction was stirred for 3 min at 0° C and quenched by the 
addition of 2 ml ice-cold water, followed by NaHCO3 sat. until a pH of about 8 was reached. The 
phases were separated and the aqueous phase was evaporated under reduced pressure. CC (2 g 
SiO2, MeOH/CH2Cl2 1:1) resulted in 2.6 mg (10.8 µmol, 79%) of 11 as a colourless solid. 
 
IR(KBr): 3442vs (br.), 2941w, 2868w, 2252w, 2127w, 2091w, 1640s (br.), 1573m, 1456m, 1384w, 
1341w, 1262w, 1072m, 1047m, 1025m, 995m, 827w, 767w, 594m. 
 
1H-NMR (600 MHz, d6-DMSO): 7.87 (d, J = 4.9, NCHarom); 6.01 (d, J = 4.9, NCHCHarom); 4.72, 
4.44 (2 br. s, 2 OH); 3.66-3.57 (m, 2H, 1HC(6’), 1HC(1’)); 3.42 (dd, J = 11.4, 5.8, 1HC(6’)); 
3.22-3.15 (m, HC(4’));  3.01 (ddd, J = 8.8, 5.8, 2.3, HC(5’));  2.59 (dd, J = 13.4, 6.2, 1H of 
HC(1’)CH2-arom.); 2.33 (dd, J = 13.4, 6.9, 1H of HC(1’)CH2-arom.); 1.92-1.86 (m, HeqC(3’)); 
1.59-1.54 (m, HeqC(2’)); 1.36-1.28 (m, HaxC(3’)); 1.25-1.17 (m, HaxC(2’)). 
 
13C-NMR (125 MHz, d6-DMSO): 168.7 (s, C(1)CH2Carom); 156.0 (d, NCHarom); 103.9 (d, 
NCHCHarom.); 83.0 (d, C(5’)); 75.4 (d, C(1’)); 65.4 (d, C(4’)); 61.5 (d, C(6’)); 43.4 (d, C(1’)); 32.4 
(t, C(3’)); 30.3 (t, C(2’)). 
 
ESI-MS: 263.0 (100, [m+Na]+). 
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HR-ESI-MS: calc. for C11H16N2O4Na1 ([m+Na]+)  263.1008; found 263.1012. 
 
4-methyl-5-(2’,3’-dideoxy-4’,6’-bis-O-benzyl-β-D-glucopyranosyl)-pyrimidin-2-one (37) 
 
 
 
To a solution of 6 mg (11.8 µmol) 45 in 1.5 ml dry CH2Cl2 was added at 0° C 70 µl (70 µmol) of a 
1 M BBr3-solution in CH2Cl2. The reaction was stirred for 3 min at 0° C and quenched by the 
addition of 1.5 ml ice-cold water, followed by NaHCO3 sat. until a pH of about 8 was reached. The 
phases were separated and the aqueous phase was evaporated under reduced pressure, the 
resulting colourless solid suspended under ultrasonic condition in CH3OH, filtered, and the 
CH3OH was evaporated. CC (2 g SiO2, MeOH:CH2Cl2 1:1) resulted in 2.4 mg (9.9 µmol, 84%) of 
37 as a colourless solid. 
 
IR(KBr): 3424vs (br.), 2955w, 2252w, 2127w, 1646s (br.), 1496w, 1384w, 1318w, 1261w, 1048m, 
1025s, 997s, 827m, 767m, 634m. 
 
1H-NMR (600 MHz, d4-MeOD): 8.21 (s, HCarom); 4.46 (dd, J = 11.1, 1.3, HC(1)); 3.37 (dd, J = 
11.8, 2.4, 1H of H2C(6’)); 3.68 (dd, J = 11.8, 6.0, 1H of H2C(6)); 3.51-3.47 (m, HC(4’)); 3.37-
3.34 (m, HC(5’)); 2.43 (s, CH3); 2.20-2.17 (m, C(3’)Heq); 1.95-1.93 (m, C(2’)Heq); 1.78-1.71 (m, 
C(2’)Hax); 1.70-1.63 (m, C(3’)Hax). 
 
13C-NMR (125 MHz, d4-MeOD): 130.6 (s, H3CCarom); 129.0 (d, HCarom); 120.9 (s, C(1)Carom); 84.9 
(d, C(5’)); 75.3 (d, C(1’)); 67.1 (d, C(4’)); 63.5 (t, C(6’)); 33.9 (t, C(3’)); 31.9 (t, C(2’)); 21.4 (q, 
CH3). 
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ESI-MS: 263.1 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C11H16N2O4Na1 ([m+Na]+)  263.1008; found 263.1008. 
 
N6-benzoyladenine  
 
 
 
To a suspension of 10 g (74.0 mmol) adenine in 70 ml pyridine was added at rt 21.5 ml (26.0 g, 
185 mmol) BzCl. After stirring for 2 h at 120° C, the pyridine was distilled out under reduced 
pressure. NaHCO3 sat. (100 ml) was added, followed by CHCl3 (20 ml), the precipitate was filtered 
off, washed with CH2Cl2 (50 ml) and recrystallized from boiling EtOH/H2O 1:1, resulting in 12.8 
g (53.5 mmol, 72%) N6-benzoyladenine as colourless needles. 
 
1H-NMR (300 MHz, d6-DMSO): 12.35 (br. s, HN(9)); 11.62 (br. s, HNCO); 8.72 (s, HC(8)); 8.48 
(s, HC(2)); 8.12 (d, J = 7.4, 2 OCCqCHarom); 7.71-7.62, 7.60-7.52 (2m, 3H, HCarom of Bz). 
 
13C-NMR (75 MHz, d6-DMSO): 171.7 (s, CO); 156.2, 151.2 (2d, HC(8), HC(2)); 149.6 (s); 137.8, 
133.7, 133.6 (3d, 5 HC of Bz);  119.8 (s). 
 
ESI-MS: 262 (69, [M+Na]+); 240 (100, [M+H]+). 
 
Anal. calc. for C12H11N5O (419.52) C 59.74 H 4.60 N 29.03; found C 60.11 H 4.02 N 29.78. 
 
 
Chapter 5: Experimental part 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 161  
N2-isobutyrylguanine 
 
 
 
To a suspension of 7.56 g (50.0 mmol) guanine in 100 ml dry DMF (Fluka, over molecular sieves) 
was added at rt 22.4 ml (21.4 g, 135 mmol) isobutyric anhydride. After stirring for 2 h at 150° C 
the clear solution was cooled to rt and evaporated to 10 ml. The formed precipitate was filtered 
off, washed with CH2Cl2 (50 ml) and NaHCO3 sat. and recrystallized from boiling EtOH/H2O (1:1), 
resulting in 9.04 g (42. 6 mmol, 85 %) N2-isobutyrylguanine hydrate as colourless needles. 
 
1H-NMR (300 MHz, d6-DMSO): 13.20, 12.12, 11.56 (3 br. s, 3 NH); 8.02 (s, HC(8)); 2.75 (sept, J 
= 6.9, HCiPr); 1.11 (d, J = 6.9, 2 CH3). 
 
1’-(4’,6’-di-O-acetyl-2’,3’-dideoxy-β-D-glucopyranosyl)uracil (48) 
 
 
 
To a suspension of 2.83 g (9.75 mmol) 17, 1.33 g (10.9 mmol) uracil in 120 ml dry CH3CN was 
added at rt 2.45 ml (1.86 g, 11.5 mmol) HMDS followed by 1.65 ml (2.07 g, 19.1 mmol) Me3SiCl. 
The reaction was stirred for 30 min at rt. 1.6 ml (3.55 g, 13.6 mmol) SnCl4 were added and the 
homogeneous colourless solution was stirred for 16 h at 44° C, cooled to rt and concentrated by 
evaporation (remaining volume 30 ml). 200 ml EtOAc were added, the reaction was extracted 
with H2O (2 x 100 ml), aq. NaHCO3 sat. (1 x 100 ml), the combined aq. phases were extracted with 
EtOAc (1 x 150 ml), the combined org. phases were extracted with aq NaClsat. (1 x 250 ml), dried 
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(Na2SO4) and evaporated. CC (150 g SiO2, EtOAc/hexane 3:1) resulted in 1.38 g (4.23 mmol, 
43%) of pure β-D-anomer 48, 210 mg (0.643 mmol, 7%) α-D-anomer 49 and 349 mg (1.63 mmol, 
17%) enolether 52. 
  
Rf (SiO2; EtOAc) 0.39 (UV254, Ce(SO4)2). 
 
IR(KBr): 3421w (br.), 3200w (br.), 3100w, 2980w, 1745vs (br.), 1690vs (br.), 1630m, 1455m, 
1382m, 1317w, 1281s, 1250s, 1197w, 1151w, 1130w, 1122w, 1086m, 1070m, 1042m, 997w, 931w, 
820w. 
 
1H-NMR (300 MHz, CDCl3): 8.12 (br. s, NH); 7.41 (d, J = 8.1, HC(6)); 5.81 (d, J = 8.1, HC(5)); 
5.74 (dd, J =10.4, 2.3, HC(1’)); 4.74 (ddd, J = 10.4, 10.2, 4.7, HC(4’)); 4.25 (dd, J = 12.1, 2.3, 1 
HC(6’)); 4.16 (dd, J = 2.3, 12.1, 1HC(6’)); 3.85 (ddd, J = 9.9, 6.4, 2.3, HC(5’)); 2.38, 2.11 (2m, 
2H, H2C(2’), H2C(3’)); 2.08, 2.07 (2s, 2 Ac); 1.74 (m, 2H, H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, CDCl3): 170.9, 170.0 (2s, MeCO); 163,4 (s, C(4)); 150.2 (s, C(2)); 139.4 (d, 
C(6)); 103.1 (d, C(5)); 81.4 (d, C(1’)); 77.8 (t, C(5’)); 66.5 (d, C(4’)); 62.8 (t, C(6’)); 29.5, 21.0 
(2t, C(2’), C(3’)). 
 
N
4-benzoyl-1-(4’,6’-di-O-acetyl-2’,3’-dideoxy-β-D-glucopyranosyl)cytosine (50) 
 
 
 
To a suspension of 1.08 g (5.02 mmol) N4-benzoylcytosine in 50 ml dry CH3CN was added at rt 
2,5 ml (2.05 g, 10.1 mmol) N,O-bis(trimethylsilyl)acetamide. After stirring for 30 min at rt, a 
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solution of 1.20 g (4.87 mmol) 17 in 25 ml dry CH3CN was added to the clear solution, followed 
by 1.5 ml (3.33 g, 12.8 mmol) SnCl4. The reaction was stirred in a preheated oil bath at 49°C for 2 
h, evaporated and the residue was dissolved in 250 ml CHCl3, extracted with aq. NaHCO3 sat. (2 x 
150 ml), aq. NaClsat. (1 x 150 ml). The combined aq. phases were extracted with CHCl3 (1 x 50 
ml). The combined org. phases were dried (Na2SO4) and evaporated. CC (140 g SiO2, CH2Cl2 
(until 52 eluted) to CH2Cl2/THF 8:1) resulted in 931 mg (2.17 mmol, 45 %) β-D-anomer 50, 246 
mg (0.573 mmol, 12 %) α-D-anomer 51 and 72 mg (0.336 mmol, 7 %) enolether 52. 
 
Rf (SiO2; EtOAc) 0.23 (UV254, Ce(SO4)2). 
 
IR(KBr) : 3422m, 3242w, 3149w, 3090w, 3072w, 3031w, 3029w, 2961w, 2882w, 1740s, 1700s, 
1672s, 1655s, 1629s, 1601m, 1560s, 1487s, 1434m, 1385m, 1377m, 1364m, 1339m, 1308m, 
1311s, 1251s, 1191m, 1146m, 1136m, 1100m, 1067s, 1044s, 1003m, 961w, 933w, 897w, 873w, 
860w, 799m, 784m, 709m, 701m. 
 
1H-NMR (300 MHz, CDCl3): 8.60 (br. s, NH); 7.91-7.88 (m, HC(6), 2 arom. H); 7.62 (tt, J = 7.2, 
1.3, 1 arom. H); 7.56-.7.48 (m, 2 arom H); 6.98 (br. s, HC(5)); 5.85 (dd, J = 10.3, 2.0, HC(1’)); 
4.78 (dt, J = 10.5, 4.7, HC(4’)); 4.29 (dd, J = 12.2, 5.6, 1 HC(6’)); 4.19 (dd, J = 12.2, 2.2, 1 
HC(6’)); 3.88 (ddd, J = 10.0, 5.6, 2.2, HC(5’)); 2.41-2.29 (m, 2H, HC(2’), HC(3’)); 2.09, 2.08 (2s, 
2Ac); 1.84-1.70, 1.68-1.54 (2m, 2H, HC(2’), HC(3’)). 
 
13C-NMR (75 MHz, CDCl3): 170.8, 169.8 (2s, CO), 166.7 (s, CO); 162.3 (s, C(4)); 154.2 (s, 
C(2)); 144.0 (d, C(6)); 133.0 (s, arom. C); 133.4, 129.0, 127.5 (3d, 3 arom. C); 97.1 (d, C(5)); 
83.1 (d, C(1’)); 78.0 (d, C(5’)); 66.8 (d, C(4’)); 62.8 (t, C(6’)); 30.4, 27.9 (2t, C(2’), C(3’)); 21.1, 
20.8 (2q, 2MeCO). 
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N6-benzoyl-9-(4’,6’-di-O-benzoyl-2’,3’-dideoxy-α/β-D-glucopyranosyl)adenine (53α/53β) 
 
 
 
A mixture of 4.30 g (11.61 mmol) 22 and 2.78 g (11.59 mmol) N6-benzoyladenine was dried 
under high vacuum (p < 10-1 mbar) at rt for 4 h and suspended under N2 in 170 ml dry CH3CN. 
1.93 ml (9.25 mmol) HMDS, 1.17 ml (9.28 mmol) Me3SiCl and 2.05 ml (17.40 mmol) SnCl4 were 
added. The yellow homogeneous solution was allowed to stand for 16 h, before 1.36 ml (11.59 
mmol) of additional SnCl4 was added while stirring and the reaction was stirred for 4 h at rt and 
worked up after a total reaction time of 20 h. NaHCO3 sat. (100ml) was added, the CH3CN was 
evaporated under reduced pressure and the residue was extracted with EtOAc (2 x 150 ml), the 
combined organic phases were extracted with NaClsat. (250 ml), dried (MgSO4) and evaporated. 
The resulting white foam was chromatographed (250 g SiO2, EtOAc) resulting in 3.56 g (6.16 
mmol, 53%) as a mixture of anomers (53β/53α = 74:26 (1H-NMR)). 
 
Rf (SiO2; EtOAc) 0.20 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CDCl3): 8.94 (br. s, NH); 8.81 (s, HC(2), 2.8H, β-D); 8.78 (br. s, HC(2), 
1.0H, α-D); 8.30 (s, HC(8), 1.1H, α-D); 8.24 (s, HC(8), 2.9H, β-D); 8.08-7.98 (m, arom. H); 7.83-
7.80 (m, arom. H); 7.65-7.37 (m, arom. H); 6.26 (dd, J = 5.5, 4.0, HC(1’), α-D); 6.05 (dd, J = 10.6, 
2.8, HC(1’), β-D); 5.25 (ddd, J = 10.3, 4.8, HC(4’), β-D); 4.71 (dd, J = 12.0, 7.1, HC(4’), α-D); 
4.68 (dd, J = 12.2, 2.6, α-D); 4.56 (dd, J = 12.0, 3.7, α-D); 4.47 (dd, J = 12.2, 5.6, 1HC(6’), β-D); 
4.37-4.27 (m, HC(5’), α-D, β-D); 2.71-2.73 (m, 1 HC(3’), α-D, β-D); 2.48-2.30 (m, 2HC(2’); α-D, 
β-D); 2.07-1.94 (m, 1HC(3’), α-D, β-D). 
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13C-NMR (75 MHz, CDCl3): 166.3, 165.4, 164.7 (3s, CO, β-D); 152.6 (d, C(2), β-D); 151.2 (s, 
C(6), β-D); 149.8 (s, C(4), β-D); 140.4 (d, C(8), β-D); 133.7, 129.6, 129.4 (3s, arom. C,  β-D); 
133.6, 133.2, 132.9, 129.7, 128.8, 128.6, 128.3, 128.0 (6d, arom. C, β-D); 122.8 (s, C(5), β-D); 
81.8 (d, C(1’),  β-D);  77.9 (d, C(5’), β-D); 67.6 (d, C(4’), β-D); 63.4 (t, C(6’), β-D); 30.6, 28.5 (2t, 
C(2’), C(3’), β-D). 
 
7- and 9-(4’,6’-di-O-benzoyl-2’,3’-dideoxy-α/β-D-glucopyranosyl)N2-isobutyrylguanine 
(54β/54α/55β) 
 
 
 
To a suspension of 2.15 g (8.99 mmol) N2-isobutyrylguanine hydrate in 20 ml refluxing CH3CN 
was added under N2 10.8 ml (44.2 mmol) N,O-bis(trimethylsilyl)acetamide and the temperature 
was reduced to 75° C. To the clear solution was added after 30 min, 1.60 g (4.32 mmol) 22 in 20 
ml dry CH3CN and 2.0 ml (11.0 mmol) CF3SO3SiMe3. The reaction was cooled to rt after 20 h 
under reflux and 30 ml CH3CN were removed under reduced pressure. The crude reaction was 
taken up in CH2Cl2 (200 ml), 100 ml NaHCO3 sat. was added and the solution stirred for 15 min. 
The resulting suspension was filtered over Celite, the organic phase was separated, the aqueous 
phase was extracted with CH2Cl2 (2 x 100 ml), the combined organic phases were extracted with 
NaHCO3 sat. (2 x 100 ml), dried (Na2SO4) and evaporated. CC (75 g SiO2, CH2Cl2/CH3OH 93:7) 
resulted in enolether 56, followed by 894 mg (1.60 mmol, 37%, N9-β/N9-α/N7-β = 80:14:6 (1H-
NMR)) 54β/54α/55β as a slightly yellow foam. 
 
Rf (SiO2; CH2Cl2/MeOH 93 :7) 0.43 (UV254, Ce(SO4)2). 
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1H-NMR (300 MHz, CDCl3): 11.97 (br. s, NH); 8.62 (br. s, NH); 8.26 (br. s, NH); 8.05-7.85 (m, 
HC(8), arom. H); 7.61-7.36 (m, arom. H); 6.20 (dd, HC(1’), N7-β); 6.00 (dd, HC(1’), N9-α); 5.65 
(dd, J = 10.9, 2.5, HC(1’), N9-β); 5.28-5.22 (m, HC(4’)); 4.70-4.61 (m, HC(6’)); 4.51-4.40 (m, 
HC(6’)); 4.27-4.17 (m, HC(5’)); 2.66-2.56 (m, Me2CHCO); 2.42-1.80 (m, HC(2’), HC(3’)); 1.26 
(d, J = 6.9, Me2CHCO); 1.24 (d, Me2CHCO); 1.22 (d, Me2CHCO). 
 
(2R, 3S)-2-(benzoylmethoxy)-3-(benzoylhydroxy)-2H,3H-dihydropyrane (56) 
 
 
 
Rf (SiO2; CH2Cl2/MeOH 93 :7) 0.80 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CDCl3): 8.06-8.02 (m, 4 arom H.); 7.59-7.51 (m, 2 arom. H); 7.46-7.39 (m, 4 
arom. H); 6.42 (dt, J = 6.1, 2.0, HC(1)); 5.43-5.36 (m, HC(2)); 4.77 (ddd, J = 7.6, 4.5, 3.1, 
HC(4)); 4.65 (dd, J = 11.9, 3.5, 1H of H2C(6));  4.51 (dd, J = 11.9, 5.5, 1H of H2C(6)); 4.41-4.35 
(m, HC(5)); 2.63 (dddd, J = 17.1, 6.0, 4.5, 0.8, 1H of H2C(3)); 2.32-2.22 (m, 1H of H2C(3)). 
 
CI-MS: 104.9 (61), 93.9 (100), 80.9 (82), 76.9 (37), 27.9 (7). 
 
ESI-MS: 361.1 (100, [m+Na]+).  
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1-(2’,3’-dideoxy-β-D-glucopyranosyl)uracil (57) 
 
 
 
A solution of 1.37 g (4.20 mmol) 48 in 17 ml conc. NH3 in CH3OH was allowed to stand at rt for 
15 h. After evaporating and drying under high vacuum (p < 10-1 mbar) 925 mg (3.82 mmol, 91%) 
57 was obtained as a colourless foam. 
 
Rf (SiO2; EtOAc/MeOH 5:1) 0.20 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 11.24 (br. s, NH); 7.71 (d, J = 8.1, HC(6)); 5.61 (d, J = 8.1, 
HC(5)); 5.51 (dd, J = 7.9, 5.1, HC(1’)) ; 4.87 (d, J = 5.2, HOC(4’)); 4.51 (t, J = 5.8, HOC(6’)); 
3.68 (ddd, J = 11.8, 5.2, 1.7, 1H of H2C(6’)); 3.48 (m, 1H of H2C(6’)); 3.39-3.16 (m, HC(4’), 
HC(5’)); 2.06-1.96, 1.78-1.71, 1.61-1.40 (3m, H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, d6-DMSO): 162.8 (s, C(4)); 149.8 (s, C(2)); 140.76 (d, C(6)); 101.5 (d, C(5)); 
83.4 (d, C(1’)); 80.8 (d, C(5’)); 63.9 (d, C(4’)); 61.0 (t, C(6’)); 31.3, 28.8 (2t, C(2’), C(3’)). 
 
N4-benzoyl-1-(2’,3’-dideoxy-β-D-glucopyranosyl)cytosine (58) 
 
 
 
To a solution of 881 mg (2.05 mmol) 50 in 82 ml THF/MeOH/H2O 5:4:1 at 0° C was added 8.2 ml 
aqueous 2 N NaOH. The reaction was stirred for 25 min at 0°C, 1.05 g (19.7 mmol) NH4Cl was 
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added as a solid and the reaction was stirred for 30 min at 0° C. The reaction was evaporated to a 
volume of 10 ml, during which a solid was formed. To complete the precipitation the reaction 
mixture was stored for 50 h at 4° C, the precipitate was filtered and washed with ice water (10 ml) 
and dried under vacuum, resulting in 695 mg (2.01 mmol, 98%) 58 as a white solid. 
 
Rf (SiO2; CH2Cl2/MeOH 9:1) 0.22 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 8.21 (d, J = 7.5, HC(6)); 8.01 (dd, J = 7.1, 1.4, 2 arom. H); 7.63 
(tt, J = 7.4, 1.3, 1 arom. H); 7.51 (t, J = 7.4, 2 arom. H);  7.34 (d, J = 7.3, HC(5)); 5.64 (dd, J = 
10.0, 1.9, HC(1’)); 4.95 (d, J = 5.2, HOC(4’)); 4.56 (t, J = 5.9, HOC(6’)); 3.71 (ddd, J = 11.7, 5.2, 
1.4, 1H of H2C(6’)); 3.58-3.50 (m, 1H of H2C(6’)); 3.47-3.32 (m, HC(4’), HC(5’)); 2.07-2.03, 
1.97-1.91, 1.71-1.50 (3m, H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, d6-DMSO): 167.3 (s, CO); 162.8 (s, C(4)); 153.6 (s, C(2)); 145.4 (d, C(6)); 
133.0 (s, arom. C); 132.6, 128.4 (2d, arom. C); 96.3 (d, C(5)); 83.4 (d, C(1’)); 82.2 (d, C(5’)); 
63.8 (d, C(4’)); 60.9 (t, C(6’)); 31.2, 29.8 (2t, C(2’), C(3’)). 
 
N6-benzoyl-9-(2’,3’-dideoxy-β-D-glucopyranosyl)adenine (59) 
 
 
 
To a solution of 1 g (1.73 mmol) 53β/53α in 100 ml THF/MeOH/H2O 5:4:1 was added at 0° C 10 
ml 2 N NaOH. The reaction was stirred for 20 min at 0° C. 1.28 g (24.0 mmol) NH4Cl was added 
and the reaction mixture was evaporated. The remaining solid was dissolved in MeOH, 1 g SiO2 
was added, evaporated and chromatographed (15 g SiO2, CH2Cl2/MeOH 8:1), resulting in 522 mg 
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(1.41 mmol, 82 %) of a diastereomeric mixture (β-D/α-D 2.3: 1 (according to 1H-NMR)). The 
diastereomeric mixture was separated by recrystallisation from 35 ml boiling MeOH resulting in 
311 mg (0.842 mmol, 70 %) pure β-D-anomer 59 as colourless needles.   
 
Rf (SiO2; CH2Cl2/MeOH 8:1) 0.17 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 11.16 (br. s, NH); 8.77 (s, HC(2)); 8.70 (s, HC(8)); 8.04 (d, J = 
7.1, 2 arom. H); 7.68-7.62 (m, 1 arom. H); 7.58-7.52 (m, 2 arom. H); 5.87 (dd, J = 10.7, 1.5, 
HC(1’)); 4.96 (d, J = 5.0, HOC(4’)); 4.56 (dd, J = 5.9, HOC(6’)); 3.70 (dd, J = 10.8, 6.0, 1H of 
H2C(6’)); 3.53-3.43 (m, HC(4’), HC(5’), 1H of H2C(6’)); 2.51-2.40, 2.18-2.07, 1.77-1.62 (3m, 
H2C(2’), H2C(3’)).  
 
13C-NMR (75 MHz, d6-DMSO): 165.5 (s, CO); 151.8 (s, C(6)); 151.8 (d, C(2)); 150.2 (s, C(4)); 
142.6 (d, C(8)); 133.2 (s, arom. C); 132.3, 128.3 (2d, arom. C); 125.4 (s, C(5)); 83.3 (d, C(1’)); 
80.7 (d, C(5’)); 64.1, (d, C(4’)); 60.9 (t, C(6’)); 31.4, 29.0 (2t, C(2’), C(3’)). 
 
ESI-MS: 408.2 (41, [m+K]+); 392.2 (12, [m+H]+); 370.2 (100, [m+H]+). 
 
N2-isobutyryl-9-(2’,3’-dideoxy-α/β-D-glucopyranosyl)guanine (60α/60β) 
 
 
 
To a solution of 185 mg (0.331 mmol) 54β/54α/55β in 14 ml THF/MeOH/H2O 5:4:1 was added at 
0° C 1.3 ml 2 N aq. NaOH. The reaction was stirred for 25 min at 0° C, then 170 mg (3.18 mmol) 
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NH4Cl was added and the reaction was stirred for 60 min at 0° C. The reaction mixture was 
evaporated. The remaining solid was dispersed in 5 ml MeOH, 1 g SiO2 was added, the material 
was concentrated and chromatographed (5 g SiO2, CH2Cl2/MeOH 5:1), resulting in 83 mg (0.236 
mmol, 76%) of 60β/60α (60β/60α = 6.3:1 (1H NMR)) as a white foam. 
  
Rf (SiO2; CH2Cl2/MeOH 5:1) 0.25 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 12.08 (br. s, NH); 11.73 (br. s, NH); 8.22 (s, HC(8), β-D, 1.00 
H); 8.18 (s, HC(8), α-D, 0.16 H); 5.91 (t, J = 4.7, HC(1’), α-D, 0.17 H); 5.56 (dd, J = 11.1, 2.0, 
HC(1’), β-D, 0.98 H); 4.97 (br. s, HOC(4’), β-D, 0.99 H) ; 4.88 (br. s, HOC(4’), α-D, 0.16 H); 4.58 
(br. s, HOC(6’)); 3.72-3.29 (m, HC(4’), H2C(6’)); 3.19-3.15 (m, HC(5’)); 2.80 (s, J = 6.7, 
Me2CHCO); 2.36-2.22 (m, 1H of H2C(2’), H2C(3’)); 2.15-1.94 (m, 2H of H2C(2’), H2C(3’)); 1.67-
1.53 (m, 1H of H2C(2’), H2C(3’)); 1.13 (d, J = 6.9, Me2CHCO). 
 
13C-NMR (75 MHz, d6-DMSO): 180.1 (s, CO); 154.7 (s, C(6)); 148.0 (s, C(2), C(4)); 137.4 (d, 
C(8)); 119.8 (s, C(5)); 83.4 (d, C(1’)); 80.4 (d, C(5’)); 63.9 (d, C(4’)); 60.7 (t, C(6’)); 34.6 (d, 
Me2CHCO); 34.6, 31.5 (2t, C(2’), C(3’)); 18.74, 18.66 (2q, Me2CHCO). 
 
1-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}uracil (61) 
 
 
 
538 mg (2.22 mmol) 57, 988 mg (2.92 mmol) (MeO)2TrCl and 12 mg (98.2 µmol) 4-
(dimethylamino)pyridine were dried under high vacuum (p < 10-1 mbar) for 10 min at rt. 7.7 ml 
pyridine, followed by 0.5 ml NEt3, was added and the red solution was stirred for 3 h, 20 min at rt. 
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1.9 ml MeOH were added and the solvent was evaporated at 30° C. The crude product was 
dissolved in 150 ml CH2Cl2, and extracted with aq. NaClsat. (3 x 80 ml). The combined aqueous 
phases were extracted with CH2Cl2 (1 x 40 ml). The combined org. phases were dried (Na2SO4), 
evaporated (t = 30 ° C), and dried for 10 min under high vacuum (p < 10-1 mbar). CC (50 g SiO2; 
EtOAc/hexane 1:1 to EtOAc) resulted in 983 mg (1.81 mmol, 81%) 61 as a colourless foam. 
 
Rf (SiO2; EtOAc) 0.24 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 11.39 (br. s, NH); 7.70 (d, J = 8.1, HC(6)); 7.40 (d, J = 6.9, 2 
arom. H); 7.28-7.20 (m, 7 arom. H); 6.84 (dd, J = 8.9, 1.6, 4 arom. H); 5.72 (d, J = 8.1, HC(5)); 
5.62 (m, HC(1’)); 4.83 (d, J = 6.0, HOC(4’)); 3.72 (s, 2 OMe);  3.57 (m, HC(5’)); 3.25-3.22 (m, 
HC(4’), 1H of H2C(6’)); 3.08 (dd, J = 10.0, 6.3, 1H of H2C(6’)); 2.05-1.99 (m, 1H of H2C(2’), 
H2C(3’)); 1.84-1.78 (m, 2H of H2C(2’), H2C(3’)); 1.61-1.53 (m, 1H of H2C(2’), H2C(3’)). 
 
13C-NMR (75 MHz, d6-DMSO): 162.8 (s, C(4)); 157.7 (s, arom. C); 150.0 (s, C(2)); 145.0 (s, 
arom. C); 140.4 (d, C(6)); 135.8, 135.7 (2s, arom. C); 129.7, 127.7, 127.5, 127.4, 112.9 (5d, arom. 
C); 101.5 (d, C(5)); 85.0 (s, COC(6’)); 81.5, 80.8 (2d, C(1’), C(5’)); 64.2 (d, C(4’)); 63.9 (t, 
C(6’)); 54.9 (q, MeO); 31.5, 28.6 (2t, C(2’), C(3’)). 
 
ESI-MS: 567.4 (100, [m+Na]+); 303.2 (4). 
 
N4-benzoyl-1-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-
glucopyranosyl}cytosine (62) 
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456 mg (1.32 mmol) 58 was suspended in 14 ml pyridine and dissolved under heating to 115° C. 
Careful cooling to rt resulted in a clear solution to which 542 mg (1.59 mmol) Bu4NClO4 and 537 
mg (1.58 mmol) (MeO)2TrCl was added. After stirring for 1 h at rt, 0.7 ml MeOH was added and 
the reaction was stirred for another 10 min at rt, evaporated (t = 30° C), dried under high vacuum 
(p < 10-1 mbar), dissolved in 60 ml CH2Cl2 and extracted with aq. NaHCO3 sat. (3 x 30 ml). The 
combined aq. phases were extracted with CH2Cl2 (2 x 20 ml) and the combined org. phases were 
dried (Na2SO4) and evaporated (t = 30° C). CC (30 g SiO2, EtOAc to EtOAc/EtOH 50:1) resulted 
in 593 mg (0.92 mmol, 69%) of 62. 
 
Rf (SiO2; EtOAc) 0.08 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 8.63 (br. s, NH); 7.93 (br.s, 2 arom. H, HC(6)); 7.61 (tt, J = 7.4, 
1.5, 1 arom. H); 7.52-7.42 (m, HC(5), 4 arom. H); 7.34-7.20 (m, 7 arom. H); 6.86-6.82 (m, 4 arom. 
H); 5.76 (dd, J = 10.4, 2.0, HC(1’)); 3.792 (s, MeO); 3.790 (s,  MeO); 3.75-3.60 (m, HC(4’), 
HC(5’)); 3.44 (dd, J = 10.0, 4.3, 1H of H2C(6’); 3.45 (dd, J = 10.0, 4.5, 1H of H2C(6’)); 2.25-2.17 
(m, 2 H of H2C(2’), H2C(3’)); 1.79-1.63 (m, 1H of H2C(2’), H2C(3’)); 1.58-1.46 (m, 1H of 
H2C(2’), H2C(3’)).  
 
ESI-MS: 670.3 (40, [m+Na]+); 242.3 (100). 
 
N6-benzoyl-9-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-
glucopyranosyl}adenine (63) 
 
 
 
Chapter 5: Experimental part 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 173  
277 mg (0.750 mmol) 59, 309 mg (0.904 mmol) Bu4NClO4 and 308 mg (0.909 mmol) (MeO)2TrCl 
were dried under high vacuum (p < 10-1 mbar) for 2 h, dissolved in 3.7 ml pyridine and stirred for 
80 min at rt. The reaction mixture was evaporated, dissolved in 50 ml CH2Cl2, extracted with aq. 
NaHCO3 sat. (2 x 20 ml) and aq. NaClsat. (1 x 20 ml). The combined aqueous phases were extracted 
with CH2Cl2 (2 x 20 ml) and the combined org. phases were dried (Na2SO4) and evaporated. CC 
(20 g SiO2, CH2Cl2/acetone 3:1 to CH2Cl2/acetone 1:1) resulted in 458 (0.682 mmol, 91%) 63 as a 
colourless foam. 
 
Rf (SiO2; CH2Cl2/acetone 3:1) 0.18 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 11.20 (br. s, NH); 8.80 (s, HC(2)); 8.70 (s, HC(8)); 8.05 (d, J = 
7.5, 2 arom. H); 7.67-7.61 (m, 1 arom. H); 7.58-7.53 (m, 2 arom. H); 7.37-7.34 (m, 2 arom. H); 
7.23-7.16 (m, 7 arom. H); 6.74-6.71 (m, 4 arom. H); 5.96 (dd, J = 10.2, 2.2, HC(1’)); 4.92 (d, J = 
6.0, HOC(4’)); 3.75-3.69 (m, HC(4’)); 3.70 (s, MeO); 3.69 (s, MeO); 3.47-3.40 (m, HC(5’)); 3.29-
3.25 (m, 1H of H2C(6’)); 3.06 (dd, J = 10.2, 6.9, 1H of H2C(6’)); 2.55-2.45, 2.17-2.09, 1.78-1.65 
(3m, H2C(2’), H2C(3’)). 
 
ESI-MS: 694.3 (100, [m+Na]+). 
 
9-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}-N2-
isobutyrylguanine (64) 
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To a solution of 55 mg (0.157 mmol) of 60β/60α (β/α = 6.8:1, (1H-NMR)) in 1.5 ml pyridine was 
added 63 mg (0.184 mmol) Bu4NClO4 and 63 mg (0.186 mmol) (MeO)2TrCl and the reaction was 
stirred for 2 h at rt. To the solution was added 0.1 ml MeOH and the reaction was stirred for 
another 15 min, evaporated, coevaporated with 2 ml toluene (to remove traces of pyridine), 
dissolved in 10 ml CH2Cl2 and extracted with NaHCO3 sat. (3 x 5 ml). The combined aq. phases 
were extracted with CH2Cl2 (3 x 5 ml) and the combined org. phases were dried (Na2SO4) and 
evaporated. CC (10 g SiO2, EtOAc/EtOH 19:1) resulted in 56 mg (85.7 µmol, 63%) pure 64β as 
colourless foam. 
 
Rf (SiO2; EtOAc/EtOH 19:1) 0.15 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, d6-DMSO): 12.24 (br. s, NH); 11.64 (br. s, NH); 8.22 (s, HC(8)); 7.37 (dd, J 
= 7.7, 1.6, 2 arom. H); 7.28-7.16 (m, 7 arom. H); 6.81 (dd, J = 8.8, 6.9, 4 arom. H); 5.68 (dd, J = 
11.3, 1.7, HC(1’)); 4.97 (d, J = 6.0, HOC(4’)); 3.743 (s, MeO); 3.739 (s, MeO); 3.67-3.62 (m, 1H 
of H2C(6’)); 3.48-3.29 (m, HC(4’), HC(5’)); 3.11 (dd, J = 10.0, 6.7, 1H of H2C(6’)); 2.84 (sept., J 
= 6.8, Me2CHCO); 2.41-2.28, 2.18-2.07, 1.72-1.59 (3m, H2C(2’), H2C(3’)); 1.12 (d, J = 6.8, 3H, 
Me2CHCO); 1.11 (d, J = 6.8, 3H, Me2CHCO). 
 
13C-NMR (75 MHz, d6-DMSO): 180.1 (s, CO); 154.7 (s, C(6)); 148.1 (s, C(2), C(4)); 137.3 (d, 
C(8)); 157.8, 144.9, 135.6 (3s, 3 arom. C); 120.0 (s, C(5)); 129.7, 127.7, 127.5, 126.4, 112.8 (5d, 
arom. C); 85.0 (s, COC(6’)); 81.6 (d, C(1’)); 80.4 (d, C(5’)); 64.3 (d, C(4’)); 63.9 (t, C(6’)); 54.8 
(q, MeO); 34.6 (d, Me2CHCO); 31.8, 29.2 (2t, C(2’), C(3’)); 18.8, 18.7 (2q, Me2CHCO). 
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1-{4’-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2’,3’-dideoxy-6’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}uracil (65) 
 
 
 
After drying for 4.5 h under high vacuum (p < 10-1 mbar) 215 mg (0.395 mmol) 61 was suspended 
under Ar at rt in 6 ml dry CH2Cl2 and 0.27 ml (1.55 mmol) (iPr)2EtN (bp 128° C, distilled over 
CaH2) and 0.14 ml (0.608 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine was added 
dropwise. During the addition of the phosphine, the reaction became clear. After stirring for 1 h at 
rt, the clear solution was diluted with EtOAc (100 ml), extracted with Na2CO3sat. (2 x 50 ml) and 
NaClsat. (40 ml), dried (Na2SO4) and evaporated. CC (10 g SiO2, EtOAc/hexane 2:1, crude 
material applied in CH2Cl2) and reprecipitation from 1 ml CH2Cl2 with 30 ml hexane resulted in 
247 mg (0.331 mmol, 84%) 65 as a colourless foam in a 1:1-diastereomeric mixture (1H- and 31P-
NMR). 
 
Rf (SiO2; EtOAc) 0.52, 0.48 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CDCl3): 9.08 (br. s, NH); 7.55-7.51, 7.48-7.44, 7.35-7.29 (3m, 9 arom. H); 
6.82-6.77 (m, 4 arom. H); 5.83, 5.81 (2d, J = 3.0, 1H, HC(6)); 5.78-5.71 (m, HC(1’)); 3.96-3.92 
(m, 1H, OCH2CH2CN); 3.79, 3.78, 3.77, 3.76 (4s, 6H, MeO); 3.75-3.72 (m, 1H, HC(4’)); 3.72-
3.57 (m, 1H, OCH2CH2CN); 3.57-3.23 (m, 5H, HC(5’), HC(6’), Me2CHN); 2.59 (t, J = 6.1, 1H, 
OCH2CH2CN); 2.41-2.32 (m, 1H, HC(2’), HC(3’)); 2.30 (dt, J = 6.2, 3.6, 1H, OCH2CH2CN); 
2.09-2.04 (m, 1H, HC(2’), HC(3’)); 1.80-1.62 (m, 2H, HC(2’), HC(3’)); 1.13, 1.09, 1.07 (3d, J = 
6.7, Me2CHN); 0.89 (m, 3H, Me2CHN). 
Chapter 5: Experimental part 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 176  
 
13C-NMR (75 MHz, CDCl3): 163.1 (s, C(4)); 158.4, 158.3 (2s, arom. C); 149.7 (s, C(2)); 144.9, 
144.7 (2s, 2 arom. C); 139.7, 139.6 (2d, C(6)); 136.1, 136.0, 135.9, 130.2, 130.1, 128.4, 128.3, 
127.6, 126.7, 126.6, 112.9 (11d, arom. C); 117.6, 117.5 (2s, CN); 102.4, 102.3 (2d, C(5)); 85.7 (s, 
C-O-C(6’)); 81.7 (d, C(1’)); 81.5, 81.4 (2d, C(5’)); 67.4 (dd, JP = 13.0, C(4’)); 66.9 (dd, JP = 16.6, 
C(4’)); 63.1, 63.0 (2t, C(6’)); 58.3, 57.3 (OCH2CH2CN); 55.1, 55.0 (2q, MeO); 43.2, 43.1, 43.0, 
42.9 (Me2CHN); 30.6, 30.1 (2t, C(2’), C(3’)); 24.6, 24.5, 24.4, 24.3, 24.2, 24.1 (Me2CHN); 22.4 
(dt, C(2’), C(3’)); 20.4, 20.1 (2dt, JP = 7.2, OCH2CH2CN). 
 
31P-NMR (121 MHz, CDCl3): 149.2, 148.5. 
 
ESI-MS: 767.4 (100, [m+Na]+); 303.2 (12). 
 
N4-benzoyl-1-{4’-O-[(cyanoethoxy)(diisopropylamino)phosphino]-2’,3’-dideoxy-6’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}cytosine (66) 
 
 
 
After drying for 4.5 h under high vacuum (p < 10-1 mbar) at rt, 278 mg (0.430 mmol) 62 was 
disolved under Ar at rt in 11 ml dry THF and 0.22 ml (1.26 mmol) (iPr)2EtN (bp 128° C, distilled 
over CaH2) and 0.14 ml (0.608 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine was 
dropwisely added. After stirring for 75 min at rt, the reaction was evaporated under reduced 
pressure (t = 28° C) and dried for 1h under high vacuum. CC (10 g SiO2, CH2Cl2/acetone/NEt3 
4:1:0.01) and reprecipitation from rapidly stirred CH2Cl2 (1 ml) with hexane (30 ml) resulted in 
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305 mg (0.360 mmol, 84%) 66 as a colourless foam in a 1:1-diastereomeric mixture (1H- and 31P-
NMR). 
 
Rf (SiO2; EtOAc) 0.37, 0.32 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 8.90 (br. s, 1H, NH); 8.04 (d, J = 7.5, 0.5 H, HC(6)); 8.00 (d, J = 
7.5, 0.5 H, HC(6)); 7.95 (d, J = 7.3, 2 arom. H); 7.64-7.46 (m, 6H, HC(5), arom.); 7.41-7.19, 6.88-
6.78 (2m, 11 arom. H); 5.82 (dd, J = 10.1, 1.7, HC(1’)); 3.88-3.62 (m, 3H, HC(4’), OCH2CH2CN); 
3.78, 3.77 (2s, 6H, MeO);  3.50-3.26 (m, 5H, HC(5’), HC(6’), Me2CHN); 2.62-2.55 (m, 1H, 
OCH2CH2CN); 2.41-2.21 (m, 3H, HC(2’), HC(3’), OCH2CH2CN); 1.88-1.72 (m, 1H, HC(2’), 
HC(3’)); 1.58-1.48 (m, 1H, HC(2’), HC(3’)); 1.17-0.91 (m, 12H, Me2CHN).  
 
13C-NMR (75 MHz, CD2Cl2): 162.6, 162.5 (2s, C(4)); 158.9, 145.5, 145.4 (3s, arom. C); 144.5 (d, 
C(6)); 136.4, 136.3, 133.7 (3s, 3 arom. C); 133.3, 130.6, 130.5, 130.4, 129.2, 128.7, 128.5, 128.0, 
127.1, 127.0, 113.3 (11d,  arom. C); 118.2, 118.1 (2s, CN); 97.1 (d, C(5)); 86.1, 86.0 (2s, 
COC(6’)); 83.6 (d, C(1’)); 82.1, 82.0 (2d, C(5’)); 68.2 (dd, JP = 12.8, C(4’)); 67.5 (dd, JP = 16.6, 
C(4’)); 63.9, 63.7 (2t, C(6’)); 58.6 (dt, JP = 18.9, OCH2CH2CN); 58.1 (dt, JP = 20.5, 
OCH2CH2CN); 55.6, 55.5 (2q, MeO); 43.4 (dd, JP = 12.2, Me2CHN); 43.3 (dd, JP = 12.5, 
Me2CHN); 31.1, 30.9, 30.7, 30.6 (4t, C(2’), C(3’)); 24.8, 24.7, 24.5, 24.3 (Me2CHN); 20.7 (dt, JP 
= 6.9, OCH2CH2CN); 20.5 (dt, JP = 7.1, OCH2CH2CN). 
 
31P-NMR (121 MHz, CD2Cl2): 148.8, 148.3. 
 
ESI-MS: 870.5 (100, [m+Na]+); 303.1 (7). 
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9-{4’-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-2’,3’-dideoxy-6’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}-N2-Isobutyrylguanine (68) 
 
 
 
To a solution of 150 mg (0.229 mmol) 64 (dried for 13 h under high vacuum (p < 10-1 mbar)) and 
0.12 ml (0.689 mmol) (iPr)2EtN (bp 128°C, distilled over CaH2) in 2.2 ml dry THF was added 
0.08 ml (0.343 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine under Ar dropwise at 
rt. After stirring for 1 h at rt, during which a precipitate was formed, the reaction was diluted with 
CH2Cl2 (60 ml) (clear solution) and extracted with ice-cold NaHCO3 sat. (3 x 30 ml) followed by 
NaClsat. (30 ml). The combined aqueous solutions were extracted with CH2Cl2 (50 ml) and the 
combined organic phases were dried over MgSO4 and evaporated. CC (6 g SiO2, 
CH2Cl2/acetone/Et3N 3:1:0.04) and three times precipitation from 1 ml CH2Cl2 with 30 ml hexane 
resulted in 129 mg (0.154 mmol, 67%) 68 as a colourless foam in a 1:1-diastereomeric mixture 
(1H- and 31P-NMR). 
 
Rf (SiO2; EtOAc) 0.24, 0.17 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 12.04, 8.90 (br. 2s, 2H, NH); 7.92 (s, 0.5H, HC(8)); 7.89 (s, 0.5H, 
HC(8)); 7.48-7.45, 7.35-7.30, 7.25-7.16, 6.79-6.73 (4m, 13 arom. H); 5.65-5.59 (m, 1H, HC(1)); 
4.02-3.60 (m, 2H, OCH2CH2CN); 3.76, 3.75, 3.75, 3.74 (4s, 6H, MeO)); 3.52-3.17 (m, 6H, 
HC(4’), HC(5’), HC(6’), Me2CHN); 2.61-2.14 (m, 5H, HC(2’), HC(3’), Me2CHCO, 
OCH2CH2CN); 1.84-1.65 (m, 2H, HC(2’), HC(3’)); 1.22-0.83 (m, 12H, Me2CHN, Me2CHCO). 
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13C-NMR (75 MHz, CD2Cl2): 179.4 (s, CO); 155.9 (s, C(6)); 148.4, 148.3, 147.88, 147.87 (4s, 
C(2), C(4)); 158.9, 145.6, 145.4, 136.4, 136.3  (5s, arom. C); 137.0, 136.9 (2d, C(8)); 130.6, 
130.50, 130.47, 128.7, 128.5, 127.9,  127.0, 126.9, 113.2, 113.1 (10d, arom. C); 121.6 (s, C(5)); 
118.3, 118.1 (2s, CN); 86.1 (s, COC(6’)); 82.2, 82.1 (2d, C(1’)); 81.6 (dd, JP = 5.3, C(5’)); 81.5 
(dd, JP = 8.1, C(5’)); 68.1 (dd, JP = 13.0, C(4’)); 67.5 (dd, JP = 15.4, C(4’)); 58.4 (dt, JP = 19.7, 
OCH2CH2CN); 58.0 (dt, JP = 20.9, OCH2CH2CN); 55.5, 55.4 (2q, MeO); 43.4 (dd, JP = 5.6, 
Me2CHN); 43.3 (dd, JP = 4.8, Me2CHN); 36.6 (d, Me2CHCO); 31.2, 30.9, 30.8, 30.7 (4t, C(2’), 
C(3’)); 24.8, 24.7, 24.6, 24.5, 24.4 (Me2CHN); 20.8 (dt, JP = 7.6, OCH2CH2CN); 20.6 (dt, JP = 
7.4, OCH2CH2CN); 19.0 (q, Me2CHCO).  
 
31P-NMR (121 MHz, CD2Cl2): 148.9, 147.9. 
 
N6-Benzoyl-9-{4’-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2’,3’-dideoxy-6’-O-
[(4,4’-dimethoxytriphenyl)methyl]-β-D-glucopyranosyl]}adenine (67) 
 
 
 
To a solution of 193 mg (0.288 mmol) 63 (dried for 14 h under high vacuum (p < 10-1 mbar)), 0.14 
ml (0.804 mmol) dry (iPr)2EtN (bp 128°C, distilled from CaH2) in 1.9 ml dry THF was added 0.10 
ml (0.434 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine dropwise at rt under Ar. 
During the addition of the phosphine the yellow solution turned colourless. After stirring for 1 h 
at rt, during which a precipitate was formed, the reaction was filtered under N2 and the filtrate was 
evaporated (t = 29° C). The white foaming residue was dissolved in EtOAc (50 ml) and extracted 
with NaHCO3 sat. (2 x 25 ml), the combined aqueous phases were extracted with EtOAc (30 ml) 
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and the combined organic phases were dried over MgSO4 and evaporated. CC (8 g SiO2, 
EtOAc/CH2Cl2/Et3N 9:9:2, at t = 8° C) and reprecipitation from 1 ml EtOAc with 30 ml hexane 
resulted in 196 mg (0.225 mmol, 78%) 67 as colourless foam of a 1:1-diastereomeric mixture (1H- 
and 31P-NMR). 
 
Rf (SiO2; EtOAc) 0.39, 0.33 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 9.31 (br. s, 1H, NH); 8.76, 8.76 (2s, 1H, HC(2)); 8.32, 8.30 (2s, 1H, 
HC(8)); 8.04 (d, J = 7.0, 2 arom. H); 7.65-7.58, 7.56-7.51, 7.50-7.43, 7.38-7.30, 7.28-7.15, 6.82-
6.74 (6m, 16 arom. H); 5.98 (dd, J = 10.5, 2.4, 1H, HC(1’)); 4.03-3.62 (m, 3H, HC(4’), 
OCH2CH2CN); 3.77, 3.76, 3.76, 3.75 (4s, 6H, MeO); 3.56-3.22 (m, 5H, HC(5’), HC(6’), 
Me2CHN); 2.62 (t, J = 6.1, 1H, OCH2CH2CN); 2.36 (t, J = 6.2, 1H, OCH2CH2CN); 2.50-2.43, 
2.38-2.15, 1.95-1.80 (3m, 4H, HC(2’), HC(3’)); 1.19-1.08 (m, 9H, Me2CHN); 0.95 (d, J = 6.7, 3H, 
Me2CHN). 
 
13C-NMR (75 MHz, CD2Cl2): 169.0 (s, CO); 163.0, 162.9 (2s, arom. C); 152.7 (d, C(2)); 150.6 (s, 
C(4)); 149.7, 149.6, 147.9  (3s, arom. C.); 143.4, 143.3 (2d, C(8)); 139.0, 138.9, 134.3, 134.2 (4s, 
arom. C); 132.2, 130.7, 128.5, 128.4, 128.4, 128.3, 127.0, 126.6, 126.4, 126.0, 125.8, 124.9, 124.8 
(13d, arom. C); 121.6 (s, C(5)); 116.1, 116.0 (2s, CN); 111.2, 111.1 (2d, arom. C); 84.1, 84.0 (2s, 
COC(6’)); 80.0, 79.9 (2d, C(1’)); 79.6 (dd, JP = 5.9, C(5’)); 79.7 (dd, JP = 8.4, C(5’)); 66.2 (dd, JP 
= 13.4, C(4’)); 65.4 (dd, JP = 16.5, C(4’)); 61.8, 61.8 (2t, C(2’)); 56.5 (dt, JP = 19.0, 
OCH2CH2CN); 56.5 (dt, JP = 20.2, OCH2CH2CN); 53.4, 53.3 (2q, MeO); 41.4 (dd, JP = 4.2, 
Me2CHN); 41.2 (dd, JP = 4.2, Me2CHN); 29.1, 29.0, 28.9, 28.8 (4t, C(2’), C(3’)); 22.7, 22.6, 22.5, 
22.5, 22.4, 22.3, 20.9, 19.0 (Me2CHN); 18.6, 18.4 (2dt, JP = 7.2, OCH2CH2CN). 
 
31P-NMR (121 MHz, CD2Cl2): 149.0, 148.4. 
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ESI-MS: 894.6 (100, [M+Na]+). 
 
2-benzoylamino-4-({2’,3’-dideoxy-4’-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-6’-O-
[(4,4’-dimethoxytriphenyl)methyl]-β-D-glucopyranosyl}methyl)-pyrimidine (77) 
 
 
 
To a solution of 243 mg (0.376 mmol) 75 (dried for 14 h under high vacuum (p < 10-1 mbar)) and 
0.25 ml (1.44 mmol) (iPr)2EtN (bp 128° C, distilled over CaH2) in 1.8 ml dry CH2Cl2 was added 
at rt under Ar 0.13 ml (0.564 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
dropwise. After stirring for 1 h at rt, the reaction was evaporated (t = 29°C). The yellow foaming 
residue was dissolved in EtOAc (120 ml) and extracted with ice-cold NaHCO3 sat. (2 x 50 ml) and 
NaClsat. (50 ml). The combined aqueous phases were extracted with EtOAc (40 ml) and the 
combined organic phases were dried over MgSO4 and evaporated. CC (8 g SiO2, EtOAc/1% NEt3) 
and reprecipitation from 1 ml CH2Cl2 with 30 ml hexane resulted in 220 mg (0.260 mmol, 69%) 
77 as a slightly yellow foam of a 1:1-diastereomeric mixture (1H- and 31P-NMR). 
 
Rf (SiO2; EtOAc) 0.39, 0.33 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 8.69-8.63 (m, 1H); 8.58 (br. s, 1H, NH); 8.49 (t, J = 4.8, 1H); 7.95-
7.87 (m, 1H); 7.75-7.68 (m, 3H); 7.61-7.12 (m, 24H, arom. H); 6.86-6.77 (m, 7H); 3.95-3.85 (m, 
1H); 3.78, 3.77, 3.76, 3.75 (4s, 12H, MeO); 3.72-2.83 (m, 16H); 2.66-2.57 (m, 1H); 2.55 (t, J = 
6.3, 1H); 2.36-2.19 (m, 3H); 1.90-1.72, 1.70-1.51 (2m, 4H); 1.22-1.03 (m, 17H); 1.12, 1.07, 0.87 
(3d, J = 6.8, 19H). 
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13C-NMR (75 MHz, CD2Cl2): 170.3, 170.2, 165.0, 164.9, 158.9, 158.8, 158.7 (7s, CO, arom. C); 
158.2 (d, arom. C); 145.8, 145.7 (2s, arom. C); 136.8, 136.7, 136.6, 135.1, 135.0 (5s, arom. C); 
132.4, 132.3, 130.5, 130.46, 130.43, 130.3, 129.0, 128.9, 128.7, 128.5, 128.0, 127.7, 127.6, 126.9, 
126.8 (15d, arom. C); 118.1, 118.0 (2s, CN); 117.20, 117.16 (2d, NCHCHarom.); 113.3, 113.2 (2d, 
arom. C); 85.91, 85.89 (2s, COC(6’)); 81.4 (dd, JP = 6.0, C(5’)); 81.3 (dd, JP = 8.1, C(5’)); 76.5 
(d, C(1’)); 69.9 (dd, JP = 13.5, C(4’)); 68.9 (dd, JP = 15.2, C(4’)); 64.4, 64.2 (t, C(6’)); 58.5 (dt, JP 
= 18.6, OCH2CH2CN); 58.1 (dt, JP = 19.7, OCH2CH2CN); 55.5, 55.4 (2q, MeO); 44.2 (t, 
C(1’)CH2-arom.); 43.4 (dd, JP = 3.3, Me2CHN); 43.3 (dd, JP = 3.4, Me2CHN); 32.4, 32.2, 31.4, 
31.3 (4t, C(2’), C(3’)); 24.7, 24.6, 24.5, 24.4, 24.3 (Me2CHN); 20.7 (dt, JP = 7.1, OCH2CH2CN); 
20.5 (dt, JP = 7.1, OCH2CH2CN). 
 
31P-NMR (121 MHz, CD2Cl2): 148.1, 147.8. 
 
ESI-MS: 868.7 (100, [m+Na]+), 303.2 (5). 
 
HR-ESI-MS: calc. for C48H56N5OPNa ([m+Na]+)  868.3815; found 868.3808. 
 
2-aminobenzoyl-4-methyl-5-{2’,3’-dideoxy-4’-O-[(2-
cyanoethoxy)(diisopropylamino)phosphino]6’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-
glucopyranosyl}-pyrimidine (78) 
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After drying for 14 h under high vacuum (p < 10-1 mbar) 342 mg (0.530 mmol) 76 dissolved under 
Ar at rt in 13 ml dry THF and 0.30 ml (1.72 mmol) (iPr)2EtN (bp 128° C, distilled over CaH2) and 
0.17 ml (0.794 mmol) chloro(2-cyanoethoxy)(diisopropylamino)phosphine was dropwisely added. 
After stirring for 70 min at rt, the reaction was evaporated (t = 29°C). CC (10 g SiO2, 
EtOAc/0.2%NEt3) and reprecipitation from 1 ml CH2Cl2 with 30 ml hexane resulted in 251 mg 
(0.297 mmol, 56%) 78 as slightly yellow foam of a 1:1-diastereomeric mixture (1H- and 31P-
NMR). 
 
Rf (SiO2; EtOAc) 0.62, 0.55 (UV254, Ce(SO4)2). 
 
1H-NMR (300 MHz, CD2Cl2): 9.10 (br. s, NH); 8.61, 8.58 (2s, HC(6)); 7.92-7.89, 7.81-7.78, 7.55-
7.18, 6.83-6.79 (4m); 4.61 (dd, J = 8.1, 1.9);  3.92-3.62 (m); 3.77, 3.763, 3.758, 3.756 (4s, MeO); 
3.59-3.05 (m); 2.58, 2.57 (2s, H3Carom); 2.01-1.98, 1.83-1.73, 1.65-1.56 (3m, H2C(2’), H2C(3’)); 
1.27-0.85 (m). 
  
13C-NMR (75 MHz, CD2Cl2): 166.9, 166.8 (2s); 165.4 (d); 158.8, 157.0, 155.7, 145.7, 145.6, 
136.7, 136.5 (7s); 135.2, 132.5, 130.64, 130.59, 130.55, 130.5, 129.3, 129.2, 129.0, 128.9, 128.8, 
128.5, 128.0, 127.9, 127.5, 127.0, 126.9  (17d, arom. C); 118.3, 118.1 (2s, CN); 113.3, 113.2 (2d); 
86.14, 86.08 (2s, COC(6’));  82.33, 82.28 (2d); 74.7. 74.6 (2d, C(1’)); 69.3 (dd, JP = 13.4, C(4’)); 
68.4 (dd, JP = 16.6, C(4’)); 64.6, 64.4 (2t, C(6’)); 58.6 (dt, JP = 18.9, OCH2CH2CN); 58.2 (dt, JP = 
19.3, OCH2CH2CN); 55.5 (q, MeO); 43.5, 43.3 (2d, Me2CHN); 32.6, 32.4, 31.0 (3t, C(2’), C(3’)); 
24.8, 24.7, 22.1 (3q, Me2CHN); 20.7, 20.5 (2t, OCH2CH2CN). 
 
31P-NMR (121 MHz, CD2Cl2): 148.2, 147.0. 
 
ESI-MS: 884.4 (14, [m+K]), 868.6 (100, [m+Na]+), 846.5 (21, [m+H]). 
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HR-ESI-MS: calc. for C48H56N5OPNa ([m+Na]+)  868.3815; found 868.3812. 
 
Common procedure for the synthesis of the 4-nitrophenylesters 69-72 
 
To a 0.1- 0.5 M solution of the dimetoxytrityl derivative 61-64 in pyridine was added 1.0-1.2 
equiv. 4-(dimethylamino)pyridine and 1.1-1.7 equiv. succinic anhydride. The mixture was stirred 
for 16-20 h at rt, evaporated and the remaining pyridine was coevaporated with toluene. The crude 
product was dissolved in CH2Cl2 and extracted with a 10% aq. citric acid solution. The aqueous 
phase was extracted with CH2Cl2 and the combined organic phases were dried (MgSO4), 
evaporated and dried for several hours at rt under high vacuum (p < 10-1 mbar). After proving the 
formation of the succinic monoesters by ESI-MS, the monoesters were dissolved in 
dioxane/pyridine 10:1 to 20:1 (concentration 0.15-0.2 M) without further purification, 1.0-1.7 
equiv. 4-nitrophenol and 1.9-2.5 equiv. DCC was added and the reaction was stirred for 3-4 h at 
rt. The formed N,N’-dicyclohexylurea was filtered off, washed with dioxane, and the filtrate was 
evaporated. Remaining traces of pyridine were removed by coevaporation with toluene. 
Purification by CC (SiO2) followed by evaporation and drying at rt with high vacuum resulted in 
colourless to slightly yellow foams 69-72. 
 
1-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-4’-O-[4-O-(4-nitrophenyl)succinyl]-β-D-
glucopyranosyl}uracil (69) 
 
 
 
Dissolving 892 mg (1.64 mmol) of 61, 220 mg  (1.80 mmol) DMAP and 229 mg (2.29 mmol) 
succinic anhydride in 5.5 ml pyridine resulted in 1.03 g (1.60 mmol, 98 %) of monoester 
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according to common procedure, from which 300 mg (0.465 mmol) were converted to 69 with 91 
mg (0.651 mmol) 4-nitrophenol and 211 mg (1.023 mmol) DCC in 2.8 ml dioxane/pyridine 15:1. 
CC (30 g SiO2, EtOAc/hexane 7:3) resulted in 280 mg (0.365 mmol, 79%) of 69. 
 
Rf (SiO2; EtOAc) 0.46 (heat (yellow, hydrolysis of p-NO2-phenylester); Ce(SO4)2 (red, cleavage 
of the DMTr-group) followed by heat (brown); UV254). 
 
1H-NMR (300 MHz, d6-DMSO): 8.27 (d, J = 9.1, 2 arom. H); 7.80 (d, J = 8.0, HC(6)); 7.39-7.34, 
7.30-7.17, 6.86-6.81 (3m, 15 arom. H); 5.75-5.71 (m, 2H, HC(1’), HC(5)); 4.96-4.86 (m, HC(4’)); 
3.89-3.84 (m, HC(5’)); 3.72 (s, 2MeO); 3.14-3.09 (m, 1HC(6’)); 2.94 (dd, J = 10.2, 4.1, 1HC(6’)); 
2.78-2.74 (m, 1H of OCCH2CH2CO); 2.67-2.35 (m, 3H of OCCH2CH2CO); 2.35-0.98 (m, H2C(2’), 
H2C(3’)). 
 
ESI-MS: 788.4 (100, [m+Na]+). 
 
N4-benzoyl-1-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-4’-O-[4-O-(4-
nitrophenyl)succinyl]-β-D-glucopyranosyl}cytosine (70) 
 
 
 
200 mg (0.309 mmol) of 62, 41 mg  (0.336 mmol) DMAP and 43 mg (0.430 mmol) succinic 
anhydride in 2.0 ml pyridine resulted, according to common procedures, in 220 mg (0.294 mmol, 
95 %) of monoester, from which 220 mg (0.294 mmol) were converted to 70 with 57 mg (0.410 
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mmol) 4-nitrophenol and 134 mg (0.649 mmol) DCC in 1.6 ml dioxane/pyridine 15:1. CC (15 g 
SiO2, EtOAc/hexane 3:1) resulted in 229 mg (0.264 mmol, 90 %) of 70. 
 
Rf (SiO2; EtOAc) 0.27 (heat (yellow, hydrolysis of p-NO2-phenylester); Ce(SO4)2 (red, cleavage 
of the DMTr-group) followed by heat (brown); UV254). 
 
1H-NMR (300 MHz, CD2Cl2): 8.92 (br. s, NH); 8.23-8.19 (m, 2 arom. H); 7.98-7.88 (m, 3H, 2 
arom. H, HC(6)); 7.59 (tt, J =7.3, 1.4, 1 arom. H); 7.52-7.47, 7.42-7.39, 7.29-7.18, 6.81-6.76 (3m, 
HC(5), 17 arom. H); 5.79 (dd, J = 10.0, 1.9, HC(1’)); 5.05-4.95 (m, HC(4’)); 3.82-3.77 (m, 
HC(5’)); 3.73, 3.72 (2s, 2MeO); 3.29 (dd, J = 10.5, 1.8, 1H of H2C(6’)); 3.13 (dd, J = 10.6, 4.3, 
1H of H2C(6’)); 2.75-2.70 (m, 2H of OCCH2CH2CO); 2.61-2.40 (m, 2H of OCCH2CH2CO); 2.32-
2.29 (m, 2H of H2C(2’), H2C(3’)); 1.85-1.61 (m, 2H of H2C(2’), H2C(3’)). 
 
ESI-MS: 891.5 (100, [m+Na]+). 
 
HR-ESI-MS: calc. for C48H44N4O12Na ([m+Na]+)  891.2853; found 891.2859. 
 
9-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-4’-O-[4-O-(4-nitrophenyl)succinyl]-
β-D-glucopyranosyl}-N2-isobutyrylguanine (72) 
 
O
O
ODMTr
NHN
N
N
O
HN
O
O
O
O
O2N
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25 mg (38.2 µmol) of 64, 5.2 mg  (42.6 µmol) DMAP and 5.4 mg (54.0 µmol) succinic anhydride 
in 0.6 ml pyridine resulted, according to common procedures, in 25 mg (33.2 µmol, 87 %) of 
monoester, from which 25 mg (33.2 µmol) were converted to 72 with 5.2 mg (37.4 µmol) 4-
nitrophenol and 12 mg (58.2 µmol) DCC in 0.4 ml dioxane/pyridine 15:1. CC (4 g SiO2, 
EtOAc/MeOH 40:1) resulted in 21 mg ( 24.0 µmol, 72 %) of 72. 
 
Rf (SiO2; EtOAc/MeOH 40:1) 0.33 (heat (yellow, hydrolysis of p-NO2-phenylester); Ce(SO4)2 
(red, cleavage of the DMTr-group) followed by heat (brown); UV254). 
 
ESI-MS: 897.6 (100, [m+Na]+). 
 
N6-Benzoyl-9-{2’,3’-dideoxy-6’-O-[(4,4’-dimethoxytriphenyl)methyl]-4’-O-[4-O-(4-
nitrophenyl)succinyl]-β-D-glucopyranosyl}adenine (71) 
 
O
O
ODMTr
NN
N
N
NHBz
O
O
O
NO2
 
 
40 mg (59.5 µmol) of 63, 8.3 mg  (67.9 µmol) DMAP and 5.4 mg (85.9 µmol) succinic anhydride 
in 1.0 ml pyridine resulted, according to common procedures, in 42 mg (54.5 µmol, 92 %) of 
monoester, from which 42 mg (54.5 µmol) were converted to 71 with 11 mg (79.1 µmol) 4-
nitrophenol and 28 mg (0.136 mmol) DCC in 0.6 ml dioxane/pyridine 15:1. CC (4 g SiO2, 
EtOAc/MeOH 20:1, 1% NEt3) resulted in 40 mg (44.8 µmol, 82 %) 71. 
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Rf (SiO2; EtOAc/hexane 3:1) 0.25 (heat (yellow, hydrolysis of p-NO2-phenylester); Ce(SO4)2 (red, 
cleavage of the DMTr-group) followed by heat (brown); UV254). 
 
ESI-MS: 915.4 (100, [m+Na]+). 
 
Common procedure for preparation of nucleoside-bonded “controlled pore glass” (CPG) 
 
To a suspension of long-chain alkylamine CPG (SynGen, pore diameter 500 Å, mesh size 175-125 
µm, substitution 60-80 µmol/g or 3-prime, pore diameter 500 Å, mesh size 75-125 µm, 
substitution 85-160 µmol/g) in DMF/Et3N 10:1 was added a solution of the nitrophenylesters 69-
72 in dioxane and the suspension was allowed to stand under swirling for 20-30 h. Immediately 
after the addition of the activated esters, the suspension turned yellow, due to the formation of 4-
nitrophenol.  Filtration over a G3 glass filter funnel (max. pore size 16-40 µm); followed by 
washing with DMF, MeOH and Et2O (3 x 10 ml)  and drying of the resin under high vacuum (p < 
10-1 mbar) at rt; the loading was determined according to the following procedure: an exactly 
defined amount of derivatized LCAA-CPG-resin (0.500-2.000 mg) was suspended in a defined 
volume of 0.1 M TsOH in MeCN or 2% dichloroacetic acid in CH2Cl2 (10.0 ml). From the 
supernatant solution, the absorption at 498 nm was determined. From the concentration of the 
(4,4’-dimethoytriphenyl)methyl-cation (ε498 = 70000) the loading of the CPG-resin [µmol/g] was 
calculated. If the loading was > 10 µmol/g, the remaining free amino groups were capped with 
Ac2O, 4-(dimethylamino)pyridine in pyridine for 20 min. This process was repeated until a 
ninhydrin test (A few beads of derivatised LCAA-CPG one drop of a solution of 2 ml 0.1 M 
KCNaq in 100 ml pyridine, one drop of a solution of 80 g phenol in 20 ml EtOH and one drop of a 
solution of 500 mg ninhydrine in 10 ml EtOH were heated for 5 min at 110° C (positive: violet, 
negative: red-brown))81 showed no remaining free amino groups on the LCAA-CPG. 
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homo-DNA-U-LCAA-CPG 
 
 
 
Treating 200 mg LCAA-CPG (3-prime) in 0.44 ml DMF/NEt3 10:1 with 12 mg (15.7 µmol) p-
nitroester 69 in 0.15 ml dioxane, according to common procedures, followed by capping with 0.12 
ml (130 mg, 1.27 mmol) Ac2O and 7 mg (57.3 µmol) DMAP in 0.6 ml pyridine resulted in a 
derivatized homo-DNA-U-LCAA-CPG with a loading of 44.5 µmol/g. 
 
Treating 198 mg LCAA-CPG (SynGen) in 0.66 ml DMF/NEt3 10:1 with 12 mg (15.7 µmol) p-
nitroester 69 in 0.15 ml dioxane, according to common procedures, followed by capping with 0.12 
ml (130 mg, 1.27 mmol) Ac2O and 7 mg (57.3 µmol) DMAP in 0.6 ml pyridine resulted in a 
derivatized homo-DNA-U-LCAA-CPG with a loading of 35.0 µmol/g. 
 
homo-DNA-C(NBz)-LCAA-CPG 
 
 
 
Treating 360 mg LCAA-CPG (SynGen) in 0.99 ml DMF/NEt3 10:1 with 25 mg (28.8 µmol) p-
nitroester 70 in 0.32 ml dioxane, according to common procedures, followed by capping with 0.22 
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ml (239 mg, 2.34 mmol) Ac2O and 13 mg (0.106 mmol) DMAP in 1.1 ml pyridine resulted in a 
derivatized homo-DNA-C(NBz)-LCAA-CPG with a loading of 41.8 µmol/g. 
 
homo-DNA-G(NIbz)-LCAA-CPG 
 
 
 
Treating 240 mg LCAA-CPG (SynGen) in 0.66 ml DMF/NEt3 10:1 with 17 mg (19.4 µmol) p-
nitroester 72 in 0.32 ml dioxane, according to common procedures, followed by capping with 0.22 
ml (239 mg, 2.34 mmol) Ac2O and 13 mg (0.106 mmol) DMAP in 1.1 ml pyridine resulted in a 
derivatized homo-DNA-G(NIbz)-LCAA-CPG with a loading of 13.9 µmol/g. 
 
homo-DNA-A(NBz)-LCAA-CPG 
 
 
 
Treating 240 mg LCAA-CPG (SynGen) in 0.66 ml DMF/NEt3 10:1 with 16 mg (17.9 µmol) p-
nitroester 71 in 0.32 ml dioxane, according to common procedures, followed by capping with 0.15 
ml (163 mg, 1.60 mmol) Ac2O and 9 mg (73.7 µmol) DMAP in 0.7 ml pyridine resulted in a 
derivatized A(NBz)-LCAA-CPG with a loading of 44.2 µmol/g. 
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Common procedure for the manual synthesis of oligonucleotides with cyanoethyl-
phosphoramidites (methode I) 
 
1.) Detritylation: Nucleoside-loaded CPG-solid support was suspended in a G3 glass filter 
funnel with 3 ml of 2% dichloroacetic acid in CH2Cl2, shaken and the 2% dichloroacetic 
acid was filtered off by applying a slight over pressure with N2. The same procedure was 
repeated twice over 2 min. The filtrates were collected and the concentration of (MeO)2Tr-
cation was determined. The solid support was immediately washed with CH2Cl2 (3 x 5 ml) 
and Et2O (3 x 5 ml) and dried by flowing N2 through the sample. 
2.) Coupling: The solid support was dried together with 8 eq of solid phosphoramidite and 30 
eq of solid 5-(ethylthio)-1H-tetrazole at rt over 45 min, flushed with Ar and suspended 
with dry CH3CN (0.2 ml per 20 mg phosphoramidite). After 1 h reaction time, under 
careful rotation, the solution was filtered off and the solid support was washed with dry 
CH3CN (3 x 5 ml), dry THF (3 x 5 ml) and dried by flowing N2 through the sample for 5 
min. 
3.) Capping: The solid support was suspended under Ar with 2 ml of a freshly prepared 
solution of 0.5 ml capping solution I (6.50 g DMAP / 100 ml dry THF) and 1.5 ml of 
capping solution II (10 ml Ac2O / 15 ml 2,6-dimethylpyridine). After 5 min reaction time, 
the solution was filtered off and the solid support was washed with dry THF (3 x 5 ml), 
MeOH (3 x 2 ml), THF/H2O/2,6-dimethylpyridine 2:2:1 (1 x 2 ml). 
4.) Oxidation: 3 ml of a 0.1 M I2 solution in THF/H2O/2,6-dimethylpyridine 2:2:1 was added 
to the solid support. After 1 min reaction time, the solution was filtered off and the resin 
washed with THF/H2O/2,6-dimethylpyridine 2:2:1 (3 x 2 ml), MeOH (3 x 5 ml), and dry 
Et2O (3 x 3 ml) and dried under a permanent flow of N2 for 5 min. 
5.) Deprotection of the phosphotriester-groups and cleavage from the solid support: The 
solid support was suspended in 8 ml conc. NH3 aq for 20 h at 55° C. The solution was 
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filtered off and the resin was washed with conc. NH3 aq (3 x 3 ml) and H2O (3 x 1 ml). The 
solution was evaporated to dryness, 5 ml H2O was added and the suspension was 
sonicated for 2 min, filtered over a Micropore (0.45 µm) membrane-filter and lyophilised. 
In this form the crude oligonucleotide was purified by HPLC.  
 
ddGlc[UU] 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 15 min 80% 0.1 M (HNEt3)OAc pH 7.0/ 20% CH3CN, during 5 min 80% 0.1 M 
(HNEt3)OAc pH 7.0/ 20% CH3CN, 2.5 min 0.1 M (HNEt3)OAc pH 7.0): 13.7 min. 
 
ESI-MS (positiv): 569.1 (70, [M+H+Na]+), 547.1 (100, [M+2H]+). 
 
ESI-MS (negative): 545.1 (100, [M-]).  
 
HR-ESI-MS (negative): calc. for C20H26N4O12P1 ([M-]) 545.1285, found 545.1291. 
 
UV (0.1 M (HNEt3)OAc pH 7.0): 259. 
 
Automated solid-phase synthesis on a “DNA synthesizer” (Expedite NAS 8905, Applied 
Biosystems: methode II) 
 
With exception of the phosphoramidite-solutions (0.1 M or 0.05 M) and the activating solution (5-
(ethylthio)-1H-tetrazole instead of 1H-tetrazole) the original reagents from Applied Biosystems 
were used: 
 
1. Detritylation: 3% trichlororacetic acid in CH2Cl2. 
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2. Coupling: 0.5 M 5-(ethylthio)-1H-tetrazole in CH3CN (Fluka, dry, over molecular sieve 
(H2O < 10 ppm)), 0.1 M (0.05 M) phosphoramidite solution in CH3CN (Fluka, dry, over 
molecular sieve (H2O < 10 ppm)). 
3. Capping: 7% 1-methylimidazole in THF/2,6-dimethylpyridine/Ac2O 15:1:1. 
4. Oxidation: 0.1 M I2 solution in THF/pyridine/H2O. 
5. Wash: CH3CN (Fluka, dry, over molecular sieve (H2O < 0.01%)). 
 
For the oligonucleotide synthesis, standard parameters were used with exception of the coupling 
time, which was in increased for some couplings from 90 s to 3 min, 30 s. In later oligonucleotide 
synthesis (with 0.05 M phosphoramidite solutions in CH3CN) typically preparations were 
performed on 0.4 µmol scale according to the 1 µmol protocol (25 eq. phosphoramidites). For all 
oligonucleotide synthesis on 0.4 µmol scale (with 0.05 M 2-(cyanoethyl)phosphoramidite 
solutions) 3 Å molecular sieve (dried for 14 h at 95° C under high vacuum (p < 10-1 mbar)) was 
added to all phosphoramidites, to the activator (5-ethylthio-1H-tetrazole) and to the wash 
acetonitril. The phosphoramidite solutions were prepared with acetonitril from Fluka (dry, over 
molecular sieve, H2O < 10 ppm). For the wash-acetonitrile, dry acetoniril from Fluka (over 
molecular sieve, H2O < 0.01%) was used. Oligonucleotides were synthesised without exception in 
the “auto-trityl-off-mode” (automatic cleavage of the of the last (MeO)2Tr-group). After 
synthesis, the solid support was suspended in conc. NH3 aq at 55° C for 16-20 h. The solutions 
were decanted and the resin was washed with conc. NH3 aq (3 x 0.3 ml) and H2O (2 x 0.2 ml). 
From the combined solutions the volatile NH3 was removed in a sonicated water bath (50° C, 30 
min). The solutions were lyophilised, dissolved in H2O and filtered over a Micropore (0.20 µm) 
membrane filter (Whatman Schleicher & Schuell, membrane: cellulose acetate). In this form the 
crude oligomer was used for analysis and purification by HPLC, respectively, if the HPLC 
showed only a single peak, by quantitative ethanol precipitation: The crude oligonucleotide was 
dissolved in 300 µl water. 30 µl 3 M Na-acetate-buffer (pH 4.8) was added, followed by 990 µl 
EtOH and the solution was freezed for at least 12 h at -20° C and spinned for 30 min at 6000 rpm. 
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The supernatant was decanted and the pellet carefully washed by adding 1 ml ice-cold 70% EtOH 
in H2O. The supernatant was decanted and the pellet dried under vacuum. 
If the analytical HPLC showed more than one peak the crude oligonucleotide was purified by 
preparative RP-C18- (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm) or DEAE-IE-HPLC 
(Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm), followed by removal of the buffer salts by Sep-
Pak®-C18-Cartridges (Waters). 
 
ddGlc[U3] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
coupling time: 3 min 30 s 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 25 min 70% 0.1 M (HNEt3)OAc pH 7.0 / 30% CH3CN): 15.2 min. 
 
UV (0.1M (HNEt3)OAc pH 7.0): 260. 
 
ddGlc[U4] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
coupling time: 1 min 30 s 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 25 min 70% 0.1 M (HNEt3)OAc pH 7.0 / 30% CH3CN): 15.3 min. 
 
UV (0.1 M (HNEt3)OAc pH 7.0): 260. 
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ddGlc[U6] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
coupling time: 3 min 30 s  
 
tR (C18-Waters Spherisorb ODS2 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 10 min 50% 0.1 M (HNEt3)OAc pH 7.0 / 50% CH3CN): 8.4 min. 
 
UV (0.1 M (HNEt3)OAc pH 7.0): 260. 
 
ddGlc[4’(U-A)36’] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
coupling time: 3 min 30 s 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 25 min 70% 0.1 M (HNEt3)OAc pH 7.0 / 30% CH3CN): 18.0 min. 
 
ESI-MS (negative) : 936.6 (27, [M+H+2Na]2-), 933.6 (34, [M+2H+K]2-), 925.6 (56, [M+2H+Na]2-
), 914.7 (100, [M+3H]2-). 
 
UV (0.1 M (HNEt3)OAc pH 7.0): 259. 
 
ddGlc[4’(U-A)46’] 
scale: 0.2 µmol 
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synthesis protocol: 0.2 µmol 
coupling time: 3 min 30 s 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 25 min 70% 0.1 M (HNEt3)OAc pH 7.0 / 30% CH3CN): 18.5 min. 
 
ESI-MS (negative) : 1252.6 (100, [M+3H+Na]2-), 1241.1 (98, [M+4H+Na]2-), 1230.5 (42, 
[M+5H]2-). 
 
UV (0.1 M (HNEt3)OAc pH 7.0): 258. 
 
ddGlc[C7] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
coupling time: 1 min 30 s 
 
tR (C18-Waters Spherisorb ODS2, 5 µm, 250 x 4.6 mm; gradient 2 min 100% 0.1 M (HNEt3)OAc 
pH 7.0, until 25 min 70% 0.1 M (HNEt3)OAc pH 7.0 / 30% CH3CN): 16.4 min. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[C7 + 5H]-) 2058.7, found 2058.4. 
 
UV (H2O): 270. 
 
ddGlc[G7] 
scale: 0.2 µmol 
synthesis protocol: 0.2 µmol 
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coupling time: 3 min 30 s 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[G7 + 5H]-) 2338.5, found 2337.8. 
 
UV (H2O): 252. 
 
ddGlc[4’UAUD(UA)26’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M phosphoramidite solution) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
15.5 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[UAUD(UA)2 + 6H]-) 2435.5, found 2435.5. 
 
ddGlc[4’UD(UA)36’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M phosphoramidite) 
coupling time: 1 min 30 s 
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tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
14.6 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[UD(UA)3 + 6H]-) 2435.5, found 2435.3. 
 
ddGlc[4’(UA)2UD(UA)26’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidite) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
17.6 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[(UA)2UD(UA)2 + 8H]-) 3066.6, found 3066.5 
 
 
ddGlc[4’UD86’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidite) 
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coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
20.8 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 291. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[UD8 + 7H]-) 2649.7, found 2649.7. 
 
ddGlc[4’A2DA56’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
23.1 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[A2DA5 + 6H]-) 2527.6, found 2527.5. 
 
ddGlc[A8] 
scale: 0.4 µmol 
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synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
26.4 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 257. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[A8 + 6H]-) 2553.6, found 2553.5. 
 
ddGlc[4’(UA)56’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
20.2 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[(UA)5 + 8H]-) 3092.6, found 3092.6. 
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ddGlc[4’(UA)3UD(UA)36’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 
24.4 min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 258. 
 
MALDI-TOF-MS (Matrix ATT): calc. ddGlc[4’(UA)3UD(UA)36’ + 12H]-) 4328.9, found 4329.2. 
 
ddGlc[U8] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
tR (Nucleogen-DEAE 60-7, 7 µm, 125 x 4 mm, gradient 2 min 85% 20 mM KH2PO4 H2O/CH3CN 
4:1, pH 6.0, 15% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0 until 30 min 25% 20 mM 
KH2PO4 H2O/CH3CN 4:1, pH 6.0, 75% 1.0 M KCl, 20 mM KH2PO4 H2O/CH3CN 4:1, pH 6.0): 9.7 
min. 
 
UV (20 mM KH2PO4 in H2O/CH3CN 4:1, pH 6.0): 259. 
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MALDI-TOF-MS (Matrix ATT): calc. ddGlc[U8 + 6H]-) 2369.4, found 2369.2. 
 
ddGlc[4’CAUA-X-GUGA6’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
ddGlc[4’UCAC-X-UAUG6’] 
scale: 0.4 µmol 
synthesis protocol: 1.0 µmol (0.05 M 2-(cyanoethyl)phosphoramidites) 
coupling time: 1 min 30 s 
 
Determination of oligonucleotide concentration in solution: Oligo-homo-deoxyribonucleotide 
concentrations were determined in buffered, neutral solutions (pH 7.0) with UV-spectroscopy at 
260 nm in the linear and nearly temperature independent region. For self-complementary 
sequences, the determination was done at a temperature higher than the melting point. The 
extinction coefficient was calculated as sum of all the extinction coefficients of all 
mononucleosides (at λ = 260 nm), for which the following, experimentally determined ε-values 
were used: ddGlc(U) 10200, ddGlc(T) 9500, ddGlc(C) 7800, ddGlc(G) 11100, ddGlc(A) 14700, 
ddGlc(D) 670. 
 
5.2 Determination of UV- and CD-melting curves 
 
UV- (resp. CD-)-melting curves were measured on a Jasco J-715 spectrapolarimeter equipped 
with a Julabo HS 18 temperature control unit. Solutions (0.15 M NaCl 0.01 TrisHCl buffer, pH 
7.0) were heated and cooled in a linear way by 0.5-1° C/min and every 0.5° C (30-60 s) 
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CD/temperature resp. absorption/temperature (at 260 nm, otherwise noted) pairs were determined. 
The samples were degassed in a sonicator for 2 min before the measurement. Melting curves are 
reported in relative hyper- (resp. hypo-)chromism (in %) vs. temperature (in °C) or in fraction 
folded (θ) vs. temperature. The percentage of hyperchromism was determined according to the 
formula: H = ((A(t)-A°)/A°) x 100, with A(t) being the absorption at the temperature t and A° the 
lowest measured absorption (for a definition of hyper- (resp. hypo-)chromism see84). The fraction 
folded (θ) was determined according to a procedure described by J.-L. Mergny and L.Lacroix85: θT 
= (L0T – AT)/(L0T – L1T), with L0T and L1T being the baseline values of the unfolded and folded 
species and AT being the absorbance at a given temperature. Tm values and thermodynamic data of 
duplex, single strand transitions were determined according to described methods.83 Van’t Hoff 
pairing enthalpies (∆H) and entropies (∆S) were determined by the linear correlation of the 
reciprocally Tm-values to the logarithm of the oligonucleotide concentration according to the 
formulas 1/Tm = (R/∆H) ln c + ∆S/∆H (bimolecular association of two self-complementary 
sequences) and 1/Tm = (R/∆H) ln c + (∆S – R ln 4)/∆H (biomolecular association of two non self-
complementary sequences) with c being the total oligonucleotide concentration and R being the 
gas constant. An indication of the errors of the data was derived from the R-factors of the linear 
regression (1/Tm vs. ln c). 
 
5.3 Crystallographic data 
Crystallised from D2O  
Empirical formula C11H17N3O3  
Formula weight [g mol-1] 239.27  
Crystal colour, habit colourless, needle  
Crystal dimensions [mm] 0.05 × 0.10 × 0.30  
Temperature [K] 160(1)  
Crystal system monoclinic  
Space group P21  (#4)  
Z 4  
Chapter 5: Experimental part 
___________________________________________________________________________ 
 
___________________________________________________________________________   
 
 204  
Reflections for cell determination 2852  
2θ range for cell determination [°] 4 – 55  
Unit cell parameters a [Å] 10.4815(2)  
 b [Å] 7.4459(1)  
 c [Å] 15.5890(3)  
 α [°] 90  
 β [°] 108.579(1)  
 γ  [°] 90  
 V [Å3] 1153.23(4)  
F(000) 512  
Dx [g cm-3] 1.378  
µ(Mo Kα) [mm-1] 0.102  
Scan type φ and ω  
2θ(max) [°] 55  
Total reflections measured 26783  
Symmetry independent reflections 2859  
Rint 0.090  
Reflections with I > 2σ(I) 2342  
Reflections used in refinement 2859  
Parameters refined; restraints 334; 1  
Final R(F) [I > 2σ(I) reflections] 0.0486  
 wR(F2) (all data) 0.1295  
Weights: w = [σ2(Fo2) + (0.0799P)2 + 0.1709P]-1 where P = (Fo2 + 2Fc2)/3
  
Goodness of fit 1.042  
Secondary extinction coefficient 0.015(3)  
Final ∆max/σ 0.001  
∆ρ (max; min) [e Å-3] 0.30; -0.35  
σ(d(C – C)) [Å] 0.004  
 
Table 6  Crystallographic Data 
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